Breast cancer: imaging and radiotherapy with synchrotron radiation by Di Lillo, Francesca
     
 
Università degli Studi di Napoli Federico II
 
Scuola Politecnica e delle Scienze di Base 
Collegio di Scienze 
Dipartimento di Fisica “Ettore Pancini” 
 
DOTTORATO DI RICERCA IN FISICA  
Ciclo XXX 
Coordinatore: Prof. Salvatore Capozziello 
Settore Scientifico Disciplinare FIS/07 
 
Breast cancer: imaging and radiotherapy 
with synchrotron radiation 
 
 
 
 Tutori  Candidata 
     
Prof. Paolo Russo Dott.ssa Francesca Di Lillo 
Prof. Giovanni Mettivier 
 
 
Anni Accademici 2014/2017 
     
 
Università degli Studi di Napoli Federico II
 
Scuola Politecnica e delle Scienze di Base 
Collegio di Scienze 
Dipartimento di Fisica “Ettore Pancini” 
 
PhD IN PHYSICS  
Cycle XXX 
Chair of PhD School: Prof. Salvatore Capozziello 
Settore Scientifico Disciplinare FIS/07 
 
Breast cancer: imaging and radiotherapy 
with synchrotron radiation 
 
 
 
 Supervisors  Candidate 
     
Prof. Paolo Russo Dott.ssa Francesca Di Lillo 
Prof. Giovanni Mettivier 
 
 
Academic Years 2014/2017
i 
 
 
 
 
 
 
       Alla mia famiglia 
 
  
ii 
 
 
 
 
 
“A scientist in his laboratory is not a mere technician:       
he is also a child confronting natural phenomena that 
impress him as though they were fairy tales” 
M. Curie        
iii 
 
Preface 
This dissertion is submitted for the degree of Philosophiae Doctor (Ph.D.) in Physics 
at Università di Napoli Federico II, Italy. I present the research on the use of the 
synchrotron radiation for imaging and radiotherapy of breast cancer.  
The studies described in this thesis were conducted under the supervision of Prof. 
Paolo Russo and co-supervision of Prof. Giovanni Mettivier who approved this 
thesis. 
My work was carried out at the following institutions/facilities: 
        
                      
 
iv 
 
Contents 
Preface.................................................................................................................................... i 
List of Publications (from November 2014 to October 2017) .............................................. v 
List of Conference Presentations ........................................................................................ vii 
List of Figures .................................................................................................................... viii 
List of Tables ...................................................................................................................... xv 
Abstract .............................................................................................................................. xvi 
Introduction ........................................................................................................................... 1 
1 PART I    Breast Computed Tomography with synchrotron radiation ............................ 4 
1.1 Introduction ........................................................................................................... 5 
1.1.1 Background ................................................................................................... 6 
1.1.2 SYRMA-CT and SYRMA-3D Projects ........................................................ 9 
1.2 Dosimetry in breast computed tomography with synchrotron radiation ............. 13 
1.2.1 Dosimeters Characterization ....................................................................... 13 
1.2.2 Breast and Phantom dosimetry.................................................................... 32 
1.3 Imaging Performance on phantom and breast samples ....................................... 42 
1.3.1 Evaluation of MTF and NPS of system ...................................................... 43 
1.3.2 Imaging of breast specimens ....................................................................... 48 
1.4 Discussion ........................................................................................................... 55 
1.4.1 Dosimetry in SR-BCT ................................................................................. 55 
1.4.2 Imaging performance of SR-BCT ............................................................... 57 
2 PART II   Breast Rotational Radiotherapy  with Synchrotron Radiation ...................... 61 
2.1 Conventional radiotherapy .................................................................................. 63 
2.2 Kilovoltage external beam radiotherapy with an orthovoltage X-ray tube ......... 66 
2.2.1 Experimental Validation of kV-EBRT ........................................................ 67 
2.3 SR3T: Synchrotron Radiation Rotational Radiotherapy for breast cancer .......... 70 
2.4 Monte Carlo simulations for SR3T ...................................................................... 73 
2.4.1 Skin sparing effect ...................................................................................... 74 
2.5 Measurements at Australian Synchrotron ........................................................... 76 
2.5.1 First feasibility study at 60 keV .................................................................. 76 
2.5.2 Study of SR3T at high energy ...................................................................... 89 
2.6 Measurements at the European Synchrotron Radiation Facility ....................... 101 
2.6.1 Profile of the X-ray beams ........................................................................ 102 
2.6.2 Radial Profile in a cylindrical phantom .................................................... 104 
2.6.3 Assessment of the periphery-to-centre dose ratio with TLD .................... 107 
2.6.4 Dose Painting ............................................................................................ 108 
2.7 Ongoing work: Preliminary results of the use of dose-enhancement agent ...... 110 
2.8 Discussion ......................................................................................................... 116 
Conclusions ....................................................................................................................... 120 
Final remarks .................................................................................................................... 122 
Acknowledgments ............................................................................................................. 124 
References ......................................................................................................................... 126 
 
v 
 
List of Publications (from November 2014 to October 
2017) 
1. Di Lillo F, Dreossi D, Emiro F, Fedon C, Longo R, Mettivier G, Rigon L, Russo P, & 
Tromba G (2015) Use of XR-QA2 radiochromic films for quantitative imaging of 
synchrotron radiation beam. J Instrum 10, C05002. 
2. Emiro F, Di Lillo F, Mettivier G, Fedon C, Longo R, Tromba G, Russo P (2015). 
Energy response of GR-200A thermoluminescence dosemeters to 60Co and to 
monoenergetic synchrotron radiation in the energy range 28–40 keV. Rad Protec Dosim 
168, 40–45. 
3. Mettivier G, Fedon C, Di Lillo F, Longo R, Sarno A, Tromba G and Russo P. (2016) 
Glandular dose in synchrotron radiation breast computed tomography Phys. Med. Biol. 
61 569–587. (Featured article) 
4. Russo P, Larobina M, Di Lillo F, Del Vecchio S, Mettivier G (2016) Combined 
SPECT/CT and PET/CT for breast imaging. Nucl. Instrum. Methods Phys. Res. A 809, 
58–66.  
5. Longo R, Arfelli F, Bellazzini R, Bottigli U, Brez A, Brun F, Brunetti A, Delogu P, Di 
Lillo F, Dreossi D, Fanti V, Fedon C, Golosio B, Lanconelli N, Mettivier G, Minuti 
M, Oliva P, Pinchera M, Rigon L, Russo P, Sarno A, Spandre G, Tromba 
G and Zanconati F. (2016) Towards breast tomography with synchrotron radiation at 
Elettra: first images Phys. Med. Biol. 61 1634–1649. 
6. Sarno A, Mettivier G, Golosio B, Oliva P, Spandre G, Di Lillo F, Fedon C, Longo R 
and  Russo P. (2016) Imaging performance of phase-contrast breast computed 
tomography with synchrotron radiation and a CdTe photon-counting detector Phys. 
Medica 32 681–690. 
7. Di Lillo F, Mettivier G, Sarno A, Tromba G, Tomic N, Devic S and Russo P. (2016) 
Energy dependent calibration of XR-QA2 radiochromic film with monochromatic and 
polychromatic x-ray beams Med. Phys. 43 583–588. 
8. Sarno A, Mettivier G, Di Lillo F and Russo P. Monte Carlo evaluation of normalized 
glandular dose coefficients in mammography In: Breast Imaging. Proc. of 13th 
International Workshop, IWDM 2016, Malmö, Sweden, June 19-22, 2016, Lecture 
Notes in Computer Science, Springer International Publishing, vol 9699, 190–196 DOI 
10.1007/978-3-319-41546-8_25. 
vi 
 
9. Giovanni M, Bliznakova K, Di Lillo F, Sarno A and Russo P. Evaluation of the 
BreastSimulator Software Platform for Breast Tomography: Preliminary Results. Proc. 
of 13th International Workshop, IWDM 2016, Malmö, Sweden, June 19-22, 2016, 
Lecture Notes in Computer Science, Springer International Publishing, vol 9699, 145–
151. 
10. Sarno A, Mettivier G, Di Lillo F, Cesarelli M, Bifulco P and Russo P. (2016) Cone-
beam micro computed tomography dedicated to the breast Med. Eng. Phys. 38 1449–
1457. 
11. Sarno A, Mettivier G, Di Lillo F and Russo P. (2016) A Monte Carlo study of 
monoenergetic and polyenergetic normalized glandular dose (DgN) coefficients in 
mammography Phys. Med. Biol. 62 306–325 . 
12. Delogu P, Golosio B, Fedon C, Arfelli F, Bellazzini R, Brez A, Brun F, Di Lillo 
F, Dreossi D, Mettivier G, Minuti M, Oliva P, Pichera M, Rigon L, Russo P, Sarno 
A, Spandre G, Tromba G and Longo R. (2017) Imaging study of a phase-sensitive 
breast-CT system in continuous acquisition mode J. Instrum 12 C01016. 
13. Sarno A, Dance D R, van Engen R E, Young K C, Russo P, Di Lillo F, Mettivier G, 
Bliznakova K, Fei B W and Sechopoulos I. (2017) A Monte Carlo model for mean 
glandular dose evaluation in spot compression mammography. Med. Phys. 44 (7), 
3848–3860.  
14. Sarno A, Golosio B, Russo P, Arfelli F, Bellazzini R, Brez A, Brun F, Delogu P, Di 
Lillo F, Dreossi D, Fedon C, Longo R, Mettivier G, Oliva P, Rigon L, Spandre G and 
Tromba G. (2017) A framework for iterative reconstruction in phase-contrast computed 
tomography dedicated to the breast. Trans. Rad. Pl. Med. Sc,  DOI 
10.1109/TRPMS.2017.2749059.  
15. Sarno A, Masi M, Antonelli N, Di Lillo F, Mettivier G, Castriconi R and Russo P. 
(2017) Dose Volume Distribution in Digital Breast Tomosynthesis: a Phantom Study. 
Trans. Rad. Pl. Med. Sc. 1(4), 322–328. 
16. Mettivier, G., Bliznakova, K., Sechopoulos, I., Boone, J., Di Lillo, F., Sarno, A., 
Castriconi R. & Russo, P. (2017). Evaluation of the BreastSimulator software platform 
for breast tomography. Phys Med Biol 62(16), 6446–6466. 
17. Stevenson, A.W., and Di Lillo, F. (2017). Estimating the absolute flux distribution for 
a synchrotron X-ray beam using ionization-chamber measurements with various 
filters. J Synchrotron Rad 24(5), 939–953. 
18. Di Lillo, F., Mettivier, G., Sarno, A., Castriconi, R., and Russo, P. (2017). Towards 
vii 
 
breast cancer rotational radiotherapy with synchrotron radiation. Phys Med, 41, 20-25. 
 
Ongoing Papers: 
1. Di Lillo, F., Mettivier, G., Castriconi, R., Sarno, A., Stevenson, A.W., Hall, C.J., 
Häusermann, D., and Russo, P. (2017) Synchrotron radiation external beam rotational 
radiotherapy of breast cancer: proof of principle. J Synchrotron Rad, under review. 
List of Conference Presentations 
1. Di Lillo, F., Stevenson, A.W., Mettivier, G., Sarno, A., Castriconi, R., Hall, C.J., 
Häusermann, D., Russo, P. “Monte Carolo simulation and simple model of dose 
distribution in synchrotron radiation rotational radiotherapy of breast cancer : An 
experimental phantom study”, Poster Presentation at International Conference on 
Monte Carlo techniques for Medical applications, Napoli, Italy,  October 16th-18th, 
2017. 
2. Di Lillo, F., Mettivier, G., Castriconi, R., Sarno, A., Hall, C.J., Häusermann, D., 
Stevenson, A.W., Russo, P. “Breast cancer rotational radiotherapy with synchrotron 
radiation”. Oral presentation at Australian Synchrotron User Meeting 2016, Melbourne, 
Australia, November 24th-25th, 2016. 
3. Di Lillo, F., Mettivier, G., Sarno, A., Russo, P. “Towards breast cancer rotational 
radiotherapy with synchrotron radiation”. Oral presentation at 1st European Congress 
of Medical Physics, Athens, Greece, September 1st-4th, 2016. This presentation was 
selected to contribute a paper to the Focus Issue of the journal Physica Medica: 
European J. Med. Phys. with the topic “ECMP 2016”. 
4. Di Lillo, F., Corvino, V., Sarno, A., Mettivier, G., Russo, P. “Performance of 
MediPROBE compact gamma camera”. Poster presentation at 9° Italian National 
Congress AIFM (Italian Association of Medical Physics), Perugia, Italy, February 25th-
28th, 2016. 
 
  
viii 
 
List of Figures 
Figure 1.1: Photo of the SYRMA-CT setup for phase-contrast breast CT at the 
ELETTRA synchrotron radiation laboratory (Trieste, Italy). The horizontal 
beam irradiates the breast hanging from a hole in the patient bed; the 
transmitted beam is recorded by a high resolution photon counting detector. 
Rotation and translation of the bed permits to acquire in successive axial scans 
over 180 deg a complete dataset for CT reconstruction. (from Sarno et al, 
2016c) ............................................................................................................ 11 
Figure 1.2: PIXIRAD-8: the single blocks are assembled and placed in a metal case 
(from Longo et al, 2016) ............................................................................... 12 
Figure 1.3: HVLs and effective energies employed in this study with monochromatic 
and polychromatic X-ray beam. (from Di Lillo et al, 2016a) ....................... 15 
Figure 1.4: Structure of Gafchromic® XR-QA2 (Di Lillo, 2014 - Private 
communication by Dott. Lewis, independent consultant formerly employed by 
Ashland) ........................................................................................................ 16 
Figure 1.5: a) Dose response curves evaluated for XR-QA2 radiochromic film 
irradiated with monochromatic beam at photon energies of 20, 30, 38 keV. The 
experimental data were fitted with the power function whose formula indicated 
on the graphs. b) Total one-sigma relative dose uncertainty and corresponding 
fitting and experimental uncertainties as a function of air kerma. (from Di Lillo 
et al, 2016a) ................................................................................................... 22 
Figure 1.6: a) Dose response curves evaluated for XR-QA2 radiochromic film 
irradiated with polychromatic beam at tube voltage of 80, 120 kV. The 
experimental data were fitted with the power function whose formula indicated 
on the graphs. b) Total one-sigma relative dose uncertainty and corresponding 
fitting and experimental uncertainties as a function of air kerma. (from Di Lillo 
et al, 2016a) ................................................................................................... 22 
Figure 1.7: a) Dose response curves of XR-QA2 film irradiated with a 
monochromatic (mono) beam at 20, 30, and 38 and with a polychromatic 
(poly) beam at 80 and 120 kV. b) Film sensitivity as a function of energy (or 
effective energy) for monochromatic and for polychromatic irradiation. (from 
Di Lillo et al, 2016a) ..................................................................................... 24 
Figure 1.8: Dose response curve of the XR-QA2 radiochromic film irradiated with a 
polychromatic source at 120 kVp, obtained by Tomic et al. (2014)  (lot # 
A07091204), Giaddui et al. (2012,2013) (lot # A04280904A) and in this work 
(lot # 01311401). (from Di Lillo et al, 2016a) .............................................. 25 
Figure 1.9: Response of LiF:Mg,Cu,P TLDs to monochromatic synchrotron 
radiation and X-ray spectrum, relative to 6 MV X-ray beam from a medical 
linear accelerator. (from Kron et al, 1998) .................................................... 27 
Figure 1.10:Comparison of energy response of LiF:Mg,Cu,P reported in this work 
and energy response reported in (Kron et al ,1998), (Bakshi et al, 2010), 
(Gonzalez et al, 2007). Note that Kron et al (1998), and in this work, 
LiF:Mg,Cu,P TLDs produced in China as GR-200A were studied. Bakshi et al 
(2010) investigated the LiF:Mg,Cu,P produced in Poland and commercially 
sold as MCP-100. Data from in Kron et al (1998) are normalized to the 
ix 
 
response to 6 MV x-rays, while data in the present work and in (Bakshi et al, 
2010), (Gonzalez et al, 2007) are relative to 60Co -rays. The calculated 
response follows from eq. 1.10 in the text. .................................................... 30 
Figure 1.11: Comparison between the simulated (close symbol) and measured (open 
symbol) ratio of CTDI values at the center of the phantom and in air at 18, 24, 
32 and 38 keV in (a) and 20, 28, 35 and 40 keV in (b). (from Mettivier et al, 
2016) .............................................................................................................. 36 
Figure 1.12: Sketch of the simulated setup. The radiation field shape was set with a 
fixed width of 150mm and a variable dimension w according to the case study. 
The samples had a cylindrical shape with a diameter d and a height h. The 
dimensions of the irradiated volume are π(d/2)2 × s where s is variable 
according to the case studied. A water box (with a volume of 13.5 dm3 ) was 
added for simulating the body of the patient. The skin thickness was 1.45 mm. 
(form Mettivier et al, 2016) ........................................................................... 37 
Figure 1.13: The MGD to the glandular mass present in the whole breast (solid 
square), or in the irradiated volume (open down triangle) or in the irradiated 
volume adding the contribution from scatter dose (close down triangle) for a 
12-cm diameter breast phantom with a glandular fraction of 50% varying the 
dimension of the irradiated volume with a 3 mm-height beam. The photon 
energy of the monoenergetic beam was 38 keV. (from Mettivier et al, 2016)
 38 
Figure 1.14: DgNCT coefficients to calculate the MGD (a, b, c) in the case of a 3 mm-
height beam irradiating a 30 mm-height slice for a breast diameter from 8 to 
16 cm in 1-cm step, and a glandular fraction of 0% (a), 50% (b) and 100% (c). 
The energy was varied from 8 to 50 keV with 1 keV step; data were represented 
as lines for ease of visualization. (from Mettivier et al, 2016) ...................... 39 
Figure 1.15: DgNCT coefficients useful to calculate the MGDv (a, b, c) in the case of 
a 3 mm-height beam irradiating a 30 mm-height slice for a breast diameter 
from 8 to 16 cm in 1-cm step, and a glandular fraction of 0% (a), 50% (b) and 
100% (c).  The energy was varied from 8 to 50 keV with 1 keV step; data were 
represented as lines for ease of visualization. (form Mettivier et al, 2016) .. 40 
Figure 1.16: DgNCT coefficients to calculate the MGDt (a, b, c) in the case of a 3 
mm-height beam irradiating a 30 mm-height slice for breast diameter from 8 
to 16 cm in 1-cm step, and a glandular fraction of 0% (a), 50% (b) and 100% 
(c). The energy was varied from 8 to 50 keV with 1 keV step; data were 
represented as lines for ease of visualization. (form Mettivier et al, 2016) .. 41 
Figure 1.17: MTF curves evaluated on the images without phase retrieval (a) and 
with phase-retrieval (b), evaluated across the PMMA edge, with voxel size of 
(60 μm)3 and (120 μm)3 obtained with 720 projections equally spaced over 180 
deg rotation scan. The dashed horizontal line indicates the 10% MTF value. 
(from Sarno et al, 2016c) ............................................................................... 44 
Figure 1.18: MTF curves for the images without phase retrieval, evaluated over the 
thin tungsten wire, with voxel size of (60 μm)3 and (120 μm)3 and with 720 
projections equally spaced over 180 deg rotation scan. The dashed lines 
indicates the 10% MTF value. (from Sarno et al, 2016c) .............................. 45 
x 
 
Figure 1.19: MTF curves for the images without phase retrieval, evaluated over the 
thin tungsten wire, with voxel size of (60 μm)3 and 720 projections equally 
spaced over 180 deg rotation scan at 10 mm, 30 mm and 50 mm from the 
scanner isocenter. (from Sarno et al, 2016c) ................................................. 46 
Figure 1.20: NNPS in the images without phase retrieval (a) and with phase retrieval 
(b). They were evaluated both with a voxel size of (60 μm)3 and of (120 μm)3 
and the reconstructions were performed from 720 projections equally spaced 
over a 180-deg rotation scan. Air kerma at isocenter = 10.4 mGy. (from Sarno 
et al, 2016c) ................................................................................................... 48 
Figure 1.21: Sample 1(diameter: 9.4 cm).(a) FBP reconstruction of 1200 projections 
and (b) 300 projections, (c) SART (αd = 4 pixel-1, αr = 0.2 cm-1) reconstruction 
of 300 projections, (d) phase retrieved SART (αd = 4 pixel-1, αr = 0.2 cm-1) 
reconstruction of 300 projections (from Longo et al, 2016). ........................ 51 
Figure 1.22: Digital mammography (planar image) of sample 1 (from Longo et al, 
2016). ............................................................................................................. 52 
Figure 1.23: Images of 0.85 mm thick slices of Sample 2 obtained (a) from FBP 
reconstruction of 1200 phase retrieved projections and (b) SART 
reconstruction of 300 phase retrieved projections (αd = 2 and αr = 0.05). (c) 
Planar image obtained from the 5 mm-thick sample at a clinical 
mammographic unit. In (a) the ROIs for CNR and C assessment are outlined 
together with the line over which the profiles in Figure 1.24 are evaluated. 
(from Longo et al, 2016) ............................................................................... 53 
Figure 1.24: Profiles across the line in Figure 1.23a, obtained both with FBP 
reconstruction from 1200 projections and a MGDV of 16.6 mGy and with 
SART algorithm (αd = 2 pixel-1, αr = 0.05cm-1) from 300 projections and a 
MGDV of 4.2 mGy. Voxel size = (120 μm)3 (from Longo et al, 2016). ....... 54 
Figure 2.1: Photo and scheme of the polyethylene cylindrical phantom with five 
cylindrical holes at various radial distances for hosting a 100-mm long ion 
chamber. (from Di Lillo et al. 2017b) ........................................................... 68 
Figure 2.2: Comparison between the measured (symbols) and simulated (lines) 
relative air kerma in a 14-cm diameter polyethylene cylindrical phantom for 
beam width of 1, 3, 7 and 14 cm. For the MC simulation, the dose distribution 
was evaluated by integrating the dose along 100 mm in the direction of the 
cylinder axis. .................................................................................................. 69 
Figure 2.3: Sketch of SR-EBRT. The patient is lying prone on a bed with her breast 
hanging from a hole. The bed is rotating around a vertical axis centered at the 
tumor site, while the collimated X-ray beam from a synchrotron radiation 
source irradiates the tumor. The bed is then translated vertically and 
horizontally and additional rotational scans are performed, in order to conform 
the treatment to the tumor volume. A dose enhancement can be obtained by 
using a radiosensitizer (e.g. gold nanoparticles or iodinated solutions). (by 
courtesy of P. Russo) ..................................................................................... 72 
Figure 2.4:  Comparison between dose distributions (percentage dose versus radial 
distance) in a 14-cm diameter PE cylinder obtained via MC simulation in this 
work (dashed red line)  and that reported by (Prionas et al., 2012) (continuous 
black line). (from Di Lillo et al. 2017a) ........................................................ 74 
xi 
 
Figure 2.5: Radial dose distribution in a 14-cm PE cylindrical phantom obtained with 
a collimated beam (15 mm × 6 mm) at 60, 80, 100, 120 and 175 keV (a) and 
corresponding periphery-to-centre dose ratio as a function of photon energy 
(b). (from Di Lillo et al. 2017a) .................................................................... 75 
Figure 2.6: a) Photo of the midplane face of the two halves cylindrical PMMA 
phantom containing a cavity for the ionization chamber and with the EBT3 
film in place; b) Setup for TLD irradiation: four TLD chips inserted in the 
PMMA housing and 100-mm pencil ionization chamber (IC) placed along the 
vertical direction. The inset shows the four chips in place in the housing. (from 
Di Lillo et al. 2017b) ..................................................................................... 77 
Figure 2.7: Calibration curve for the response of a) the pencil IC and b) TLD 
dosimeters at 60 keV. The continuous line is a linear fit to the data points. 
(from Di Lillo et al. 2017b) ........................................................................... 79 
Figure 2.8: Dose-response curves evaluated for a) EBT3 and b) XR-QA2 
radiochromic films at 60 keV. The power function indicated on the graphs was 
employed to fit the experimental data. (from Di Lillo et al. 2017b) ............. 79 
Figure 2.9: a) Dose map of the SR beam at 60 keV acquired with radiochromic film 
XR-QA2, the film response was calibrated in terms of air kerma in air. b) 
Horizontal average profile in the ROI shown in a) at 60 keV evaluated in the 
radiochromic film dose map. The maximum horizontal variation is about 6%. 
(from Di Lillo et al. 2017b) ........................................................................... 80 
Figure 2.10:  Experimental setup for radial dose profile measurement at AS. In this 
image, the IC is positioned in the central hole of the phantom. (from Di Lillo 
et al. 2017b) ................................................................................................... 81 
Figure 2.11: Comparison between the measured (symbols) and simulated (lines) 
relative air kerma in a 14-cm diameter polyethylene cylindrical phantom for 
beam width of 1.5, 4, 7 and 15 cm. For the MC simulation, the dose distribution 
was evaluated by integrating the dose along 100 mm in the direction of the 
cylinder axis.  (from Di Lillo et al. 2017b) ................................................... 82 
Figure 2.12: Dose profile along a diameter, obtained via MC simulation in a 14-cm 
diameter polyethylene cylindrical phantom for beam width of a) 1.5 cm and b) 
15 cm. For each beam collimation, the dose profile was evaluated scoring the 
energy in the irradiated volume (ROI 1 in Figure 2.13), in the not irradiated 
volume (ROI 2 + ROI 3 in Figure 2.13) and in whole volume used for the 
measurements (ROI 1+ ROI 2 + ROI 3 in Figure 2.13). Each profile was 
normalized to its central value (from Di Lillo et al. 2017b).......................... 83 
Figure 2.13: 2D map of the energy released in the 14-cm PE cylindrical phantom. 
The map was obtained via MC simulation. The ROIs used for evaluation of the 
dose distribution reported in figure 2.12 are showed. ................................... 84 
Figure 2.14: Dose profile obtained via MC simulation in a 14-cm diameter 
polyethylene cylindrical phantom, for various widths of the horizontal 
collimation (from 1.5 cm to 15 cm). The dose profile was evaluated in the 
irradiated phantom slice. (from Di Lillo et al. 2017b) .................................. 85 
Figure 2.15: a) 2D dose distributions evaluated with radiochromic film EBT3 in a 
14-cm diameter PMMA phantom and b) corresponding surface plots of 
percentage of maximum dose: two off-center foci (left side) and line 
xii 
 
distribution (right side). ROIs where the average dose distributions were 
evaluated are showed. The intended dose distribution was obtained with 
multiple rotations. c) Showing, for ease of visualization of the sample 
geometry, a photo taken during the placement of one half of the cylindrical 
phantom on the rotation stage, where the piece of EBT3 film is visible at mid-
plane in the PMMA phantom. Above the film is visible the half cavity realized 
for hosting the ion chamber. (from Di Lillo et al. 2017b) ............................. 87 
Figure 2.16: Two off-center foci and line dose distributions in a 14-cm diameter 
PMMA phantom obtained via MC simulations and line dose profiles evaluated 
in terms of percentage of maximum dose. (from Di Lillo et al. 2017b) ....... 87 
Figure 2.17: Line dose profiles of the percentage of maximum dose for 60-keV 
irradiation of a) two off-center foci or b) for a linear distribution. For the two 
foci irradiation, the centre of the phantom was also indicated at position 55 
mm. Dashed line: experimental; continuous line: simulated data. (from Di Lillo 
et al. 2017b) ................................................................................................... 88 
Figure 2.18: Horizontal average profile in a ROI evaluated in the radiochromic film 
dose map at 80 keV (a) and 100 keV (b). The position 0 corresponds to the 
center of the beam.......................................................................................... 90 
Figure 2.19: Comparison between the measured (symbols) and simulated (lines) 
relative air kerma in a 14-cm diameter polyethylene cylindrical phantom for 
beam width of 1.5, 4, 5.5, 7 and 16 cm at 60 keV (a), 80 keV (b), and 100 keV 
(c). .................................................................................................................. 91 
Figure 2.20: Percentage periphery-to-centre dose ratio obtained via MC simulations 
as a function of photon energy. The beam height was fixed at 1.5 cm, the beam 
width was set at 16, 7, 5.5, 4, or 1 cm. The periphery value was evaluated at 
6.5 cm. ........................................................................................................... 94 
Figure 2.21: Calibration curve for the response of radiochromic film EBT3 at 100 
keV. The continuous line is a fit with a power function to the data points. .. 95 
Figure 2.22: Line dose profile along the horizontal direction evaluated with 
radiochromic film for the irradiation of a single spot in the centre of the 14-cm 
diameter PMMA phantom. The beam size was 1.5 cm × 1.0 cm (H×V). The 
inset shows the 2D air kerma map imaged by film. The cyan continuous lines 
are exponential fits to the left-hand and right-hand side tails of the distribution.
 96 
Figure 2.23: Experimental setup for dose distribution measurement at AS. Three 
pieces of radiochromic film were placed at mid-plane of the 14-cm PMMA 
cylindrical phantom. The longitudinal section of the phantom was covered with 
film with the exception of a small rectangular area in the centre. ................. 96 
Figure 2.24: 2D dose map at mid-plane in a 14-cm PMMA cylindrical phantom. The 
pixel values are air kerma free-in-air in Gy. .................................................. 98 
Figure 2.25: Isodose Curves obtained using a X-ray beam collimated at 1.5 cm in the 
horizontal direction. The dose distribution was evaluated in a 14-cm PMMA 
cylindrical phantom. The pixel value were normalized to the maximum. The 
isodose legends in percent of the maximum dose are indicated on the subpanel 
on the right side. ............................................................................................ 98 
xiii 
 
Figure 2.26: Vertical average profile evaluated in the radiochromic film dose map at 
1 cm (a) and 5 cm (b) from the cylinder axis at 100 keV. ............................. 99 
Figure 2.27: 2D dose distributions and evaluated with radiochromic film EBT3 in a 
14-cm diameter PMMA phantom at 100 keV and b) corresponding line dose 
profile. The intended dose distribution (two foci) was obtained with two 
rotations by shifting the center of rotation 2.5 cm. ........................................ 99 
Figure 2.28: Vertical air kerma rate profile evaluated in 14-cm diameter PMMA 
phantom along the cylinder axis with the semiflex ionization chamber at 100 
keV. The dose rates were normalized to the maximum. ............................. 101 
Figure 2.29: Horizontal average profile in a ROI evaluated in the radiochromic film 
dose map at 80 keV (a), 100 keV (b), 120 keV (c), and 175 keV (d). The 
position 0 corresponds to the center of the beam. ....................................... 103 
Figure 2.30: Experimental setup for radial dose profile measurement at ESRF, in this 
image the IC is positioned in the central hole of the phantom. The PE phantom 
was placed on a single PMMA slice of thickness 1 cm............................... 103 
Figure 2.31: Comparison between the measured (symbols) and simulated (lines) 
relative air kerma in a 14-cm diameter polyethylene cylindrical phantom for 
beam width of 1.5, 4, 7 and 14 cm at 80 keV (a) and 100 keV (b). For the MC 
simulation, the dose distribution was evaluated by integrating the dose along 
100 mm in the direction of the cylinder axis. .............................................. 105 
Figure 2.32: Comparison between the measured (symbols) and simulated (lines) 
relative air kerma in a 14-cm diameter polyethylene cylindrical phantom for 
beam width of 1.5, 4, 7 and 14 cm at 120, and 175 keV. For the MC simulation, 
the dose distribution was evaluated by integrating the dose along 100 mm in 
the direction of the cylinder axis. ................................................................ 106 
Figure 2.33: Calibration curve for the response of TLD dosimeters at 100 keV. The 
continuous line is a linear fit to the data points. .......................................... 107 
Figure 2.34: 2D dose distributions evaluated with radiochromic film EBT3 in a 14-
cm diameter PMMA phantom at 100 keV. and b) corresponding line dose 
profile. The intended dose distribution (three foci) was obtained with three 
rotations by shifting the centre of rotation 1.5 cm. ...................................... 109 
Figure 2.35: 2D dose distributions evaluated with radiochromic film EBT3 in a 14-
cm diameter PMMA phantom at 100 keV. and b) corresponding line dose 
profile. The intended dose distribution (line distribution) was obtained with 
five rotations by shifting the centre of rotation 0.5 cm. .............................. 109 
Figure 2.36: Comparison of the dose measured with radiochromic film EBT3 in air, 
water, iodinated solutions with different concentration of iodine (320 mg I/ml, 
32 mg I/ml) and solutions of gold nanoparticle of different size (5nm, 20 nm, 
100 nm). The comparison is reported at 60 keV (a), 80 keV (b) and 100 keV 
(c). The radiochromic film was calibrated in terms of air kerma free-in-air. The 
dose was estimated as the average pixel value in a ROI of size (0.3 cm × 1.0 
cm) on the films. The horizontal dash line indicated the dose value measured 
when the film was immersed in water. ........................................................ 112 
Figure 2.37: Dose map imaged with radiochromic film at 60 keV. The film was 
immersed in a iodinated solution with a concentration of 320 mg I/ ml. The 
ROI used for the dose evaluation is shown. ................................................ 113 
xiv 
 
Figure 2.38: Absorption coefficient of air, water, iodine and gold as function of 
photon energy. The values were estimated with the XMuDat software 
(Nowotny, 1998). ......................................................................................... 113 
Figure 2.39: Comparison of the X-ray transmission acquired with Hamamatsu 
C9252DK-14 flat panel detector. The phantom cavity was filled with air, 
water, iodinated solutions with different concentration of iodine (320 mg I/ml, 
32 mg I/ml, 3.2 mg I/ml, 1 mg I/ml) and solutions of gold nanoparticle of 
different size (5nm, 20 nm, 100 nm). The comparison is reported at 60 keV (a), 
80 keV (b) and 100 keV (c). The X-ray transmission was estimated as the 
average of pixel values in a ROI of size (0.3 cm × 1.0 cm). The horizontal dash 
line indicates the transmission value measured when cavity was filled of water.
 115 
Figure 2.40: Crop of the 2D map of X-ray transmission at 60 keV with the cavity 
filled of iodinated solution with a concentration of 32 mg I/ ml. The ROI used 
for the transmission evaluation is shown. .................................................... 115 
Figure 2.41: Attenuation coefficient of air, water, iodine and gold as function of 
photon energy. The values were estimated with the XMuDat software 
(Nowotny, 1998). ......................................................................................... 115 
 
  
xv 
 
List of Tables 
 
Table 1.1: Air kerma calibration factor for Radcal ion chamber. The values were 
estimated with reference to a calibrated transmission chamber on the SYRMEP 
beamline at ELETTRA SR facility. (from Di Lillo et al, 2016a) .................. 15 
Table 1.2: Nominal thickness, density, elemental compositions by atoms for each 
layer of the Gafchromic XR-QA2. (Di Lillo, 2014 - Private communication by 
Dott. Lewis, independent consultant formerly employed by Ashland) ......... 16 
Table 1.3: Characteristics of polychromatic beams used for film irradiation. (from 
Di Lillo et al, 2016a) ..................................................................................... 18 
Table 1.4: Average absolute error for each calibration curve function. The absolute 
error is the difference between calculated and delivered air kerma. (from Di 
Lillo et al, 2016a) .......................................................................................... 21 
Table 1.5: Reduced chi-square of the fitting procedure of dose response data. (from 
Di Lillo et al, 2016a) ..................................................................................... 21 
Table 2.1: Mean percentage difference in the dose distribution between 
measurements and MC simulations evaluated in this work and in (De Lucia, 
2015). ............................................................................................................. 69 
Table 2.2: Periphery-to-center dose ratio simulated with MC code and measured with 
TLD100, radiochromic film EBT for a SR beam collimated at 1.5 cm along the 
horizontal direction at 60 keV. (from Di Lillo et al. 2017b) ......................... 86 
Table 2.3: Mean percentage difference in the dose distribution between 
measurements and MC simulations evaluated for beam collimations of 1.5, 4, 
5.5, 7, and 16 cm at 60, 80, and 100 keV. ..................................................... 92 
Table 2.4: Periphery-to-center dose ratio evaluated at 5.72 cm with measurements 
for beam collimations of 1.5, 4, 5.5, 7, and 16 cm at 60, 80, and 100 keV. .. 93 
Table 2.5: Periphery-to-center dose ratio evaluated at 6.5 cm via MC simulations for 
beam collimations of 1.5, 4, 5.5, 7, and 16 cm at 60, 80, and 100 keV. ....... 94 
Table 2.6: Mean percentage difference in the dose distribution between 
measurements and MC simulations evaluated for beam collimations of 1.5, 4, 
7, and15 cm at 80, 100, 120, and 175 keV. ................................................. 106 
Table 2.7: Periphery-to-centre dose ratio simulated with MC code and measured with 
TLD100 for a SR beam collimated at 1.5 cm and 15 cm along the horizontal 
direction at 100 keV. ................................................................................... 108 
 
  
xvi 
 
Abstract 
The breast cancer is the most common cancer in woman worldwide. In this scenario, 
two aspects are very important: the early diagnosis and the efficacy of the care. The 
gold standard for the screening of breast cancer is the two-view mammography and 
the standard care includes surgery, usually coupled with chemotherapy or 
radiotherapy with 6-MV X-ray tangential beams from a linear accelerator. The 
problem of superimposition of tissue along the direction of the beam, which can 
make difficult the task of lesion detection in mammography, has led to the 
development of 3D techniques – such as Digital Breast Tomosynthesis (DBT) and 
Breast Computed Tomography (BCT) – which resolve the breast anatomy also in the 
longitudinal direction. In addition, in the last decades the use of phase-contrast (PhC) 
imaging techniques (which permit to detect the phase-shift of the X-ray beam in 
tissue) produced improvements in the detection of breast cancer. As regards adjuvant 
radiotherapy of breast cancer, an effective treatment has to guarantee the maximum 
sparing to the healty tissues, in particular to the skin. For this purpose, new 
techniques – such as IMRT, helical tomotherapy, VMAT – are under clinical 
investigation. Moreover, new kilovoltage rotational radiotherapy techniques with X-
ray beam from orthovoltage X-ray tube as well as linear accelerator have been 
proposed. 
In this work, we investigated the use of the synchrotron radiation (SR) for both low-
dose phase-contrast breast computed tomography (PhC-BCT) and breast rotational 
radiotherapy, via Monte Carlo simulations and measurements. Experiments were 
conducted at three different synchrotron radiation facilities: ELETTRA (Trieste, 
Italy), ESRF (Granoble, France), Australian Synchrotron (Melbourne, Australia). 
Phase contrast mammography on a cohort of patients was pioneered at ELETTRA 
in the last decade, showing the advantage of propagation based PhC imaging in 
producing higher conspicuity of breast masses; the ongoing projects at ELETTRA 
aim at devising a setup and a protocol for future computed tomography (CT) scans 
of the breast. 
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The first part of the work, carried out in the framework of the SYRMA-CT/3D 
projects funded by INFN (National Institute for Nuclear Physics, Italy), showed the 
dosimetry measurements as well as the first imaging test of PhC-BCT at ELETTRA, 
carried out at 38 keV or lower energies. New dose metrics were introduced to take 
into account the partial breast irradiation envisaged for the exam; in addition, we 
carried out a characterization of dosimeters (TLD GR-200A and radiochromic film 
XR-QA2) to be employed for beam and phantom dosimetry. Finally, we showed the 
results of the first imaging test with a breast tissue specimen. 
In the second part of this PhD work, we demonstrated the feasibility of rotational 
breast radiotherapy with synchrotron radiation laying the foundations for the study 
of a new image-guided radiotherapy technique for breast cancer. This technique 
employs the same setup used for BCT but uses higher energies (60–120 keV) and 
higher intensity SR beams. The use of such low photon energies (with respect to 
megavoltage photon energies used in conventional radiotherapy) would provide a 
higher dose-enhancement when a radiosensitizing (e.g. gold nanoparticles) is used 
for breast radiotherapy. Possible applications of this technique could be the treatment 
of the small lesion and hypo-fractionated radiotherapy. 
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Introduction 
Breast cancer is the most common cancer in women. The effective care 
requires an early diagnosis by mammography screening and includes surgery, 
usually coupled to chemotherapy and radiotherapy. The conventional radiotherapy 
of breast cancer uses 6-MV tangential X-ray beams produced with a medical 
accelerator (linac). In the last decades, 3D conformal radiotherapy (3D-CRT), 
Intensity Modulated Radiotherapy (IMRT) and Protontherapy are also employed for 
treatment of the breast cancer. 
 In the last years, the use of a synchrotron radiation (SR) source has been 
proposed for investigating improvements of the mammography technique through 
phase-contrast imaging, which may permit to increase the contrast between tumour 
and healthy tissue and the lesion conspicuity. This activity has been carried out, in 
particular, at the SYRMEP beamline of ELETTRA synchrotron radiation facility in 
Trieste, Italy. The National Institute of Nuclear Physics (INFN) in Italy has promoted 
research projects dedicated to phase-contrast breast computed tomography (BCT) 
with SR by using a high-spatial resolution photon counting detector. These projects 
(SYRMA-CT and SYRMA-3D), based at ELETTRA, involve a large collaboration 
including University of Trieste, University of Napoli Federico II, University of 
Cagliari, University of Sassari, University of Pisa, University of Siena, University of 
Ferrara, and the INFN sections of Napoli, Trieste, Cagliari, Pisa and Ferrara as well 
as the INFN spin-off PIXIRAD srl (the latter involved in the SYRMA-CT project).  
At the same time, as a specific outcome of the activity of Naples medical 
physics group on cone-beam BCT as well as SR-BCT, the Naples team proposed the 
use of the high intensity monoenergetic SR beam for breast radiotherapy as an 
alternative to the conventional treatment with 6-MV X-ray beams. 
Both CT breast imaging with SR source and phase contrast techniques, and 
breast radiotherapy with a SR source, have been the object of my PhD activity on 
breast cancer research, during the period November 2014 – October 2017. As a 
consequence, this thesis comprises two parts, as briefly outlined in this introduction 
and thoroughly illustrated in the following pages. 
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My thesis work has been focused, for the first part, on the SYRMA-CT project 
in which the Naples medical physics group has been responsible for phantom and 
beam dosimetry. I participated in all mesurement shifts at the ELETTRA facility 
dedicated to beam and phantom dosimetry, and to the corresponding data analysis. 
My specific contribution was on the assessment of accuracy and energy response of 
the dosimeters employed in the SYRMA-CT experiment (TLDs, radiochromic films, 
ion chambers), and in the analysis of the first images. 
As regards research on SR breast radiotherapy, a project (SR3T) has been 
recently approved by INFN and will involve activities carried out at the European 
Synchrotron Radiation Facility (ESRF) (Grenoble, France), Australian Synchrotron 
(AS) (Melbourne, Australia) and also Canadian Light Source (Saskatoon, Canada). 
The study of SR rotational radiotherapy for breast cancer treatment has been the main 
object of the second part of my thesis work. I was totally involved in conceiving and 
in the first tests of SR breast radiotherapy by participating in all phases of data 
acquisition, data analysis and scientific publications. 
In this thesis, from measurements carried out at the ELETTRA facility within 
the SYRMA-CT/SYRMA-3D collaborations, the synchrotron radiation (SR) source 
(photon energy = 38 keV) proved to be effective in producing high contrast, high 
resolution phase-contrast images of the breast anatomy in mastectomy samples, after 
retrieval of the phase map. For Monte Carlo (MC) determination of normalized 
glandular dose coefficients in a SR BCT scan, new dose metrics will be presented, 
which will take into account the different geometry of a mammography or a 
dedicated cone-beam CT scan (where the whole breast is irradiated) with respect to 
the partial irradiation of a SR BCT scan (where only a thin layer of the breast is 
irradiated).  
The analysis of the mono-energetic dose distributions in such 360-deg scans 
around the breast, derived from MC simulations, led us naturally to explore the case 
of the SR irradiation in a circular orbit of a small volume of the breast, simulating a 
small lesion. In this case the SR beam is collimated horizontally – in addition to 
being collimated in the vertical direction for definition of the breast layer. We then 
investigated the possibility of performing (high-dose) breast 3D radiotherapy in 
addition to (low-dose) breast 3D imaging, by adopting a (horizontally collimated) 
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rotational irradiation of the pendant breast with a SR beam with photon energy in the 
range 60-120 keV. Indeed, such a new technique of kilovoltage rotational 
radiotherapy of breast cancer with a SR source can produce skin-to-tumor dose ratios 
comparable to those achievable with conventional megavoltage breast radiotherapy, 
and also comparable to that indicated by J. Boone at UC Davis using orthovoltage 
rotational breast radiotherapy. With respect to this last technique (operating at about 
320  kVp, effective energy about 180 keV) the SR source would present the 
advantage of a higher flux and of a lower achievable energy (down to e.g. 60 keV), 
which would permit to have higher dose enhancements when using a radiosensitizing 
agent (e.g. gold nanoparticles) for breast radiotherapy.  
The thesis is divided in two parts.  
In the first part, I describe the work related to phase-contrast breast computed 
tomography.  
In the second part of this thesis, I present the first feasibility studies of SR3T 
carried out at Imaging and Medical Beamline (IMBL) of AS and ID 17 beamline of 
ESRF. In particular, I report the results of the first proof-of-concept at 60 keV as 
well as the study at higher energies in the range 80–175 keV and the preliminary 
results of the use of dose-enhancement agents. 
The strategy followed in writing my thesis was to illustrate the diverse 
scientific papers, which are the scientific product of this thesis work, highlighting 
my role in SYRMA-CT/3D and SR3T collaboration. The list of papers that I co-
authored in the last three year as well as the list of conference presentations, which I 
attended for poster or oral presentation, are present in the previous pages and include 
both my activities. 
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1 PART I  
 
 
Breast Computed Tomography with 
synchrotron radiation 
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1.1 Introduction 
This paragraph of the thesis presents the description of the projects on breast 
computed tomography with synchrotron radiation (SYRMA-CT and SYRMA-3D) 
in which I was involved during my PhD work. The text describes the content of the 
following publications: 
- Longo, R., Arfelli, F., Bellazzini, R., Bottigli, U., Brez, A., Brun, F., Brunetti, A., 
Delogu, P., Di Lillo, F., Dreossi, D., Fanti, V., Fedon, C., Golosio, B., Lanconelli, 
N., Mettivier, G., Minuti, M., Oliva, P., Pinchera, M., Rigon, L., Russo, P., Sarno, 
A., Spandre, G., Tromba, G., & Zanconati, F. (2016). Towards breast tomography 
with synchrotron radiation at Elettra: first images. Phys. Med. Biol. 61(4), 1634–
1649. 
 
- Delogu, P., Golosio, B., Fedon, C., Arfelli, F., Bellazzini, R., Brez, A., Brun, F., Di 
Lillo, F., Dreossi, D., Mettivier, G., Minuti, M., Oliva, P, Pinchera, M., Rigon, L, 
Russo, P., Sarno, A., Spandre, G., Tromba, G., Longo, R. (2017) Imaging study of 
a phase-sensitive breast-CT system in continuous acquistion mode. J. Instrum. 12, 
C01016. 
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1.1.1 Background 
The gold standard imaging technique for screening of breast cancer is 
mammography. The introduction of the screening program in the late 80’s (Shapiro 
et al, 1998) resulted in a significant reduction of the rates death due to the breast 
cancer in women in the next years. In a study on the cancer mortality predicted for 
2017 in Europe, Malvezzi et al. (2017) show that the rate of more than 20 cancer 
deaths per 100.000 females in 1990 decreased to 15.19 per 100.000 females in 2012; 
they also predict a rate of cancer deaths of about 14.03 per 100.000 females in 2017. 
Similar results are showed by Siegel et al. (2016) for cancer statistics in USA where 
the death rates were from about 35 per 100.000 female in 1990 to about 20 per 
100.000 females in 2012. Although mammography specificity – defined as the 
percentage of non-cancer with a negative initial interpretation (BCSC 2009) – is 
about 90.3 % (BCSC 2009), its sensitivity – defined as the percentage of cancers 
with an initial positive interpretation (BCSC 2009) – is about 84.9 % (BCSC 2009). 
The main limitation of sensitivity for mammography is that it is a form of planar 
imaging which cannot overcome the superimposition of the tissues in the direction 
of the X-ray beam. This makes difficult the detection of breast lesions immersed in 
normal glandular tissue. 3D imaging techniques such as Digital Breast 
Tomosynthesis (DBT) (Sechopoulos, 2013a, 2013b) and Breast Computed 
Tomography (BCT) (Sarno et al, 2015, Prionas et al 2010, O’Connell et al, 2014, 
Zhao et al, 2015) have been proposed to overcome this problem. In DBT, several 
projections of the organ are acquired at different angles in a limited range by rotating 
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the X-ray tube around the compressed breast while detector can be fixed or can rotate 
with the surface perpendicular to the X-ray beam. The reconstructed images provides 
“a 3D distribution of the tissue with an anisotropic spatial resolution” 
(Sechopoulos, 2013a, 2013b). DBT is now a clinical practice which can be employed 
coupled with mammography. In BCT, the patient is prone on a bed with a hole for 
the hanging breast. The X-ray tube as well as the X-ray detector is on a rotating 
gantry and rotates around the uncompressed breast. This technique permits to obtain 
a 3D image of the breast with an isotropic spatial resolution (Sarno, 2017a). 
However, the dose to the organ is a significant constraint for the technique (Kalender 
et al, 2012, Vedantham et al, 2013, Sarno et al, 2015). Indeed, the mean dose to the 
glandular tissue (MGD) in a BCT exam may be comparable with, or lower than, the 
MGD delivered to the same breast in a mammography exam with the compressed 
breast. This value ranges between 3 and 4 mGy in two-view mammography, for a 
standard breast (Sarno et al, 2015). The BCT scanner produced by Koning corp 
(http://koninghealth.com/) is the only system which obtained CE mark (2012); in its 
FDA approval document (2015) this device should be used as diagnostic technique 
coupled with two-view mammography (Sarno, 2017a). BCT did not receive FDA 
approval for breast cancer screening, but it provides additional information with 
respect to mammography to determine if a patient with a suspicious abnormality 
needs a needle biopsy. 
The conventional CT is based on the detection of the X-ray attenuation signal 
and provides a 3D map of the attenuation coefficient of the sample. In the last 
decades, new techniques for phase-shift detection, called phase-contrast (PhC) 
imaging techniques, have been investigated (Fiedler et al, 2004; Bravin et al, 2013; 
Keyriläinen et al, 2005, 2008; Momose et al, 1996; Sztrókay et al, 2013; Takeda et 
al, 1998, 2000; Zhao et al, 2012; David et al, 2007; Cai and Ning, 2009; Snigirev et 
al, 1995; Wilkins et al, 1996). The simplest PhC technique to be implemented is 
Propagation-based imaging (PBI) (Snigirev et al, 1995; Wilkins et al, 1996) which 
requires an acquisition system similar to that used in attenuation-based imaging 
without any sophisticated X-ray optics (Wilkins et al, 1996). This setup employs an 
X-ray beam with high-spatial coherence – such as Synchrotron Radiation (SR) beam 
(Snigirev et al, 1995, Longo et al, 2016, Sarno et al, 2016a, Nesterets et al, 2015) or 
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the X-ray beam from a micro-focus X-ray tube (Wilkins et al, 1996, Auweter et al 
2014, Sarno et al, 2016d) – and a detector with high-spatial resolution placed at a 
distance from the sample sufficient to detect the interference pattern in the 
transmitted beam. However, the requirement for the high-spatial resolution detector 
may, in some cases, be relaxed in the case of micro-focus X-ray sources in the 
laboratory context. The PBI technique can provide an edge-enhancement in the 
attenuation images useful to recognise small details in the image. Moreover, the 
phase signal can be separated from the absorption signal by applying a specific 
algorithm on the projection images before CT reconstruction. The most diffuse 
algorithm is based on the homogeneous transport of an intensity equation (Paganin 
et al, 2002).  
The use of PBI technique for breast imaging with SR source is under 
investigation (Castelli et al, 2011, Longo et al, 2014, 2016, Nesterets et al, 2015, 
Sarno et al, 2016c, Coan et al, 2013). The SR source provides a monoenergetic 
laminar X-ray beam, tunable in energy, with high flux and a very high-spatial 
coherence which permits to investigate the phase effects. The first clinical trial of 
PhC-mammography with SR was performed at SYRMEP beamline of ELETTRA 
synchrotron facility in Trieste, Italy (Castelli et al, 2011, Longo et al, 2014) showing 
an improvement of the image quality with MGD values comparable to that delivered 
for conventional two-view mammography in the order of 3-4 mGy for a standard 
breast (Sarno et al, 2015). Moreover, recent study on BCT with synchrotron radiation 
(SR-BCT) have compared the PBI to absorption-based imaging revealing a 
significant improvement of the image quality when the PhC technique is employed 
(Pacilè et al, 2015; Nesterets et al, 2015; Longo et al, 2016). At the present, SR-BCT 
is investigated at the SR facility ELETTRA (Trieste, Italy) (Castelli et al 2011; Quai 
et al 2013; Longo et al 2014, 2016; Pani et al 2004; Pacilè et al 2015; Tromba et al, 
2016), at the European Synchrotron Radiation Facility in Grenoble, France (Fiedler 
et al 2004; Bravin et al 2013; Keyriläinen et al 2005, 2008) and at the Imaging and 
Medical beamline of the Australian Synchrotron (Nesterets et al 2015, Tromba et al, 
2016).  
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1.1.2 SYRMA-CT and SYRMA-3D Projects 
The SYRMA-CT project (2014-2016) has been proposed in the scenario described 
in the previous section. Its following project SYRMA-3D (2017-2018) should 
conclude the five-year research effort for demonstrating the feasibility of BCT with 
monoenergetic X-rays using phase-contrast techniques and a synchrotron radiation 
source. The SYRMA-CT/3D (SYnchrotron Radiation- MAmmography-Computed 
Tomography/three-Dimensional) collaboration aims “to set-up the first clinical trial 
of PhC breast CT with SR at the SYRMEP (SYnchrotron Radiation for MEdical 
Physics) beamline of Elettra, the synchrotron radiation laboratory in Trieste (Italy)” 
(Longo et al, 2016). The projects have a number of innovative elements such as the 
use of a CdTe single-photon counting detector, state-of-art CT reconstruction 
techniques and phase retrieval algorithms, and an ad-hoc dose metric. The merge of 
these elements will provide the highest image quality with the lower delivered dose. 
The SYRMA-CT/3D projects, funded by INFN (Istituto Nazional di Fisica Nucleare. 
Italy) involve several Italian institutions such as University of Napoli “Federico II”, 
University of Trieste, University of Cagliari, University of Pisa, University of Siena 
and University of Ferrara, together with the INFN sections of Napoli, Trieste, 
Cagliari, Pisa and Ferrara and the INFN spin-off PIXIRAD srl (partner in SYRMA-
CT project only) and the Elettra-Sincrotrone Trieste SPcA where the SYRMA-
CT/3D system is installed.  
Setup @ SYRMEP 
ELETTRA is a third generation SR facility with a 259.2 m-circumference 
storage ring, which operates in “top-up” mode at two different electron energies of 
2 and 2.4 GeV. The ring current is 300 mA and 140 mA at 2.0 GeV and 2.4 GeV, 
respectivelyg(https://www.elettra.trieste.it/lightsources/elettra/elettra-parameters. 
html?showall=). 
SYRMEP beamline is dedicated to research in medical diagnostic radiology, 
material science and life science applications. The X-ray beam produced by a storage 
ring bending magnet is monochromatized by a double-crystal Si (111) 
monochromator working in the energy range 8–38 keV with an energy resolution of 
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0.2%f(https://www.elettra.trieste.it/lightsources/elettra/elettra-beamlines/syrmep/ 
specification.html.). SYRMEP has three hutches: the optical hutch, the experimental 
hutch, the patient room. The maximum beam size in the patient room is 220 mm 
(horizontal) × 5 mm (vertical, Gaussian shape, evaluated as the FWHM of the 
Gaussian shape) (Abrami et al, 2005). The patient room hosts a clinical bed in carbon 
fibre (210-cm length and 80-cm width) with a 25-cm diameter hole (Figure 1.1) The 
patient lies prone on the bed with one breast hanging from the hole. A compression 
system can be used for mammographic exam. The detector is placed on a dedicated 
rail which permits to select the optimal sample-to-detector distance, up to 2 m, for 
detecting phase effects. Since the beam is fixed, the patient support has to rotate in 
order to collect the CT projections.  
SYRMEP has a specific dose control system to guarantee low dose levels to 
the patient during the exams. It consists of a set of shutters with a fast 
opening/closing system and two parallal-plate ionization chambers (IOC). The IOCs 
are employed as dose monitor on the beamline. They were designed and constructed 
at ELETTRA laboratories specifically for the laminar beam geometry. Their 
response was calibrated against the air kerma primary standard of the INMRI-ENEA 
(Italia National Institute for Ionizing Radiation Metrology) in the energy range 8–28 
keV. 
As regards the acquisition protocol, the negligible horizontal divergence of 
SR beam (7 mrad) permits acquisition in parallel geometry and therefore the CT scan 
will be performed in axial mode over 180 degrees. On the other hand, the laminar 
shape of the SR beam requires multiple rotations to image the breast volume. In order 
to reduce the scan time and limit the number of rotations of the patient, the SYRMA-
CT collaboration plans to irradiate only the part of the breast where the suspected 
lesion is localized with a rotate/translate scan geometry (Longo et al, 2016).  
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Figure 1.1: Photo of the SYRMA-CT setup for phase-contrast breast CT at the ELETTRA synchrotron 
radiation laboratory (Trieste, Italy). The horizontal beam irradiates the breast hanging from a hole in 
the patient bed; the transmitted beam is recorded by a high resolution photon counting detector. 
Rotation and translation of the bed permits to acquire in successive axial scans over 180 deg a 
complete dataset for CT reconstruction. (from Sarno et al, 2016c) 
CdTe single photon counting detector: PIXIRAD 
One of the innovative elements of SYRMA-CT/3D projects is the use of a photon 
counting detector. The collaboration decided to employ a multi-block module 
(PIXIRAD-8) of 8 units (PIXIRAD)  for a global active area of 250mm × 25mm. 
The detector is produced by PIXIRAD Imaging counter s.r.l 
(http://www.pixirad.com/), an INFN Pisa spin-off company. PIXIRAD is a hybrid 
detector composed of a 0.65 mm-thick CdTe sensor layer with an area of 30.96 mm 
× 24.98 mm electrically connected to a CMOS VLSI chip with an active area of 
30.7mm × 24.8mm by bump-bonding process. The CdTe sensor (ACRORAD Co., 
Ltd.)) is a Schottky  type array of diodes. As reported by Bellazzini et al (2013), 
“ASIC is organized as a matrix of 512×476 hexagonal pixels that match the identical 
pixel arrangement of the CdTe crystal. Each pixel is connected to a charge amplifier 
which feeds two discriminator and two 15-bit counters.” The pixel  pitch is 60 m. 
The detector can work in either dual-thresholds mode (2 colours mode) or single-
threshold continuous reading mode (Bellazzini et al, 2013).  
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Figure 1.2: PIXIRAD-8: the single blocks are assembled and placed in a metal case (from Longo et 
al, 2016) 
In continuous reading mode, both counters work by using the same threshold and 
photons are counted in one counter while reading the other one. In this way, a dead-
time free modality is obtained. The modular structure of PIXIRAD-8 detector 
produces a dead space of 180 μm between adjacent blocks. 
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1.2 Dosimetry in breast computed tomography with 
synchrotron radiation 
1.2.1 Dosimeters Characterization  
During the first part of the SYRMA-CT project on which my work was centred, due 
attention was given to determine an accurate beam dosimetry. This implies the use 
of TLD dosimeters and film dosimeters, which we characterized at the energy of the 
SR beam. This work resulted in the publication of the following two papers in 
international scientific journals. Here, we describe this work as illustrated in the 
corresponding papers. 
- Di Lillo, F., Mettivier, G., Sarno, A., Tromba, G., Tomic, N., Devic, S. & 
Russo, P. (2016a) Energy dependent calibration of XR‐QA2 radiochromic 
film with monochromatic and polychromatic x‐ray beams. Med. Phys. 43(1), 
583–588. 
 
- Emiro, F., Di Lillo, F., Mettivier, G., Fedon, C., Longo, R., Tromba, G. & 
Russo, P. (2015) Energy response of GR-200A thermoluminescence 
dosemeters to 60Co and to monoenergetic synchrotron radiation in the energy 
range 28–40 keV. Rad. Prot. Dosim. 168(1), 40–45. 
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TLDs and radiochromic films were characterized in the effective photon energy in 
the range 18–46.5 keV, corresponding to half value layer (HVL) extending from 0.55 
mm Al to 6.09 mm Al as shown Figure 1.3. A 100-mm long ionization chamber 
(mod. 20X6-3CT, with mod. 2026C dosimeter, Radcal Corp., Monrovia, CA, USA, 
with an active volume of 3 cm3) was used as reference. This chamber is factory 
calibrated at 150 kV, HVL = 10.2 mm Al with an accuracy ± 4% after temperature 
and pressure correction. However, for beam energies in the range 18–28 keV, the 
response of the chamber was calibrated in terms of air kerma free-in-air, with respect 
to a calibrated parallel-plate transmission chamber (IOC) employed as the dose 
monitor on the SYRMEP beamline. For calibration, the ionization chamber was 
positioned horizontally along the beam width direction and translated along the 
vertical direction to expose its entire active volume to the thin laminar beam (Prezado 
et al, 2011). Table 1.1 reports the air kerma calibration factors for the Radcal 
ionization chamber estimated at 18, 20, 24, and 28 keV. For energies higher than 28 
keV, since the SYRMEP monitor chamber are not calibrated, the air kerma values 
measured with the 100-mm chamber were obtained by using the manufacturer 
calibration data. Furthermore, temperature, pressure, and energy dependence 
corrections were applied; the coefficients for energy dependence correction were 
those provided by the manufacturer.  
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Figure 1.3: HVLs and effective energies employed in this study with monochromatic and 
polychromatic X-ray beam. (from Di Lillo et al, 2016a) 
Table 1.1: Air kerma calibration factor for Radcal ion chamber. The values were estimated with 
reference to a calibrated transmission chamber on the SYRMEP beamline at ELETTRA SR facility. 
(from Di Lillo et al, 2016a) 
Photon energy (keV) Calibration factor  
18 0.978 
20 0.935 
24 0.932 
28 0.911 
1.2.1.1 Characterization of radiochromic film XR-QA2 
The GafChromic XR-QA2 film (Ashland, NJ, USA) is intended for quality control 
in radiology applications. These films can also be used as 2D dosimeters. By 
specifications, the film is sensitive in the dose range 1200 mGy in the photon energy 
range 20200 keV. The film consists of a 25-µm thick active layer attached to an 
acrylic adhesive layer of 20-µm thickness and sandwiched between two 97-m thick 
polyester layers, one with an orange colour on the front and the other with a white 
colour on the back (Figure 1.4). Nominally, the active layer consists of H, Li, C, N, 
O, Bi (table 1.2). The inclusion of Bi (Z = 83) boosts the photoelectric cross section 
and improves the film sensitivity to lower X-ray energy. On the other hand, the 
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presence of bismuth in the elemental composition of active layer results in a  Zeff 
55.2 (Devic et al, 2016) which is much larger than Zeff of soft tissue (Zeff = 7). The 
white polyester layer also presents a Zeff of 27.5 (Devic et al, 2016) because of the 
Barium (Z = 56), while the other layers have a Zeff close to 6 (Devic et al, 2016). 
These characteristics indicate that the high response at radiological photon energies 
is obtained at the price of losing the tissue equivalence which characterizes the 
radiochromic film for radiotherapy applications, such as EBT series. Indeed. Xr-
QA2 films are used clinically only for quality assurance in radiology setups. 
The change in optical reflectance of the film increases with increasing doses of 
ionizing radiation, particularly in the red part of its optical reflection spectrum. The 
film requires digitization using a reflective densitometry due to the incorporation of 
the white polyester film layer, although optical film scanning via transmission 
densitometry has also been reported for this film model (Giaddui et al, 2012).  
 
Figure 1.4: Structure of Gafchromic® XR-QA2 (Di Lillo, 2014 - Private communication by Dott. 
Lewis, independent consultant formerly employed by Ashland) 
 
Table 1.2: Nominal thickness, density, elemental compositions by atoms for each layer of the 
Gafchromic XR-QA2. (Di Lillo, 2014 - Private communication by Dott. Lewis, independent 
consultant formerly employed by Ashland) 
 
Layer 
Nominal 
thickness 
(µm) 
Density 
(g/cm2) 
Composition (Atom %)  
H Li C N O S Ba Bi 
Yellow 
Polyester Film 
97 1.35 36.36 0 45.45 0 18.18 0 0 0 
Acrylic 
adhesive 
20 
approx. 
1.2 
33.33 0 57.14 0 9.52 0 0 0 
Active layer 
(assumes 
7.5% 
moisture) 
25 
approx. 
3.9 
56.34 1.00 27.64 1.60 11.72 0 0 1.70 
White 
polyester film 
base 
97 
approx. 
1.6 
33.80 0 42.25 0 21.55 1.20 1.20 0 
17 
 
 The evaluation of the energy dependent dose response of XR-QA2 has been 
reported by Tomic et al. (2014), covering a broad range of effective beam energies 
from 12.7 to 56.3 keV (half value layer, HVL, from 0.16 to 8.25 mm Al), 
corresponding to beam qualities used in diagnostic radiology examinations. Those 
authors reported a significant variation (close to 190%) in XR-QA2 film response in 
that energy range, at the value of 80 mGy air kerma in air, a finding that motivates 
further investigations. In addition, Tomic et al. (2014) reported on the 
characterization of XR-QA2 film calibration curve by testing three fit functions 
(rational, linear exponential, and power); the power function was evaluated as the 
most appropriate for expressing the dose vs. net optical reflectance curve, for 
reference radiochromic dosimetry with XR-QA2 films. We reported a 
characterization for monochromatic X-ray beams with a synchrotron radiation (SR) 
source (at 28, 35, 38 and 40 keV photon energy), using a logarithmic function to 
express the functional dependence between air kerma in air and net variation in 
optical reflectance (Di Lillo et al, 2015); the logarithmic function was proposed in 
Tomic et al. (2014) for a polychromatic beam. The issue of the optimal fit function 
for the dose response curve of XR-QA2 films exposed to monochromatic X-rays 
beam is still to be investigated: indeed, error uncertainty analysis for calibration 
curve fitting of radiochromic films is necessary for establishing the optimal trade-off 
between fit precision and fit accuracy. Starting from ths considerations, we exposed 
the XR-QA2 radiochromic films to monoenergetic X-ray beams (in the range 18–40 
keV) from a SR source to assess their energy dependent response and test various 
dose-response fitting functions. Additionally, we extended the study to polyenergetic 
X-ray beams (range of effective energies from 38 to 46.5 keV – for each 
polyenergetic X-ray beam, effective energies were evaluated as the energy, E, 
corresponding to the attenuation coefficient of Aluminium, 𝜇𝐴𝑙(𝐸), which provides, 
by means the relation 𝐻𝑉𝐿 =  
ln 2
𝜇𝐴𝑙(𝐸)
, an HVL equal to that measured).  
Film Irradiation and digitization  
The measurements with the monochromatic beam were performed at the SYRMEP 
beamline of ELETTRA with a laminar SR beam of transverse size 16 cm × 0.335 cm 
(H × V). In order to evaluate the best fit function for the dose response curve of the 
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films, pieces of film were irradiated by the SR beam to various air kerma, Kair, values 
in the range 1–20 mGy. The film pieces (30 mm×50 mm) were cut from a single 
sheet (lot no. 01311401) and irradiated free-in-air in a plane transverse to the beam 
at the same distance from the x-ray source where the air kerma measurements with 
the ionization chamber were performed. In order to obtain a uniform film exposure 
over its height of 50 mm, the film was translated across the 3.35-mm beam size along 
the vertical direction, at a constant speed (Brown et al, 2012). Calibration curves 
were created for 20, 30, and 38 keV photon energies. In order to assess the energy 
dependent response of the radiochromic film, film pieces were irradiated at beam 
qualities from 18 to 40 keV with energy step of 1 keV, to a nominal air kerma of 10 
mGy. Actually, the experimental air kerma obtained in each exposure was slightly 
different from the nominal value, with an average value of 10.26 mGy, a maximum 
variation in the range 9.87–10.50 mGy, and a standard deviation of 0.18 mGy.  
 For polychromatic beam irradiation of the XR-QA2 film, a microfocus X-ray 
tube was used (Hamamatsu mod. L8121-03), at tube voltages of 80 kV, 100 kV or 
120 kV, with HVLs (measured in narrow beam geometry and using 99.99% pure Al 
foils) as given in Table 1.3. The tube operated at constant voltage with a ripple of 
about 0.1%. The film pieces were positioned free-in-air at the same position where 
the ionization chamber was placed during air kerma measurement. The latter was 
acquired with the pencil chamber positioned along the vertical direction (anode-
cathode axis) at 400 mm from the focal spot. Temperature, pressure and beam quality 
corrections were applied. For film calibration, nine air kerma values were selected 
in the range 5–100 mGy. At each air kerma value, three film pieces (30 × 30 mm2) 
were irradiated, cut from a single sheet (lot no. 01311401).  
Table 1.3: Characteristics of polychromatic beams used for film irradiation. (from Di Lillo et al, 
2016a) 
Tube Voltage (kV) Effective energy (keV) HVL (mm Al) 
80 38 
4.03 
100 43 
5.25 
120 46.5 
6.09 
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A flatbed scanner (Epson Perfection V750 Pro, EPSON Scan readout 
software) was used in reflectance mode for scanning films with an image resolution 
of 96 dpi without color correction factors or filters. The images were saved as tagged 
image file format (TIFF) files in 48-bit RGB mode. Each scan was repeated five 
consecutive times after a first preview acquisition. The scanner warm-up response 
was stable after the third scan, and the average over the last three acquisitions was 
analysed (Menegotti et al, 2008, Devic et al, 2005).The film response analysis was 
performed by using the open software ImageJ 1.49n (National Institutes of Health, 
Bethesda, MD) (Abramoff et al, 2004). Following Tomic et al (2010, 2014), the 
response of the film was evaluated in terms of reflectance change, R, in the 16-bit 
red channel of the RGB image, defined as: 
𝚫𝐑 =
𝟏
𝟐𝟏𝟔
[𝐏𝐕𝐁𝐞𝐟𝐨𝐫𝐞 − 𝐏𝐕𝐀𝐟𝐭𝐞𝐫]    (1.1) 
By error propagation, the corresponding uncertainty σΔ𝑅 was calculated: 
𝛔𝚫𝑹 =
𝟏
𝟐𝟏𝟔
√(𝛔𝑷𝑽𝑩𝒆𝒇𝒐𝒓𝒆)
𝟐
+ (𝛔𝑷𝑽𝑨𝒇𝒕𝒆𝒓)
𝟐
   (1.2) 
where: (PVBefore, σ𝑃𝑉𝐵𝑒𝑓𝑜𝑟𝑒), (PVAfter, σ𝑃𝑉𝐴𝑓𝑡𝑒𝑟) are the mean pixel value and standard 
deviation, respectively, estimated before and after the exposure, in a Region of 
Interest (ROI) of size 10 mm × 10 mm; the statistical uncertainty due to scanner 
response repeatability calculated as the standard deviation of the three scans of a film 
(Rampado et al, 2006) was also evaluated. A film not exposed was used as control 
film in order to quantify any reflectance change due to effects different from the X-
ray exposure. After determining the change of reflectance for this control piece, 
 Δ𝑅𝑐𝑜𝑛𝑡𝑟𝑜𝑙, by means equation 1.1, the net reflectance R can be calculated: 
𝑛𝑒𝑡 Δ𝑅 =  Δ𝑅 − Δ𝑅𝑐𝑜𝑛𝑡𝑟𝑜𝑙                  (1.3) 
with an uncertainty, σnetΔ𝑅: 
𝛔𝐧𝐞𝐭𝚫𝑹 =
𝟏
𝟐𝟏𝟔
√(𝛔𝑷𝑽𝚫𝑹)
𝟐
+ (𝛔𝑷𝑽
𝚫𝑹𝒄𝒐𝒏𝒕𝒓𝒐𝒍
)
𝟐
    (1.4)   
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Dose-response fitting curve 
The XR-QA2 radiochromic film based dosimetry system was calibrated in terms of 
net reflectance within the ROI versus the air kerma measured in air at the plane where 
the film was positioned. By using the graphics and analysis software Origin 9 
(OriginLab Corporation, Northampton, MA), the four different functions proposed 
in literature for this for polychromatic beams were investigated for fitting the 
calibration data points (Tomic et al, 2010, 2014): 
 Rational function: 𝑦 =
𝑎𝑥
1+𝑏𝑥
 ; 
 Exponential function: 𝑦 = 𝑎𝑥 𝑒𝑚𝑥 ; 
 Power function: 𝑦 = 𝑎𝑥 + 𝑏𝑥𝑛; 
 Logarithm function: 𝑦 = 𝑎 +
𝑏𝑥
ln 𝑥
.                             
The adequacy of the various fitting functions was tested using the dose 
uncertainty analysis. Following Devic et al. (2004), for each function, the total dose 
uncertainty was calculated as: 
𝛔𝒚
𝟐 = ∑ (
𝝏𝒚
𝝏𝒙𝒊
)
𝟐
∙ 𝛔𝒙𝒊
𝟐
𝒊     (1.5) 
where  σ𝑦 is the total estimated uncertainty (standard deviation) for a dose 
determined with one of the fit functions and σ𝑥𝑖  represents the standard deviations 
for the net reflectance (σ𝑛𝑒𝑡∆𝑅)  and the fitting parameters. Thus, the overall dose 
uncertainty consists of two terms: a term from the experimental uncertainty and 
another term due to the fitting process and its parameters determined during film 
calibration. The experimental uncertainty comprised sources including 
measurements reproducibility, scan reproducibility, film and scanner non-
uniformity, temporal and thermal mismatch of the film pieces, differences in average 
response values between different film pieces, and stochastic nature of dose 
deposition (Devic et al, 2004). Moreover, the average of the absolute errors was 
calculated. The absolute error was calculated as the difference between delivered and 
measured air kerma value obtained by the conversion of netR using calibration 
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curve. Table 1.4 and Table 1.5 show the results of the analysis of the best fitting 
function in terms of average absolute errors and reduced chi-square of the fit.  
Table 1.4: Average absolute error for each calibration curve function. The absolute error is the 
difference between calculated and delivered air kerma. (from Di Lillo et al, 2016a) 
Fitting 
curve type 
Average absolute error (%)  
Monochromatic beam Polychromatic beam 
20 keV 30 keV 38 keV 80 kV 120 kV 
Rational 3.75 6.65 7.15 2.03 3.04 
Exponential 3.90 6.97 7.64 5.57 2.91 
Power 3.59 5.46 5.07 3.89 3.36 
Logarithm 7.25 8.45 6.10 5.27 2.48 
Table 1.5: Reduced chi-square of the fitting procedure of dose response data. (from Di Lillo et al, 
2016a) 
Fitting 
curve type 
Reduced chi-square  
Monochromatic beam Polychromatic beam 
20 keV 30 keV 38 keV 80 kV 120 kV 
Rational 2.06 4.75 7.05 0.71 1.06 
Exponential 2.18 4.97 7.69 3.37 1.14 
Power 2.02 3.24 4.25 1.78 1.17 
Logarithm 7.39 7.28 3.20 3.44 0.93 
 
Figure 1.5 and Figure 1.6 show the calibration curves and the one sigma dose 
uncertainty as a function of air kerma, for the radiochromic films irradiated with 
monochromatic (Figure 1.5) or polychromatic x-ray beams (Figure 1.6). In 
particular, Figure 1.5b and Figure 1.6 b show the one-sigma relative uncertainty of 
the measured dose together with the corresponding fitting error and experimental 
uncertainties, for monochromatic and polychromatic beams, respectively. 
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Figure 1.5: a) Dose response curves evaluated for XR-QA2 radiochromic film irradiated with 
monochromatic beam at photon energies of 20, 30, 38 keV. The experimental data were fitted with 
the power function whose formula indicated on the graphs. b) Total one-sigma relative dose 
uncertainty and corresponding fitting and experimental uncertainties as a function of air kerma. (from 
Di Lillo et al, 2016a) 
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Figure 1.6: a) Dose response curves evaluated for XR-QA2 radiochromic film irradiated with 
polychromatic beam at tube voltage of 80, 120 kV. The experimental data were fitted with the power 
function whose formula indicated on the graphs. b) Total one-sigma relative dose uncertainty and 
corresponding fitting and experimental uncertainties as a function of air kerma. (from Di Lillo et al, 
2016a) 
The power function gives a total uncertainty of less than 6% above 6 mGy of air 
kerma at 20 and 30 keV, as well as above 3 mGy at 38 keV (Figure 1.5b); for 
polychromatic irradiation, the relative uncertainty is less than 5% in the whole air 
kerma range (Figure 1.6b).  Moreover, the evaluation of the average absolute error 
indicates a global fit accuracy within 5%. 
The four fitting functions reported by Tomic et al. (2012, 2014) for reference 
radiochromic film dosimetry protocol with a polychromatic X-ray source can also fit 
the experimental data obtained with a monochromatic X-ray source. In our work, the 
uncertainty analysis and absolute error study show that in the range of 
monochromatic or effective energies 20−46.5 keV, the power function provides the 
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best agreement between fit precision (evaluated via uncertainty analysis) and fit 
accuracy (assessed via average air kerma absolute error). This finding is in agreement 
with that carried out by Tomic et al. (2014), for the same radiochromic film irradiated 
with polychromatic X-ray beams in the range 50−140 kV (12.7−56.3 keV beam 
effective energy). 
Energy dependence 
A first evaluation of the energy dependent response was performed by 
comparing the dose-response curve of the XRQA2 film for monochromatic and 
polychromatic beam irradiations (Figure 1.7a). For photon or effective energy from 
20 to 38 keV, there is an increasing vertical shift of the response curve toward lower 
dose values, while the response curve at 120 kV shows a reversal of this trend with 
a vertical shift toward higher dose with respect to the curve at 80 kV. An accurate 
assessment of the energy dependent response of film can be carried out by evaluating 
the sensitivity of the film at each photon energy defined as the ratio between the 
change in radiochromic film response and the actual dose, which caused this change.  
Figure 1.7b shows the sensitivity of the radiochromic film as a function of photon 
energy (monochromatic beam, open square data symbols) or of effective energy 
(polychromatic beam, filled circle symbols). The sensitivity of the film under 
monochromatic irradiation increases with increasing energy in the range 18–39 keV, 
with a maximum variation of about 170% calculated as the ratio between the 
maximum and the minimum sensitivity values in this energy range. For 
polychromatic irradiation, the data show a variation of 118% in the film response 
with the increment of the effective energy beam in the range 38–46.5 keV. This 
variation was calculated as the ratio between the sensitivity values at effective 
energies of 38 keV (0.02098 mGy−1) and 46.5 keV (0.01774 mGy−1). For 
comparison, Tomic et al (2014) showed a significant variation of the film response 
of about 120 % at 80 mGy in the effective energy range 1839 keV.  
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Figure 1.7: a) Dose response curves of XR-QA2 film irradiated with a monochromatic (mono) beam 
at 20, 30, and 38 and with a polychromatic (poly) beam at 80 and 120 kV. b) Film sensitivity as a 
function of energy (or effective energy) for monochromatic and for polychromatic irradiation. (from 
Di Lillo et al, 2016a) 
Comparison with literature data 
A comparison between the dose-response curves obtained in this work and 
curves reported by Tomic et al (2014) and Giaddui et al (2012, 2013) at 120 kV for 
the same film type and comparable values of the beam HVLs is shown in Figure 1.8. 
In this graph, data by Tomic et al (2014)  and Giaddui et al (2013)  show a remarkable 
agreement; on the other hand, data by Giaddui et al (2012) for the same film type 
show a marked under-response (14%–38%, average value 34%, calculated as percent 
relative difference in response), while data in this work indicate an over-response 
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with respect to published data (Tomic et al, 2014, Giaddui et al, 2012,2013). In 
particular, we evaluated an over-response of XRQA2 radiochromic film in the range 
24%–27% (average value, 26%) with respect to data by Tomic et al. (2014). A 
maximum difference of 55% was observed (data in this work with respect to the 
work of Giaddui et al. (2013)). These discrepancies point toward a significant batch-
to-batch variation in the response of the XR-QA2 film for this beam quality (120 kV, 
HVL 6 mm Al). This could be attributed to differences in chemical composition of 
sensitive and adhesive layers among various batches, regarding the lithium 
concentration (Private communication by Dott. Lewis, independent consultant 
formerly employed by Ashland). In favour of this explanation, it is worth noting that 
Giaddui et al (2012, 2013) found two completely different dose response curves for 
the same film batch. If different scanners are used for film digitization for the same 
film manufacturer and model, this difference might also contribute, at least in part, 
to a different response curve for the same film batch. The differences may arise from 
scanner lamp aging, scanner mechanics, and variation in the readout noise. One of 
the ways to check for the presence of this specific source of bias in the derivation of 
the film dose response, and to correct it, is the use of a scanner optical calibration 
procedure based on a grey scale step wedge prior to the film calibration procedure. 
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Figure 1.8: Dose response curve of the XR-QA2 radiochromic film irradiated with a polychromatic 
source at 120 kVp, obtained by Tomic et al. (2014)  (lot # A07091204), Giaddui et al. (2012,2013) 
(lot # A04280904A) and in this work (lot # 01311401). (from Di Lillo et al, 2016a) 
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1.2.1.2 Characterization of GR-200A thermoluminescence dosimeters  
Thermoluminescence dosimeters (TLD) are usually used for personnel, 
environmental and clinical dosimetry. They were produced, for the first time, in 
powder form by Nakajima et al (1978), by doping LiF with Mg, Cu and P impurities. 
Presently, there are several companies that manufacture LiF:Mg,Cu,P dosimeters 
such as Solid Dosimetric Detector & Method Laboratory in Beijing, China (type GR-
200), Nemoto in Japan (type NTL-500), Institute of Nuclear Physics in Poland (type 
MCP-N) and by Thermo Scientific in USA (type TLD-100H, TLD-600H,TLD-
700H) (Bos, 2001). TLD is a dosimeter with a good tissue equivalence – Bacci et al 
(1993) reported for GR-200A dosimeter a Zeff between 7 and 8 –  high sensitivity, 
linear dose response, low fading rate and low residual signal (Shen et al, 2002). 
However, data reported in literature show a strong dependence of their response on 
the photon energy, due to the influence of the concentration of dopants and the spatial 
distribution of the energy deposition events (Horowitx, 1984). For x-rays, the photon 
ionization density, expressed by mean linear energy or by Linear Energy Transfer 
(LET), varies with photon energy because of changes in secondary electron spectra. 
LiF:Mg,Cu,P shows an anomalous response to low-energy x-rays (< 100 keV), due 
to its high dependence on LET: small changes of this (due to the gradual transition 
of x-ray interaction from predominantly photoelectric effect to Compton scattering 
(Olko et al, 1993)) lead to observable change in the response. Kron et al (1998) 
studied the energy response of various radiation detectors (including LiF:Mg,Ti and 
LiF:Mg,Cu,P TLD dosimeters) to monoenergetic and polyenergetic photons and 
proved that irradiation with monoenergetic beams permits to avoid the compounding 
effect of the spectral distribution of x-rays from conventional sources. They also 
showed an enhancement up to about 50% of the LiF:Mg,Ti response to 
monoenergetic photon beams in the energy range 10-100 keV, with respect to 6 MV 
spectral x-rays from a medical linear accelerator. On the other hand, the response for 
LiF:Mg,Cu,P was close to the 6 MV response, considering the experimental 
uncertainties, with some over-response up to about 20% at energies around 25 keV 
(Figure 1.9).  
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Figure 1.9: Response of LiF:Mg,Cu,P TLDs to monochromatic synchrotron radiation and X-ray 
spectrum, relative to 6 MV X-ray beam from a medical linear accelerator. (from Kron et al, 1998) 
 
Using monoenergetic synchrotron radiation (SR), Duggan et al (2004) irradiated 
LiF:Mg,Cu,P TLDs from two manufacturers (MCP-N, Poland; GR-200 series, 
China) and LiF:Mg,Ti (GR-100, China) in the range 10-26 keV. Their results 
confirmed both qualitatively and quantitatively those of Kron et al (1998), showing 
an increased response up to a factor of 1.5 for LiF:Mg,Ti and a response close to 
unity for LiF:Mg,Cu,P, relative to 6 MV irradiation. Their experimental findings 
confirmed the model prediction of Kron et al (1998).  
We investigated the energy response of the cylindrical LiF:Mg,Cu,P TLDs (type 
GR-200A,  Solid Dosimetric Detector & Method Laboratory, Beijing, China) of 4.5 
mm diameter and thickness of 0.8 mm in the energy range 18–40 keV following the 
same protocol which we reported in Emiro et al (2015).  The annealing of TLD was 
obtained by heating it at 235°C for 20 minutes. A Thermo Scientific™ Harshaw 
TLD™ Model 4500 reader was employed to read the dosimeter. The reading 
procedure consisted of heating the sample to a temperature of 240° with a linear ramp 
of 8 °C/s without pre-heat step.  
First, the response of GR-200A TLDs to the irradiation with a 60Co source 
with known calibrated activity was calibrated in terms of air kerma. Dosimeters were 
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placed in a PMMA phantom at a depth of 5.07 mm to provide charged particle 
equilibrium. The distance from source was 1m. The exposure time was tuned in order 
to obtain three different air kerma levels. A linear calibration curve was used for 
fitting the experimental data (air kerma in mGy vs. corresponding reading in nC). 
 The measurements for the evaluation of energy response were acquired at 
SYRMEP beamline of ELETTRA. A SR beam of size 15 cm × 0.34 cm (H × V) 
irradiated the dosimeter free-in-air at energy in the range 1840 keV, with a step of 
1 keV. The circular section of dosimeter was in the plane transverse to the direction 
of the beam propagation. A uniform exposure of TLD dosimeter was obtained by 
translating across the beam along the vertical direction. At each energy, four TLD 
were irradiated at a nominal air kerma of 10 mGy. The calibrated ionization chamber 
measured the real air kerma free-in-air during the irradiations. 
We calculated the air kerma relative response of each TLD, Rn, as: 
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where  nairSRK  is the air kerma in the SR beam, measured with the ionization chamber 
and  nairCoK 60  represents the air kerma in the 60Co reference beam that would give the 
same reader output Tn obtained with SR beam. airCoK 60 was estimated by means of 
linear calibration curve: 
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where sn is the slope of the calibration curve. Relative uncertainty in this value was 
estimated by propagating the uncertainties on calibration parameters. 
 Uncertainty on Rn, Rn), was estimated by propagating the uncertainties on 
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In equation 1.8, (sn) is the uncertainties on slope of the calibration curve of the nth 
dosimeter calculated using the least mean square method.  airSRK  is the uncertainty 
on 
air
SRK  (Tn) was evaluated with repeated measure on a single TLD and it is about 
2%. 
 At each energy, the average air kerma response (RE) was calculated as the 
weighted mean, with weights wn and weighted standard deviation R, of the air 
kerma response, Rn, of TLDs exposed to that energy: 
   




n n
R
n
n
n n
nn n
E
wR
w
w
Rw
R
E
1
;
1
;
2


   (1.9) 
Following (Olko et al., 1999), we evaluated the theoretical trend of relative response 
as: 
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which takes into account light self-absorption FL
E and attenuation of X-rays Fc
E in 
the TLD. The attenuation correction factor at energy E, Fc
E, was defined as: 
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where d is the thickness of the dosimeters and µen/ and  are the mass energy 
absorption coefficient and the density of LiF:Mg,Cu,P, respectively, for photons of 
energy E, calculated with the software XMuDat (Nowotny, 1998). 
The light correction factor at energy E, FL
E, was calculated according the 
following expression: 
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where l is the light absorption coefficient. 
Figure 1.10 shows the air kerma response of GR-200A TLDs to monochromatic 
SR in the energy range 1840 keV, relative to the response to 60Co -rays. The 
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continuous line represents the theoretical trend of the relative response, calculated 
according to equation 1.10. The following TLD composition by weight was used for 
the calculation (Olko et al., 1999): fluorine 0.7252, iodine 0.2648, magnesium 
0.0019, phosphorus 0.0069, copper 0.00121. A comparison between data in this 
work and data from Kron et al (1998) and Bakshi et al (2010), and data from 
Gonzalez et al (2007) and Emiro et al (2015) is also shown in Figure 1.9. It is to be 
noted that normalization is for 6 MV X-rays in Kron et al (1998), and for 60Co -rays 
in Bakshi et al (2010), Gonzalez et al (2007), Emiro et al (2015) and in the present 
study.  
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Figure 1.10:Comparison of energy response of LiF:Mg,Cu,P reported in this work and energy 
response reported in (Kron et al ,1998), (Bakshi et al, 2010), (Gonzalez et al, 2007). Note that Kron 
et al (1998), and in this work, LiF:Mg,Cu,P TLDs produced in China as GR-200A were studied. 
Bakshi et al (2010) investigated the LiF:Mg,Cu,P produced in Poland and commercially sold as MCP-
100. Data from in Kron et al (1998) are normalized to the response to 6 MV x-rays, while data in the 
present work and in (Bakshi et al, 2010), (Gonzalez et al, 2007) are relative to 60Co -rays. The 
calculated response follows from eq. 1.10 in the text. 
Data of this work show an increment of the relative response from 0.8 at 18 keV 
to 1.05 at 32 keV. For energies higher than 32 keV, a constant relative response of 
about 1.05 is observed. Martella in an application note shows similar result with a 
maximum of TLD response around 40 keV. This behaviour agrees with the expected 
trend estimated via equation 1.13. Our previous data published in (Emiro et al, 2015) 
suggested an over-response of LiF:Mg,Cu,P GR-200A dosemeters (produced in 
China) with respect to 60Co in the range 28-40 keV. This agrees with the results 
obtained in this work. However, a different behaviour was observed. In Emiro et al 
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(2015), we indicated a dip in the trend of the air kerma response vs. photon energy 
from 28 to 40 keV, which is considered significantly above the experimental error. 
On the other hand, the expected response showed a smooth trend. The measurements 
reported in this PhD work revealed a behaviour following the smooth trend of 
theoretical response without any dip. We want to highlight that different procedure 
for the ionization chamber calibration were employed. In Emiro et al (2015), the 
ionization chamber was calibrated in terms of air kerma with reference to the IOC 
chamber of SYRMEP in the whole range. However, the reference chamber was not 
calibrated in the energy range of interest. As already illustrated, in this thesis, we 
employed the IOC chamber as reference only in its calibration range (1828 keV), 
while the beam quality correction factor provided by manufacturing was applied in 
the range (2940 keV). For reference, we compared the air kerma measured with the 
IC at 28 keV using the IOC chamber calibration factor and the manufacture 
calibration factor. We evaluated values of 10.60 mGy using the calibration factor 
from the reference IOC chamber and 10.93 mGy taking into account the beam quality 
correction factor from manufacture. The relative difference of about 3% within the 
measurement uncertainty. Data in the literature for the response of GR-200A TLDs 
to low-energy monochromatic x-rays refer to few studies.  Bakshi et al (2010) 
measured the energy response, R, of MCP-100 LiF:Mg,Cu,P relative to 60Co and 
showed that there is a decrease from R = 1.0 to R = 1.23 (data interpolated from 
figure 10 in (Bakshi et al, 2010)) in going from 16 to 34 keV for SR monochromatic 
x-rays. In comparison, for those dosemeters, their Monte Carlo simulations indicated 
values (corrected for the detection efficiency of TLD material) between 0.95  and 
1.10 for the relative response, at 30 keV and 34 keV, respectively. Gonzalez et al 
(2007) presented the relative (to 60Co) energy response of GR-200A dosemeters 
produced in China, exposed to x-rays from x-ray tubes operated at tube potential in 
the range 30-250 kV. The corresponding data points in Figure 1.9 refer to their data 
at beam effective energies of 24, 34.5 and 42 keV, for which the estimated 
uncertainty on the response is 4%. Their data have a maximum value of 1 (i.e., equal 
response to 60Co) at effective energies between 34 and 42 keV and decrease both at 
lower and higher energies, so showing an under-response of GR-200A of 20% at 24 
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keV. It is to be noted, however, that these results refer to polychromatic X-ray 
spectra, while the data in this work are for monochromatic X-rays. For example, the 
34.5 keV effective energy in (Gonzalez et al, 2007) corresponded to photon spectra 
extending up to 80 keV. Indeed, two different manufacturers were implied in the two 
sets of literature data (Kron et al ,1998, Bakshi et al, 2010). Moreover, the 
experimental data reported in Bakshi et al (2010) (R  1.25) are not consistent (within 
the experimental uncertainties) with the experimental data of Kron et al (1998) (R  
1). On the other hand, GR-200A exposed to x-ray tube radiation show an under-
response in this range of effective energies (Gonzalez et al, 2007). This could be an 
indication of a material-specific and manufacturer-specific air kerma response of 
LiF:Mg,Cu,P TLDs in the low energy range explored in the present study, where 
significant deviations from R  1 (i.e., from the response to 60Co) have been observed 
with monochromatic irradiation between 28 and 40 keV.  
1.2.2 Breast and Phantom dosimetry 
My work for breast and phantom dosimetry included also the validation of the MC 
simulations (developed within SYRMA-CT collaboration) for estimation of the 
MGD in a breast CT exam with SR. The validation was performed by measurements 
of absorbed dose in phantoms. This work resulted in the publication of the following 
paper in international scientific journals. Here, we describe this work as illustrated 
in the corresponding paper. 
- Mettivier G., Fedon C., Di Lillo F., Longo R., Sarno A., Tromba G. & Russo P. 
(2016) Glandular dose in breast computed tomography with synchrotron radiation. 
Phys. Med. Biol. 61(2), 569–587. 
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The partial breast irradiation planned by SYRMA-CT collaboration for SR-BCT 
calls for the specific evaluation of the glandular dose and normalized glandular dose 
coefficients – via Monte Carlo (MC) simulations – in cases where not all of the 
(glandular mass in the) breast is irradiated. This evaluation must be performed (for a 
given breast size, breast composition and monochromatic beam energy) by 
considering various heights of the total scanned section (in the longitudinal direction 
from chest wall to nipple), in dependence on the total height of the thick section of 
the breast selected for imaging. A specific dosimetric protocol of this type is needed 
for assessing the imaging scan procedure. The condition of partial breast irradiation 
is different from that of (full field) 2D mammography (Dance 1990, Wu et al, 1994), 
of DBT (Sechopoulos, 2013a, 2013b) as well as of BCT (Boone et al, 2001a, 2004, 
Thacker and Glick, 2004, Yi et al, 2011). In dosimetric protocols adopted for those 
2D and 3D imaging techniques, the whole breast volume is irradiated and the 
definition of the mean glandular dose (MGD) refers to the total energy (Eg) deposited 
in the glandular tissue divided by the total glandular mass (Mg) of the breast 
(Hammerstein et al, 1979). However, dosimetric protocols dedicated to SR-BCT are 
not available yet, in cases where partial breast irradiations are performed. Indeed, the 
above protocols, if based on the calculation of the energy eg deposited in the 
glandular mass in the partially irradiated volume divided by the whole glandular 
mass Mg of the breast, may represent an underestimation of the MGD, since eg is less 
than Eg due to the presence of scatter dose in breast regions adjacent to the irradiated 
volume, and the actual irradiated mass (mg) is only a fraction of the whole mass of 
the breast (Mg). Hence, in the case of an irradiated section of the pendant breast 
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whose height is less than the full height of the breast (from chest wall to nipple), 
specific dosimetric evaluations are needed, for polychromatic as well as for 
monochromatic x-ray beams. In this study, we estimate, via Monte Carlo (MC) 
simulation, the breast glandular dose for a SR-BCT scan for various sizes and 
compositions of the pendant breast, at various energies of the monochromatic SR 
beam and at a fixed height of the laminar SR beam, by considering different 
thicknesses of the total irradiated section of the breast. This permitted to calculate 
also the normalized glandular dose coefficients (DgN) for given breast size and 
composition, at the monochromatic beam energy E, to be used for in vivo SR-BCT 
scans. 
1.2.2.1 New dose metrics 
The conventional definition of the MGD metric implies that, in the case where the 
whole breast volume is irradiated, MGD (mGy) is calculated from the total energy 
deposited (Eg) in the total glandular mass of the breast (Mg), as: 
𝑀𝐺𝐷 =  
𝐸𝑔
𝑀𝑔
      (1.13)  
In an analogous way, in the case where a fraction of the breast volume is irradiated, 
a quantity MGDv (mGy) can be calculated from the energy (eg) deposited only in the 
glandular mass of the directly irradiated breast volume (mg), as:  
𝑀𝐺𝐷𝑣 =  
𝑒𝑔
𝑚𝑔
     (1.14) 
 
The energy eg takes into account also energy deposits in the mass mg from radiation 
scattered from regions outside the irradiated volume. However, one has to consider 
also the dose delivered indirectly to the glandular tissue outside the irradiated 
volume: this dose originates from radiation scattered to breast regions adjacent to the 
irradiated ones. Then, one can define a third quantity, MGDt, as the ration between 
the total energy deposited in the whole breast (Eg) and the glandular mass in the 
irradiated volume (mg): 
𝑀𝐺𝐷𝑡 =
𝐸𝑔
𝑚𝑔
     (1.15) 
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where Eg is greater than eg due to scatter dose and therefore MGDt is greater than 
MGDV. The two quantities are coincident only in the limit where the whole breast is 
scanned. In the axial scanning of a section of the breast in multiple successive 
rotations and corresponding vertical translations of the patient support, for a given 
width of the SR beam, MGDV and MGDt  should be evaluated as a function of the 
total height of the scanned section, since the tails of the longitudinal scatter dose 
profiles from each axial scan overlap and sum up to determine the multiple scan 
average dose to the glandular tissue. If the height of the irradiated section 
corresponds to that of the beam (i.e. just one axial scan is performed), then the MGDt 
metric is related to the notion of the computed tomography dose index (CTDI) metric 
in whole body CT dosimetry (Kalender, 2014). Both of metrics take into account the 
scatter dose, i.e. the energy deposited by the scatter radiation outside the irradiated 
section. Indeed, as reported in IAEA (2011), AAPM (2010), Kalender (2014), “CTDI 
is defined as: 
𝐶𝑇𝐷𝐼100 =
1
𝑁𝑇
∫ 𝐷(𝑧) 𝑑𝑧
+50𝑚𝑚
−50𝑚𝑚
    (1.16) 
where T is the nominal slice thickness, N is the number of slices measured 
simultaneously and D(z) is the profile of absorbed dose in air originating  from one 
axial rotation along 100 mm of a line perpendicular to the tomographic plane. The 
CTDI100 is usually measured with 100-mm ionization chamber in a 15-cm height 
PMMA cylindrical phantom with a diameter of 16 cm (head section) or 32 cm (chest 
section). Phantom has one central and four peripheral holes for inserting the 
chamber.” 
1.2.2.2 Monte Carlo code validation 
MC code was based on Geant4 toolkit 10.00 (Agostinelli et al, 2003). It was 
developed by Dr. C. Fedon, Università di Trieste, Italy, within the SYRMA-CY 
collaboration (Fedon, 2016). The G4EmLivermorePhysics library were used for the 
particle transport, according to Fedon et al (2015) for applications in breast 
dosimetry. The code was validated with a direct comparison with data extracted from 
the literature (Boone 2002, Boone et al 2004, Mittone et al 2014a), in terms of 
mammographic normalized glandular dose coefficients (DgN), and ad hoc 
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experimental data, in terms of CTDI. In this thesis, we show the results of the 
comparison with CTDI measurements. The validation with literature data is reported 
in Mettivier et al. (2015). 
In order to perform the CTDI measurements, a Radcal ionization chamber (mod. 
10X6-3CT) connected with the dosimeter Accu-Pro was used (Radcal, Monrovia, 
CA, USA). The dosimeter provides the exposure time and the air kerma value 
corrected for temperature, pressure and calibration factors. The ionization chamber 
is a cylinder with an active volume of 3cm3 (142-mm length, but only 100-mm 
active, and base area of 0.3cm2). The nominal energy range is from 35 to 150 keV 
where the accuracy is ±5% as indicated by the manufacturer. During the 
measurement, the phantom rotated by 360 deg with a speed of 3°/s. The 
measurements were carried out in four different homogeneous PMMA cylinders with 
a diameter of 8, 10, 12 and 14 cm and a height of 15 cm. The energy was varied from 
8 to 40 keV. Figure 1.11 shows the comparison between the simulated (close symbol) 
and measured (open symbol) ratio of CTDI values measured in the centre of the 
phantom to the air kerma at the scanner isocenter. The agreement is in the order of 
5%. 
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Figure 1.11: Comparison between the simulated (close symbol) and measured (open symbol) ratio of 
CTDI values at the center of the phantom and in air at 18, 24, 32 and 38 keV in (a) and 20, 28, 35 and 
40 keV in (b). (from Mettivier et al, 2016) 
1.2.2.3 Dose Assessment 
By using the validated MC code, the dose was evaluated in cases, which matched the 
characteristics of the SR beam specifications. A sketch of the simulated setup is 
reported in Figure 1.12. The radiation field shape was a rectangular one, with a fixed 
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width of 15 cm and a variable dimension w according to the case studied. The 
samples had a cylindrical shape (diameter = d) with a height h of 1.5 times the 
sample’s radius, as in Boone et al (2004), and was composed of a homogeneous 
mixture of adipose and glandular tissues. A water box (with a volume of 13.5 dm3) 
was added for simulating the body of the patient. The skin thickness and the 
glandular fraction by weight used in this study were 1.45 mm (Huang et al, 2008, 
Shi et al, 2013) and 0%, 50% and 100%, respectively. We used the elemental 
composition reported in Hammerstain et al. (1979).  
 
Figure 1.12: Sketch of the simulated setup. The radiation field shape was set with a fixed width of 
150mm and a variable dimension w according to the case study. The samples had a cylindrical shape 
with a diameter d and a height h. The dimensions of the irradiated volume are π(d/2)2 × s where s is 
variable according to the case studied. A water box (with a volume of 13.5 dm3 ) was added for 
simulating the body of the patient. The skin thickness was 1.45 mm. (form Mettivier et al, 2016) 
 
The dimensions of the irradiated volume were calculated as π(d/2)2 × s where s is 
variable according to the case studied. A CT scan simulation consisted of a rotation 
of the phantom from 0 to 360 deg with a 1 deg step; for each projection image up to 
1 million photon histories were generated. We evaluated the dose, in terms of MGD, 
MGDV and MGDt, in the case of partial breast irradiation fixing the height w of the 
beam to 3 mm. In this case, the vertical dimension, s, of the irradiated breast volume 
was varied from 3 to 87 mm by translating vertically the beam with a step of 3 mm. 
This is the case closest to the SR-BCT scan conditions in the SYRMA-CT project. 
The photon fluence was kept constant and the energy was varied from 8 to 50 keV 
at 1 keV steps. In addition, we calculated the normalized glandular dose coefficient 
DgNCT defined as:  
𝐷𝑔𝑁𝐶𝑇 =
𝑀𝐺𝐷
𝐾𝑖𝑠𝑜
     (1.17) 
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where Kiso is the air kerma at isocenter. In particular, we estimated the DgNCT, 
DgNCTv DgNCTt to obtain the MGD, the MGDv  and the MGDt values, respectively, 
from the measurement of the air kerma at the scanner isocentre. The sample had a 
cylindrical shape with a diameter ranging from 8 cm up to 16 cm with a glandular 
fraction of 0, 50%, and 100% by weight. Since SYRMA-CT collaboration plans to 
irradiate a breast section of height 3 cm by translating vertically ten times the patient 
bed in 0.3-cm step corresponding to beam size, the DgNCT values were calculated 
for a 3-cm high (s = 3 cm, w = 3 mm) irradiated volume. 
Figure 1.13 shows the MGD whole breast, the MGDv and the MGDt for a 12 cm 
breast diameter (h = 9 cm) with a glandular fraction of 50% at a fixed energy of 38 
keV (one of the energy values that will be adopted in the SYRMA-CT project) as a 
function of the height s of the irradiated volume. We observe a linear dependence of 
the MGD whole breast on the height of the irradiated volume, due to the linear 
increase of the deposited energy with the increasing vertical dimension of the 
irradiated volume. On the other hand, the MGDv increases with a sub-linear trend 
with the increasing vertical dimension of the irradiated volume, because the 
deposited energy increases together with the glandular mass of the irradiated volume.  
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Figure 1.13: The MGD to the glandular mass present in the whole breast (solid square), or in the 
irradiated volume (open down triangle) or in the irradiated volume adding the contribution from 
scatter dose (close down triangle) for a 12-cm diameter breast phantom with a glandular fraction of 
50% varying the dimension of the irradiated volume with a 3 mm-height beam. The photon energy of 
the monoenergetic beam was 38 keV. (from Mettivier et al, 2016)   
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For the MGDt, the energy is deposited throughout the whole breast but the glandular 
mass used in the calculation of the corresponding dose is that of the irradiated 
volume. This dose MGDt is almost constant with a little decrease with the vertical 
dimension of the irradiated slice since as the irradiated area approximates the size of 
the entire breast, the energy delivered outside the slice is gradually smaller. The 
DgNCT in the case s = 3 cm with a w = 0.3 cm height beam is reported in Figure 1.14, 
Figure 1.15 and Figure 1.16. Figure 1.14 (a)–(c) show the DgNCT coefficients, which 
will be used to calculate the MGD to the whole breast for a breast diameter from 8 
to 16 cm at 0%, 50% and 100% glandular fraction, respectively. Figure 1.15 (a)–(c) 
and Figure 1.16 (a)–(c) show the DgNCTv and DgNCTt coefficients, needed for 
calculating the MGDv and MGDt for a slice of 30mm height (breast diameter varied 
from 8 to 16 cm, glandular fraction of 0%, 50% and 100%, respectively).  
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Figure 1.14: DgNCT coefficients to calculate the MGD (a, b, c) in the case of a 3 mm-height beam 
irradiating a 30 mm-height slice for a breast diameter from 8 to 16 cm in 1-cm step, and a glandular 
fraction of 0% (a), 50% (b) and 100% (c). The energy was varied from 8 to 50 keV with 1 keV step; 
data were represented as lines for ease of visualization. (from Mettivier et al, 2016) 
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All DgN coefficients - DgNCT, DgNCTv and DgNCTt – increase by increasing the 
photon energy of the incident beam, and they decrease by increasing the breast 
diameter at the chest and by increasing the glandular fraction. Moreover, DgNCT, 
DgNCTv, DgNCT values increase up to 0.5 mGy/mGy, to 0.9 mGy/mGy and 1.0 
mGy/mGy, respectively. For fixed air kearma, these values produce low level of 
MGD for the partial breast irradiation and higher value of MGDt and MGDv. This 
behaviour indicates that the use of the parameter MGD could produce an 
underestimate of the risk from radiation in the case of partial irradiation, because the 
energy deposition occurres in a limitated area of the organ resulting in a higher 
absorbed dose in that area. 
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Figure 1.15: DgNCT coefficients useful to calculate the MGDv (a, b, c) in the case of a 3 mm-height 
beam irradiating a 30 mm-height slice for a breast diameter from 8 to 16 cm in 1-cm step, and a 
glandular fraction of 0% (a), 50% (b) and 100% (c).  The energy was varied from 8 to 50 keV with 1 
keV step; data were represented as lines for ease of visualization. (form Mettivier et al, 2016) 
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Figure 1.16: DgNCT coefficients to calculate the MGDt (a, b, c) in the case of a 3 mm-height beam 
irradiating a 30 mm-height slice for breast diameter from 8 to 16 cm in 1-cm step, and a glandular 
fraction of 0% (a), 50% (b) and 100% (c). The energy was varied from 8 to 50 keV with 1 keV step; 
data were represented as lines for ease of visualization. (form Mettivier et al, 2016) 
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1.3 Imaging Performance on phantom and breast samples 
This paragraph of the thesis presents the results of the first imaging performance 
assessment reported by the SYRMA-CT collaboration (including my contribution to 
data analysis and manuscript preparation/revision). This work resulted in the 
publication of the following paper in international scientific journals. Here, we 
describe this work as illustrated in the corresponding papers. 
 
- Sarno, A., Mettivier, G, Golosio, B, Oliva, P, Spandre, G, Di Lillo, F, Fedon, C., 
Longo, R., Russo, P. (2016c) Imaging performance of phase-contrast breast 
computed tomography with synchrotron radiation and a CdTe photon-counting 
detector. Phys. Med. 32(5), 681–690. 
 
 
- Longo, R., Arfelli, F., Bellazzini, R., Bottigli, U., Brez, A., Brun, F., Brunetti, A., 
Delogu, P., Di Lillo, F., Dreossi, D., Fanti, V., Fedon, C., Golosio, B., Lanconelli, 
N., Mettivier, G., Minuti, M., Oliva, P., Pinchera, M., Rigon, L., Russo, P., Sarno, 
A., Spandre, G., Tromba, G., & Zanconati, F. (2016). Towards breast tomography 
with synchrotron radiation at Elettra: first images. Phys. Med. Biol. 61(4), 1634–
1649. 
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1.3.1 Evaluation of MTF and NPS of system 
 
A system is defined linear when the response to a linear combination of stimuli with 
given coefficients is equal to the linear combination of the response to each 
individual stimulus, with the same coefficients. A noteworth application of this 
description is the analysis of a linear system to an arbitrary input in terms of its 
Fourier components. In order to evaluate the spatial resolution and the noise 
characteristics of our phase-constrast BCT system, we assume the applicability of 
linear system analysis theory for phase-contrast imaging. The high-resolution 
detector of the SYRMA-CT system, and the practical absence of penumbra due to 
the almost parallel beam geometry, contribute to produce high-resolution CT scans 
over a 180-deg angular span. The spatial resolution of the SYRMA-CT scanner was 
evaluated by measuring the system MTF; a limiting spatial frequency was evaluated 
at 10% MTF value (MTF0.1). A sharp polymethylmethacrylate (PMMA) edge (for 
which (E) = 1.845 × 10-7 and (E) = 1.219 × 10-11@ E = 38 keV (XOP 2.3), where 
andare the component of the refractive index of the material𝑛 = 1 −  𝛿 + 𝑗𝛽; 
thickness = 2 mm; height = 90 mm) was imaged in order to evaluate the system edge 
spread function (ESF), from which the line spread function (LSF) of the system was 
evaluated, by numerical differentiation. In order to reduce the noise, in the case of 
the MTF evaluation with the PMMA edge, the ESF curves have been averaged over 
10 consecutive rows. The PMMA slab introduced little attenuation but sizeable phase 
shifts in the X-ray beam. Then, the system MTF (normalized to the value at zero 
44 
 
spatial frequency) was computed via numerical Fourier transform. It is worth noting 
that the fringes on the phase-contrast image of the PMMA edge (determining the 
edge enhancement effect typically observed in in-line phase-contrast imaging) may 
distort the MTF curves derived in the above way, introducing an artifact (i.e. 
normalized MTF values greater than 1) similar to the one occurring in CT 
reconstruction with the use of some kernels, characterized by undershoots in the 
kernel curve, see, e.g., Boone (2001b). The system MTF was evaluated also by using 
a highly attenuating object, a 50-m diameter tungsten wire placed parallel to the 
rotation axis, at 50 mm radial distance from the axis, slightly tilted (2 deg) with 
respect to the rotation axis in order to obtain the presampled LSF. This technique is 
commonly used for spatial resolution assessment in cone-beam breast CT (Kwan et 
al, 2007, Mettivier et al, 2011a). The evaluation of the system MTF was carried out 
with two reconstruction voxel sizes (60 × 60 × 60 m3 and 120 × 120 × 120 m3, 
respectively). This voxel size is smaller than that usually used in BCT (between 200 
m and 400m). This choice is related to the necessity to visualize the edge 
enhancement effects of SR propagation, which require a pixel size much less than 
200-m. On the other hand, the high efficiency of the single photon counting detector 
and its superior SNR performance with respect to energy integrating detectors, 
permit to investigate the performance of our system in such high resolution 
conditions.  
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Figure 1.17: MTF curves evaluated on the images without phase retrieval (a) and with phase-retrieval 
(b), evaluated across the PMMA edge, with voxel size of (60 μm)3 and (120 μm)3 obtained with 720 
projections equally spaced over 180 deg rotation scan. The dashed horizontal line indicates the 10% 
MTF value. (from Sarno et al, 2016c) 
Figure 1.17 shows the system MTF in the images obtained without phase retrieval 
(Figure 1.17a) and with phase retrieval (Figure 1.17b), evaluated using the PMMA 
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edge. The curves were obtained from 720 projections equally spaced over a 180-deg 
scan and with an isotropic voxel of (60 m)3 and of (120 m)3. The edge 
enhancement effects cause an increase in the signal, as demonstrated in (Figure 
1.17a). Such effects determine MTF curves which exceed the normalization value at 
zero spatial frequency. Due to the system spatial resolution reduction, such a 
phenomenon reduces as the voxel size increases from (60 m) 3 to (120 m) 3. Honda 
et al (2006) showed a similar result in polychromatic propagation based phase-
contrast mammography, related to an ‘‘improvement of sharpness caused by the edge 
effect” (Honda et al, 2006). Figure 1.18 shows system MTF curves for the images 
without phase retrieval (evaluated with the method of the thin tungsten wire) not 
influenced by the phase effects. In these curves the limiting frequency at MTF0.1 is 
6.7 mm-1 with voxels of (60 m)3; it reduces to 2.5 mm-1 (evaluated over the PMMA 
edge) when a Paganin filter was applied to the projections (Figure 1.17b). 
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Figure 1.18: MTF curves for the images without phase retrieval, evaluated over the thin tungsten wire, 
with voxel size of (60 μm)3 and (120 μm)3 and with 720 projections equally spaced over 180 deg 
rotation scan. The dashed lines indicates the 10% MTF value. (from Sarno et al, 2016c) 
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Figure 1.19: MTF curves for the images without phase retrieval, evaluated over the thin tungsten wire, 
with voxel size of (60 μm)3 and 720 projections equally spaced over 180 deg rotation scan at 10 mm, 
30 mm and 50 mm from the scanner isocenter. (from Sarno et al, 2016c) 
 
Increasing the voxel size to (120 m)3 reduces the limiting spatial frequency 
both in the images without phase retrieval (evaluated with the tungsten wire) and 
with phase retrieval (evaluated over the PMMA edge) down to 4mm-1 and 1.7 mm-
1, respectively. However, the frequency at MTF0.1 evaluated with the method of the 
thin tungsten wire (6.7 mm-1 for a voxel size of (60 m)3) does not differ significantly 
from that obtained with the PMMA edge (7.2 mm-1); for a voxel size of (120 m)3 
the limiting frequencies are 4 mm-1 and 3.8 mm-1, respectively. Figure 1.19 shows 
the MTF curves for the tungsten wire, for the images without phase retrieval, at 10 
mm, 30 mm and 50 mm from isocenter. The curves do not significantly differ from 
each other, and the slight difference can be attributed to the uncertainty in the 
evaluation. 
The common metric for the evaluation of noise properties in attenuation based 
CT imaging is the (3D) NPS, which describes the spatial decomposition of noise 
variance in an image as a function of the spatial frequency, thus expressing the noise 
transfer property of the system. For the experimental determination of the NPS a 
scan was performed of a homogeneous mammographic phantom ((E) = 1.619 × 10-
7; (E) = 0.697 × 10-11; @ E = 38 keV (CSIRO)), a CIRS phantom BR 50/50 mod. 
014AD simulating a 50/50 breast tissue (i.e. a 50% glandular, 50% adipose tissue) 
(CIRS Inc., Norfolk, VA, USA). The 1D coronal NPS was evaluated as indicated in 
Yang et al (2008). The 2D NPS was estimated by the 2D fast Fourier transform from 
a region of interest (ROI), which did not include any target, in the coronal view. 
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Then, the 1D noise power spectrum was computed by radially averaging the 2D NPS. 
Pixel values in phase-contrast CT slices represent the attenuation coefficient 
(proportional to the local value of b) of the imaged object, and the pixel value of 
images after phase retrieval is proportional to . Then, normalized NPS (NNPS) 
curves were evaluated, by dividing the NPS curves by the square root of the mean 
signal value in the ROI where the NPS was evaluated. These curves do not depend 
on the signal units of measurement, so permitting to compare noise power spectrum 
in the images obtained with and without phase retrieval. Figure 1.20 shows the NNPS 
curves evaluated on the images without phase retrieval (Figure 1.20a) and with phase 
retrieval (Figure 1.20b). Such curves were evaluated with an image voxel size of (60 
m)3 as well as for a voxel of (120 m)3. Since the (raw processed) detector pixel 
pitch is 30 m, the corresponding signal bandwidth extends up to 16.7 mm-1 (Yang 
et al, 2008), and in the case of reconstructed coronal pixel pitch of 60 m and 120 
m, the sampling theorem indicates that signal aliasing may be present, producing 
signal spectra distortions. This effect was observed in the NNPS curves in the case 
that the Paganin filter is not applied, where the signal deviates significantly from 
zero for the highest frequencies (Figure 1.20a). Such a filter is a low-pass filter, 
which decreases signal noise as well as the influence of aliasing (Figure 1.20b). The 
voxel size has strong influence on NNPS for the images without phase retrieval: 
indeed, the maximum of the curve with a voxel size of (120 m)3 is less than half of 
the maximum of the curve related to a voxel size of (60 m)3. The voxel size had 
weaker influence on NNPS obtained with phase retrieval. In this case, the NNPS 
curves show a drastic reduction in the noise level in comparison to that in images 
obtained without phase retrieval. For a voxel size of (60 m)3, the maximum of the 
NNPS curve in the images without phase retrieval is more than one order of 
magnitude greater than the maximum of the curve with phase retrieval. Moreover, 
the first curve presents a maximum at 3 mm-1, and it reduces to about 1mm-1 after 
the Paganin filter (as a result of spatial filtering). The noise in phase retrieval 
imaging, being less prominent at high spatial frequencies than in the case of the 
images without phase retrieval, may better fit the need of detecting smaller lesions, 
and balance the reduction in the system spatial resolution due to the Paganin filtering. 
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Figure 1.20: NNPS in the images without phase retrieval (a) and with phase retrieval (b). They were 
evaluated both with a voxel size of (60 μm)3 and of (120 μm)3 and the reconstructions were performed 
from 720 projections equally spaced over a 180-deg rotation scan. Air kerma at isocenter = 10.4 mGy. 
(from Sarno et al, 2016c) 
1.3.2 Imaging of breast specimens 
 
Tomographic data sets were acquired from breast tissue specimens in order 
to perform a preliminary evaluation of PhC breast CT images of potential clinical 
interest. Two breast tissues (sample 1 and sample 2) containing cancer were studied. 
Both of them were fixed in formalin and sealed in a vacuum bag. This work was 
carried out following the Directive 2004/23/EC of the European Parliament and of 
the Council of 31 March 2004 on setting standards of quality and safety for the 
donation, procurement, testing, processing, preservation, storage and distribution of 
human tissues. The images presented in this study were acquired in order to guide 
the pathologist in the localization of the lesions for the histological preparation, 
according to the standard procedures of the Pathology Unit of the Academic Hospital 
of Cattinara, Trieste University, accredited by JCI (Joint Commission International). 
The samples were prepared from specimens of breast lumpectomy and were derived 
from surgical material sent to the Pathology Unit according to local guidelines for 
histological examination. 
Sample 1 contains an infiltrating ductal carcinoma, about 1.5 cm diameter. It is 8 
mm thick and it was embedded in agar gel inside a plastic cup in order to obtain an 
object with dimension and attenuation comparable to that of a breast section. The 
diameter of the holder is about 9.4 cm. Acquisition parameters were: air kerma rate 
0.52 mGy s−1, 1200 projections equally spaced over 180 degrees, 50 ms per 
projection, MGDv equal to 23 mGy evaluated with a MC conversion factor 0.73 mGy 
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mGy−1. Sample 2 contains a large (2.5 cm diameter) solid papillary carcinoma 
(poorly differentiated, G3 grade). Sample dimensions are about 89 mm × 36 mm, 5 
mm thickness. Acquisition parameters were: air kerma rate 0.36 mGy s−1, 1200 
projections equally spaced over 180 degrees, 50 ms per projection, MGDv equal to 
17 mGy evaluated with a MC conversion factor 0.77 mGy mGy−1. For both samples, 
we selected an acquisition time of 50 ms per and a detector acquisition rate of 20 
frames/s – close to the real conditions of the clinical trial. The imaging was 
performed at “high dose values” (around 20 mGy in terms of MGDv), by selecting a 
dose rate for Sample 1 – which was fixed in agar gel – higher than for Sample 2 in 
order to have the same signal on the detector. 
 We used two reconstruction algorithms: a standard FBP algorithm and an 
iterative SART algorithm. FBP reconstruction on datasets with a relatively large 
number of projections was used as a gold standard to evaluate the performance of 
other reconstruction algorithms with a reduced number of projections and phase-
retrieval pre-processing. The SART algorithm has been successfully applied to a 
wide range of CT applications (Camerani et al, 2004, Golosio et al, 2004, Cauzid et 
al, 2007); it is relatively fast compared to other iterative algorithms, and its 
convergence properties have been well studied (Kak and Slaney 1988). In the SART 
algorithm, the iterative corrections are made angle-by-angle, i.e. for each angular 
view, the corrections are evaluated and applied simultaneously to all rays of the 
projection. One iteration is considered to be completed when all the projections have 
been used. We used a random ordering for the projections in order to avoid 
systematic errors in the reconstruction. A few iterations are sufficient for the 
algorithm to converge. The reconstructions presented in this work were made using 
five iterations. The correction was multiplied by a relaxation factor, which grows 
linearly from zero to a maximum in the first few projections used by the 
reconstruction algorithm (the first 10 in this work) and decreases linearly from this 
maximum to zero when the number of projections increases. The relaxation factor 
suppresses residual oscillations, ensuring stability and convergence of the iteration 
(Golosio et al, 2004). A bilateral filter was combined with the iterative reconstruction 
in order to improve image regularization. This type of filter takes two parameters: a 
spatial filter parameter, αd, which controls the amount of smoothing differences in 
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coordinates, and a range filter parameter αr, which accounts for smoothing 
differences in intensities. In this work αd is expressed in pixel units, while αr is 
expressed in cm−1. The latter are the same units used for the linear absorption 
coefficient distribution obtained by the tomographic reconstruction algorithms. In 
order to exploit the phase information carried out by the projections, a phase retrieval 
filter following the Homogeneous Transport of Intensity (TIE-Hom) Algorithm 
(Paganin et al, 2002) was applied prior to the actual reconstruction, with a fixed value 
of the δ/β ratio, namely 2508. This value was extracted from a publicly available 
database (https://ts-imaging.net/Services/Simple/ICUtilXdata.aspx) for the adipose 
tissue at 38 keV. The projections obtained by applying the phase retrieval algorithm 
were normalized to the same average intensity as the projections without phase 
retrieval. The phase retrieval pre-processing were applied to the data sampled at 60 
μm pixel size, even if the image was reconstructed with 120 μm pixel size, in order 
to maximize the effectiveness of the algorithm, which is based on edge enhancement 
signals.  
In Figure 1.21, image reconstructions of sample 1 are presented. Figure 1.21a 
has been obtained with the FBP algorithm by using 1200 projections and a MGDv of 
23 mGy. The voxel of the reconstructed images is (120 μm)3, as a good compromise 
between spatial resolution and signal-to-noise ratio. The black details inside the 
object are air bubbles due to the folding of the plastic bag containing the sample; 
edge-enhancement effects are visible at the air–plastic foil interface. Figure 1.21b 
shows the FBP reconstruction of 300 projections, obtained by reducing the MGDv 
(about 6 mGy) of a factor 4 with respect to Figure 1.21a. Figure 1.21c shows the 
same 300-projections data set reconstructed by means of SART (αd = 4 and αr = 0.2). 
The image in Figure 1.21d was obtained by applying a phase retrieval filter prior to 
using the same SART algorithm used in Figure 1.21c. Images reconstructed using 
SART present lower noise and a preserved spatial resolution. In contrast to Figure 
1.21 a–c, in the phase-retrieved image (Figure 1.21d) the glandular tissue appears 
brighter than the agar gel surrounding the sample. As expected, the phase-retrieved 
image does not show edge enhancement effects, but the noise is significantly 
reduced. The conventional mammography of sample 1, before agar gel inclusion, is 
presented in Figure 1.22 to show the fine parenchymal structures present in the 
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sample. They are visible in both digital mammography and CT images. However, in 
the latter, no overlapping features are present. 
 
Figure 1.21: Sample 1(diameter: 9.4 cm).(a) FBP reconstruction of 1200 projections and (b) 300 
projections, (c) SART (αd = 4 pixel-1, αr = 0.2 cm-1) reconstruction of 300 projections, (d) phase 
retrieved SART (αd = 4 pixel-1, αr = 0.2 cm-1) reconstruction of 300 projections (from Longo et al, 
2016).  
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Figure 1.22: Digital mammography (planar image) of sample 1 (from Longo et al, 2016). 
Sample 2 was studied without inclusion in the agar-gel. The MGDv was about 17 
mGy for 1200 projection over 180 degrees. According to Zhao et al (2015), in 
clinical breast CT, even if the voxel size is smaller than 1 mm, the radiologist adjusts 
the slice thickness during the image evaluation according to the diagnostic 
requirements, up to about 2 mm. In order to evaluate the potential clinical application 
of our low-dose images, 0.84 mm thick slices were obtained by adding 7 images 
from the sample 2 data sets. In Figure 1.23 the results are presented for the FBP 
reconstruction from 1200 phase-retrieved projections (a) and for a low dose 
reconstruction obtained by applying the SART technique on 300 phase retrieved 
projections (b) with a dose reduction of a factor 4 (MGDv is 4.25 mGy). Ring 
artefacts are visible due to the gaps between the 8 sensors of the PIXIRAD-8 
detector, which were not perfectly corrected by the seaming procedure in a couple 
of cases. Figure 1.23c shows the planar image of the specimen obtained at a clinical 
mammographic unit; the nodule thickness in the sample in not constant, therefore 
the contrast modulation inside the cancer in the mammographic image is due to its 
irregular shape and not to any density inhomogeneity of the nodule.  
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Figure 1.23: Images of 0.85 mm thick slices of Sample 2 obtained (a) from FBP reconstruction of 
1200 phase retrieved projections and (b) SART reconstruction of 300 phase retrieved projections (αd 
= 2 and αr = 0.05). (c) Planar image obtained from the 5 mm-thick sample at a clinical mammographic 
unit. In (a) the ROIs for CNR and C assessment are outlined together with the line over which the 
profiles in Figure 1.24 are evaluated. (from Longo et al, 2016) 
 
In order to quantify the effect of the dose reduction and the application of the iterative 
reconstruction, contrast (C) and contrast-to-noise ratio (CNR) values were calculated 
in Figure 1.23a and Figure 1.23b.  The contrast and CNR were evaluated according 
the following definition: 
𝑪 =
|𝑺𝟏−𝑺𝟐|
𝑺𝟐
      (1.18) 
𝐶𝑁𝑅 =
|𝑆1−𝑆2|
√
𝜎1+𝜎2
2
          (1.19) 
where S is the average voxel value in the selected region of interest (ROI) and σ2 is 
the signal variance in the same region. The subscript numbers indicate the two ROI 
between which C and CNR were evaluated. 
Moreover, the possible loss in spatial resolution, due to the reduction in projection 
in the SART image, has been investigated by measuring the signal profiles at the 
boundary of the lesion in both image reconstructions. In Figure 1.23a, the ROIs 
selected for the CNR and contrast evaluation are outlined. The contrast and the CNR 
for the FBP reconstruction with 1200 phase retrieved projections (Figure 1.23a) are 
0.28 and 18 respectively, while, for the SART reconstruction with 300 phase 
retrieved projections (Figure 1.23b), C = 0.29 and CNR = 13, indicating that the 
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contrast is constant while a reduction of 30% of CNR is observed with a dose sparing 
of 75%.  
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Figure 1.24: Profiles across the line in Figure 1.23a, obtained both with FBP reconstruction from 
1200 projections and a MGDV of 16.6 mGy and with SART algorithm (αd = 2 pixel-1, αr = 0.05cm-1) 
from 300 projections and a MGDV of 4.2 mGy. Voxel size = (120 μm)3 (from Longo et al, 2016). 
 
Figure 1.24 shows the signal intensity profiles of the images (evaluated across the 
line in Figure 1.23a for both the FBP reconstruction with 1200 phase retrieved 
projections (Figure 1.23a) and for the SART reconstruction with 300 phase retrieved 
projections (Figure 1.23b); they presented a FWHM of 420 μm and the results were 
quite similar. These results suggest that the SART technique is a very promising 
candidate for the tomographic reconstruction of the SYRMA-CT images. 
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1.4 Discussion 
1.4.1 Dosimetry in SR-BCT 
In SR-BCT exam, the limited vertical dimension of the SR beam and the 
necessity to translate and rotate the patient pose practical limits to the efforts made 
to achieve the in vivo exam of the female breast, related to the duration of the exam 
and to the discomfort for the patient. In order to overcome these limitations the 
SYRMA-CT collaboration plans to image only a fraction of the pendant breast, by 
investigating only regions where a suspicious lesion has been previously located. 
This strategy has important dosimetric consequences. The use of the MGD in the 
case of the irradiation of a limited fraction of the breast could lead to an 
underestimation of the delivered dose. The value of this underestimation depends on 
the dimensions of the irradiated breast: specifically, it increases with the decrease of 
the irradiated volume up to 97% in the case of irradiation of a single slice of 3mm 
height. On the basis of these results, we introduced two new MGD parameters related 
only to the irradiated volume: MGDv and MGDt. The MGDv is defined as the ratio 
between the deposited energy and the glandular mass in the irradiated volume, whilst 
the MGDt is defined as the ratio between the deposited energy in the glandular mass 
of the whole breast and the glandular mass in the irradiated volume. The use of 
MGDv and MGDt is intended to estimate absorbed dose in the glandular tissue. We 
noted that the MGDt is almost independent of the height of the irradiated volume and 
that it assumes values similar to the MGD value for the whole breast irradiation. In 
addition, we point out the close proximity between the MGDt and the CTDI concept. 
Indeed, in whole body CT the CTDI100 is evaluated in single axial scan with an ion 
chamber which integrates the dose along the z-axis over a length of 100mm; 
similarly, in the software evaluation of the MGDt parameter the energy deposited by 
scattered radiation outside the irradiated volume is attributed to the glandular mass 
in this volume, as an additional contribution to the dose. On the other hand, the 
proposed MGD metric can be interpreted as an actual dose value to the glandular 
breast, while CTDI100 does not represent the dose in the patient body. The parameter 
MGDv was also proposed by Sarno et al. (2017b) as dose metric in spot compression 
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mammography with X-ray tube which is employed as diagnostic exam in patient 
with suspicious lesion. 
SYRMA-CT collaboration plans to use TLDs and radiochromic films for beam 
and phantom dosimetry. We performed a characterization of radiochromic film XR-
QA2 and TLD GR-200A for the irradiation with a monoenergetic X-ray beam in the 
range 1840 keV. This work showed that dose response curves of XR-QA2 films 
exposed to monoenergetic ( as well as polyenergetic) X-ray beams exhibit a 
significant dependence on photon energy, with film sensitivity ranging from a 
minimum of 0.0127 to a maximum of 0.0219 at 10 mGy air kerma in air, in the range 
of HVL values from 0.55 to 6.1 mm Al photon and corresponding effective energies 
from 18 keV to 46 keV. A significant variation of the response for even the very 
same batches of the film was also observed. These findings, also compared with the 
reported experience of different groups in the evaluation of the response of XR-QA2 
radiochromic films, indicate the opportunity of a batch-specific, beam-quality 
dependent characterization of these films for their use in  high accuracy, high 
precision reference dosimetry. The response of GR-200A TLDs to monochromatic 
x-rays in the range 18-40 keV showed a strong dependence on the energy. In 
particular, an increment of the air kerma response relative to 60Co with a plateau at 
energy higher that 32 keV was observed. Data in the range 29-40 keV reported in 
this work will be updated in the next months when a calibration of IOC chamber on 
SYRMEP beamline with reference to the primary standard of INMRI-ENEA (Italian 
National Institute for Ionizing Radiation Metrology) will be performed at energy 
higher than 28 keV. 
The dosimetric results reported in this thesis represent most of the work of the 
dosimetry group in the SYRMA-CT project. The new dose metrics will be used as 
dose reference in the examination protocol for the clinical trial. The radiochromic 
film characterized in this thesis will be used to provide a quantitative evaluation of 
the beam dosimetry before perfoming exam, as a part of the quality control 
procedure. Moreover, we are now testing the use of such radiochromic film for off-
line dose monitoring after the exam, by recording beam variations during the breast 
irradiation. A piece of radiochromic film positioned in a circle around the breast – 
hanging in an acrylic tube or hosted in a breast holder – will record the history of the 
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full irradiation scan. In addition, the periodically quality assurance control will also 
include the evaluation of the dose distribution in phantoms which will be performed 
will be performed with TLD characterized in this thesis. 
1.4.2 Imaging performance of SR-BCT 
The combination of the fine pixel pitch, the high resolution X-ray detector 
embodied in the SYRMA-CT scanner, the high-spatial coherence monochromatic X-
ray beam and the large distance between scanned object and detector plane (about 2 
meters), permitted to detect phase-contrast effects produced by X-ray beam 
refraction in free-space propagation based imaging. No phase-contrast effects were 
present in CT slices of a breast specimen in a previous study at ELETTRA with the 
same geometry: this was attributed to the larger pixel pitch (200 m) of the detector 
used in that previous study, which hindered the visibility of the signal overshoot and 
undershoot at object edges (Pani et al, 2004). In this work, with a 60-m pitch 
detector, reconstruction voxel size of 60 m and 120 m side preserved the phase-
contrast information. In previous investigations at ELETTRA with monochromatic 
SR film-screen mammography, propagation-based phase-contrast imaging showed 
higher contrast detail visibility than conventional mammography at a comparable or 
lower dose (Castelli et al, 2007). In this new SR setup at ELETTRA, the fine pitch 
featured by the single-photon counting detector determined a spatial resolution as 
high as 6.7 mm-1 at 10% MTF, in slices with voxel size of (60 m)3 reconstructed 
via FBP algorithm and without phase retrieval. This system spatial resolution is 
significantly higher than that of polychromatic cone-beam BCT scanners (Sarno et 
al, 2015), and compares well with the 5.6 mm-1 limiting frequency of the helical BCT 
scanner developed at University of Erlangen equipped with a high-resolution single-
photon counting detector (Steiding et al, 2014). The spatial resolution limit of the 
SYRMA-CT setup reduced to 2.5 mm-1 when a Paganin filter was applied on the 
projections, in the application of the phase retrieval algorithm. The edge 
enhancement effects seen in phase-contrast images of test objects increased the MTF 
curve to values higher than its zero frequency value; Honda et al (2006), in 
propagation-based phase-contrast mammography, related a similar effect seen in 
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their images to an improvement of the edge sharpness of the object in projected 
images due to the phase effects. The Paganin filter reduced drastically the image 
noise: the NNPS curves for images without phase retrieval had a maximum value 
several times greater than that in phase retrieval images. The voxel size had weak 
influence on noise in images obtained with phase retrieval. The NNPS curves in the 
images without phase retrieval reached their maximum value at about 3 mm-1; on the 
other hand, the curves in the images with phase retrieval had their maximum at 1 
mm-1, balancing in part the reduction of the system spatial resolution due to the 
Paganin filter.  
The first images of the SYRMA-CT collaboration on a breast specimen of about 
9 cm in diameter indicate that clinical PhC breast CT with SR is technically feasible. 
An uncompressed breast diameter of 9–10 cm at chest wall corresponds to a 
compressed breast thickness of about 2 cm, for which the MGD for two-view 
mammography is 1–2 mGy (Boone et al, 2005). Hence, the minimum dose level 
(MGDv about 4 mGy) attained in this study is only 2–4 times higher than that of a 
two-view mammography for a 2 cm compressed breast. Noticeably, a MGD about 7 
times higher than that of a two-view mammography has been reported for a 2 cm 
compressed breast in a polychromatic cone-beam CT clinical prototype 
(Sechopoulos et al, 2010).  
The imaging study reported in this thesis was carried out at 38 keV showing the 
high performance of SYRMA-CT/3D setup in terms of spatial resolution and noise 
characterization and the improvement obtained with the SART technique for the 
tomographic reconstruction. It represents the start point of the optimation of the 
exam parameters for the future clinical trial. In order to obtain the highest image 
quality with the lowest possible dose, the SYRMA-3D collaboration is now studying 
the performance of the PhC-BCT setup, in terms of hardware – such as detector, bed 
setup –  (Sarno et al, 2016c, Delogu et al, 2017a, Delogu et al, 2017b) and software 
– such as reconstructyion algorithm (Fardin et al, 2016, Sarno et al, 2017c). Nesterets 
et al (2015) and Baran et al (2017) have recently reported on the parameters 
optimization in propagation-based PhC-CT with synchrotron radiation, using setups 
different from that of SYRMA-CT/3D. Nesterets et al (2015) in a study on 
cylindrical phantom at 35, 45, and 50 keV showed that it is possible to detect the 
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phase effects also using a detector with relatively large pixel size: this results from 
the adoption of long sample-to-detector distances up to 5 m. They also report that 
the energy which optimizes the image quality, in terms of Contrast-to-Noise Ratio 
per unit of dose and the FOM (“the ratio of the CNR per unit dose to FWHM of the 
material boundaries”), depends on the analysed materials. Successively, Baran et al 
(2017) found that the propagation-based technique gives significant promise for low-
dose BCT on patient when employing a photon  energy of 32 keV, a sample-to-
detector distance of 9 m and TIE-Hom phase retrieval pre-processing combined with 
iterative CT reconstruction algorithms. The projections are acquired with a 
conventional-flat panel detector (pixel size about 100 m) or a high-resolution CCD 
TDI sensor coupled to a CsI scintillator (pixel size about 54 m) (Baran et al 2017). 
Our setup for clinical trial provides a maximum sample-to-detector distance of 2 
metres which may reduce the image quality according to Baran et al. (2017); on the 
other hand, the setup includes a single-photon counting detector with a high spatial 
resolution (60 m) and high efficiency, which is expected to improve the imaging 
performance of the system. 
It is important to take into account that PhC techniques different from 
propagation-based imaging (PBI) – such as analysed-based imaging (ABI), grating 
interferometry (GI) or edge illumination (EI) – are also under investigation for breast 
imaging by using a synchrotron radiation source or an X-ray tube. The analyser-
based PhC technique (which uses an analyser crystal between sample and imaging 
detector, Coan et al. 2013) showed good performance for breast imaging (Ando et 
al, 2008), providing images comparable to those obtained from histopathology slice 
(Coan et et al, 2013, Kerilainen et al, 2008, Sztrókay et al, 2012) and with an imaging 
dose comparable to that of two-view mammography (Coan et et al, 2013, Zhao et al, 
2012). Although previous studies were performed with synchrotron radiation, 
images with high contrast at low doses can also be obtained with a laboratory-based 
X-ray source (Coan et al, 2013).  GI uses a Talbot grating interferometer and was 
investigated for breast imaging with a synchrotron source (Sztrókay et al, 2013, 
Willner et al, 2014) as well as with an X-ray tube (Willner et al, 2014, Stampanoni 
et al, 2011, Grandl et al, 2013). This technique permits to obtain three different kind 
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of images – absorption, refraction and scattering images. The combination of these 
images may produce an improvement in the detection of mammographic lesions 
(Coan et al, 2013, Stampanoni et al, 2011). However, the critical issue of this 
technique is the dose to the organ that is still much larger than that of the 
conventional two-view mammography. Also the EI technique is based on the use of 
grids (coded apertures), but it is not an interferometric technique – the sample is 
irradiated with a narrow beam and an absorption edge is placed in front of the 
detector (Coan et al, 2013). The first studies of this technique (Olivo et al, 2013, 
Szafraniec et al, 2015) on phantom and breast specimens for 2D imaging showed an 
improvement of the image quality with respect to the images from conventional 
exams at comparable dose level.  
Although all these PhC techniques showed good results in terms of image 
quality, we notice that most literature reports were performed either on phantoms or 
on ex-vivo specimens, rather than in vivo. Moreover, ABI and GI techniques need to 
resolve critical issues such as the more complicated setup and, in the case of the GI, 
the dose to the organ for a possible clinical application. On the other hand, the EI 
technique seems to give good promise for future clinical application, but only 2D 
imaging has been investigated so far. In this scenario, PBI is the only technique 
which kas been validated on a clinical trial on mammography exam (Castelli et al, 
2011, Longo et al, 2014) and a planned clinical trial program on breast computed 
tomography.  
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2 PART II 
 
 Breast Rotational Radiotherapy  
with Synchrotron Radiation 
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The feasibility study of breast cancer rotational radiotherapy with synchrotron 
radiation has been a major part of my activity during the second half of the PhD 
thesis work. This work resulted in the publication of the following two papers in 
international scientific journals. Here, we describe this work as illustrated in the 
corresponding papers. 
- Di Lillo, F., Mettivier, G., Sarno, A., Castriconi R., & Russo, P. (2017a). 
Towards breast cancer rotational radiotherapy with synchrotron radiation. 
Phys. Med. 41, 20–25 
 
- Di Lillo, F., Mettivier, G., Castriconi, R., Sarno, A., Hausermann, D., Hall, 
C, Stevenson, A.W., Russo, P. (2017b) Synchrotron radiation external beam 
rotational radiotherapy of breast cancer: proof of principle. J Synchrotron 
Rad, under review. 
In addition, some results obtained during my co-supervision of the M.Sc. thesis in 
Physics of Dott. Paolino Alberto De Lucia “Kilovoltage Rotational External Beam 
Radiation Therapy (kV-EBRT) for breast cancer treatment” 2015 are presented. (De 
Lucia, 2015) 
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2.1  Conventional radiotherapy 
Breast cancer is the most common malignancy in woman (Torre et al, 2016). The 
standard care after breast-conserving surgery includes postoperative radiotherapy to 
remove any cancer cells that may be left in the breast. The commonly used technique 
for breast cancer is megavoltage photon 3D-conformal radiotherapy (3D-CRT), 
using a medical linear accelerator: the therapy (45 to 50 Gy in 25 fractions of 1.8 to 
2 Gy) is normally delivered with two opposed tangential fields to encompass the 
breast, often including part of the underlying chest wall and the lower axilla. The 
treatment planning consists in designing the radiation fields on the basis of CT data 
sets from the individual patient (Cox & Kian Ang, 2010). In order to reduce troubles 
due to the patient repositioning, marks are placed on the patient after CT scan to 
identify the isocentre of the irradiation field. The effectiveness of the breast 
radiotherapy strongly depends on the dosimetry. The 3-D treatment planning systems 
are also able to include the contribution of the scattered radiation into the dose 
calculation providing an accurate dose model. During the treatment, the patient is 
usually in a supine position. However, radiotherapy in prone position can be 
evaluated for patients with a large breast (Merchant et al, 1994; Kirby et al, 2010; 
Lymberis et al, 2012). X-ray irradiation with 6-MV X-ray beam produces a so called 
buildup effect whereby the dose to the surface tissue layers several millimeters below 
the skin is reduced to a fraction of the maximum dose at depth in the tissue, so 
avoiding skin tissue complications after therapy. After the conventional radiotherapy 
treatment, a radiation boost can be delivered with electron or photon beams in order 
to reduce the risk of local recurrence (Cox & Kian Ang, 2010). Patients who undergo 
a breast-conserving surgery are treated with a boost to the tumour bed delivering 
doses ranging between 10 and 16 Gy depending on the status of the surgical margins 
(Cox & Kian Ang, 2010). For patients who undergo mastectomy, an additional boost 
of 60 Gy is delivered to the chest wall (Cox & Kian Ang, 2010). 
One of the critical issues of breast radiotherapy is the associated increased rate 
of ischemic heart desease, especially in patients treated for left-sided breast cancer 
(Darby at al, 2013; Manna et al, 2016, Henson et al, 2013). With improved survival, 
more patients will be at risk for long-term radiation-induced toxicity, thus making it 
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even more important to reduce the dose to all organs at risk. As the rate of the 
ischemic heart disease is proportional to the mean heart dose, the goal is to reduce 
the dose to the heart as much as possible. Intensity modulated radiotherapy (IMRT) 
with photons has been investigated in order to improve the dose homogeneity and to 
minimize doses to surrounding organs at risk with both fixed and rotating beams. 
Then, photon planning using 3D-techniques, deep inspiration breath-hold, and prone 
position are implemented to minimize cardiopulmonary dose for patients. However, 
the radiation dose to the heart remains relatively high, even with the use of advanced 
photon-based techniques (Mast et al, 2014). Due to its ballistic physical 
characteristics (high dose localization and high cell-killing effect at the Bragg peak 
of the energy deposition curve), proton beam radiotherapy (PBT) may eventually 
enable a further decrease of the dose to the heart. A proton beam is characterized by 
a dose distribution that is finite and adjustable in depth depending on the beam 
energy. For this reason, PBT is increasingly being investigated to treat breast cancer 
showing a considerable reduction of the mean heart dose with respect to 3D-CRT 
and IMRT (MacDonald, 2016). To address the question of whether proton therapy 
can meaningfully decrease radiation-induced cardiovascular toxicities in breast 
cancer, in early 2016 started the Patient-Centered Outcomes Research Institute-
funded Radiotherapy Comparative Effectiveness (RadComp): a pragmatic 
randomized trial of proton therapy versus photon therapy for patients with 
nonmetastatic breast cancer (Verma et al, 2016).   
In the last decades, new radiotherapy techniques based on the orbital rotation 
of the Megavoltage X-ray beam – such as IMRT tomotherapy, Intensity Modulated 
Arc Therapy (IMAT) or Volumetric-Modulated Arc Therapy (VMAT) – have been 
developed (Khan and Gibbson, 2014). The geometry of these systems is similar to 
that of the CT scan. The accelerator head is on a rotanting gantry and rotate around 
the axis of the longitudinal axis of the patient treatment. In IMRT tomotherapy, the 
patient is treated slice-by-slice, as in a CT imaging exams; the intensity modulation 
is produced by means of a Multi Leaf Collimator (MLF) with a specific design and 
the couch can be stationary during the irradiation of a single slice or can continuously 
translate during the treatment (Khan and Gibbson, 2014). The latter, called helical 
tomotherapy, was introduced by Mackie et al (1993) and is more utilized than the 
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static-based technique nowdays. Whilst the IMRT tomotherapy adopted a fan beam, 
IMAT and VMAT technique employ a cone beam permiting to irradiate the whole 
volume instead of slice-by slice. IMAT (Yu, 1995) is based on the overallapping  of 
the delivery from multiple arcs to obtain the intensity modulation (Rao et al, 2010). 
However, the introduction of a new generation of linear accelerator which permits to 
change the MLC leaf position, dose rate and the speed of rotation of the gantry (Rao 
et al, 2010) has allowed to introduce a new method, called VMAT (Otto, 2008), to 
deliver the prescribed radiation dose with a single arc (Rao et al, 2010). These 
rotational radiotherapy techniques have shown to provide a more precise dose 
distribution with a major sparing of the healthy tissue. In particular, the studies on 
the use of tomotherapy for breast cancer treatment have demonstrated the possibility 
of reducing the dose to the heart (Coon et al, 2010, Gonzalez et al, 2006) in the case 
of left-sided whole-breast irradiation. In addition, for accelerated partial breast 
irradiation (APBI) Rault et al (2016) showed that IMRT tomotherapy provides a 
more efficient spare of the non-target breast tissue volume and an improvement in 
the cosmetic result with respect to the 3D-CRT. Moreover, in the last years a 
particular attention is on the use of VMAT for breast cancer treatment. Recent studies 
have carried out a significant reduction of the dose to healthy tissue (Fogliata et al, 
2017) and a significant improvement in target coverage and conformity with respect 
to IMRT (Moorthy, 2016). However, Fogliata et al (2017) also reported that the spare 
of the normal tissue occurs with some “high dose spillage” (Fogliata et al, 2017) 
requiring additional studies to provide the optimal balance and reduce future late 
toxicity and secondary cancer induction risk (Fogliata et al, 2017). 
A recent study on phantom and breast patients (Breitkeutz et al, 2017) –  based 
on Monte Carlo simulations – showed the feasibility of kilovoltage arc-therapy 
(KVAT) with 200-kV X-ray beam in both supine and prone positions. However, the 
quality of dose distributions obtained were lower than those obtained with VMAT 
plans (Breitkeutz et al, 2017). The study also showed the improvement of the dose 
distribution for the prone breast phantom with respect to the supine position because 
of the increment of the treatment angle (Breitkeutz et al, 2017). 
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2.2 Kilovoltage external beam radiotherapy with an 
orthovoltage X-ray tube 
In 2012, in a pioneering paper (Prionas et al, 2012), J. Boone and his team at 
University of California Davis set forth the idea of performing external-beam 
rotational radiotherapy (kV-EBRT) of the breast cancer with an orthovoltage X-ray 
tube.  kV-EBRT requires a dedicated setup employs an orthovoltage X-ray tube 
operating at 320 kVp and rotating in full circles around the breast, rather than a 
megavoltage X-ray beam from a medical linac irradiating the breast with two 
tangential beams, as in conventional breast radiotherapy with photons. The technique 
could be implemented on the rotating gantry of a cone-beam computed tomography 
scanner dedicated to the breast (Sarno et al, 2015), e.g. as realized by the Davis group 
and operating at 80 kVp, thus providing precise 3D localization of the tumour mass 
in the breast volume. The advantages of the kV-EBRT technique with respect to 
conventional radiotherapy were described as a simplified and more economical setup 
(which also does not require a bunker), the potential for reduced patient repositioning 
error and improved treatment accuracy in fractionated radiotherapy, the use of a 
prone rather than a supine patient position. The well-known effect of absorbed dose 
build-up of such 610 MV photon beams  which assures dose sparing to the surface 
tissues in conventional radiotherapy, with a maximum dose at 15 mm below the zero-
depth layer in tissue at 6 MV  is much reduced for the 320 kVp X-ray beam adopted 
in Boone's setup. Indeed, for orthovoltage X-ray beams the nominal depth of 
maximum dose beneath the patient's surface is zero (Podgorsak 2005). On the other 
hand, for 6 MV X-ray photons the dose buildup effect produces a surface dose as 
low as 15% of the maximum depth dose (Podgorsak 2005). Despite the practical 
unavailability of the buildup region for kilovoltage photons, the principle of 
rotational summation leads to higher dose at the tumour site  where the axis of 
rotation of the gantry is positioned  by suitably collimating the beam, substantial 
skin tissue sparing could be obtained. Indeed, the summation of the dose deposited 
by the collimated X-ray beam irradiating the breast from a plurality of angles in a 
full rotation results in a dose distribution peaked at the centre of rotation. The width 
and shape of the peak depend on the beam collimation on the horizontal plane (and 
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to some extent also on the vertical plane), while the vertical collimation determines 
the extent of the longitudinal height of the irradiated target (in the direction from 
chest wall to nipple). In their feasibility study, (Prionas et al, 2012) obtained via MC 
simulations a dose ≤ 5% of target dose deposited at 4 cm from the treatment field 
(along the chest wall-to-nipple direction) for a 2-cm z-collimated treatment beam 
centred in the middle of a 14-cm diameter breast, for whole breast irradiation or 
partial breast irradiation. However, there are some limits of this technique related to 
the relatively low dose rate available at practical distances (50100 cm) from the 
collimator units of an orthovoltage tube (in the order of 1 Gy/min) and to the thick 
lead collimator for a 320 kVp beam, which introduces penumbra and scatter.  
2.2.1 Experimental Validation of kV-EBRT 
The technique of kV-EBRT with orthovoltage X-ray tubes has been validated 
experimentally at 120 kVp by the team of Prof. Boone (Prionas et al, 2012). 
Following the work of the Davis’ group, we carried out an experimental validation 
at 300 kVp (De Lucia, 2015) by using an orthovoltage X-ray tube (Siemens 
Stabilipan 2) available at the Department of Physics “E. Pancini” of Università di 
Napoli Federico II. We measured the radial dose profiles in a PE cylindrical phantom 
(diameter of 14 cm and height of 15 cm) with a 100-mm pencil ionization chamber 
(mod. 20x6-3CT, Radcal Corp., Monrovia, CA, USA) tuning the collimation of the 
X-ray beam. The phantom had 1.3 cm-diameter holes drilled at different distances 
from the cylinder axis, for allocating the pencil chamber (Figure 2.1). The X-ray tube 
operated at 300 kVp, 12 mA and the X-ray beam was filtered with 1 mm Al, 0.25 
mm Cu, 1.2 mm Sn, 3.12 mm Cu. For this spectrum, we measured a half value layer 
(HVL) of 4.25 ± 0.009 mm Cu and an air kerma rate free in air of  0.0330 ± 0.0001 
Gy/min at the isocenter (@ 94.5 cm from the focal spot). The radial profiles were 
measured collimating the X-ray beam at 10 cm along the direction of the cylinder 
axis and at 1 cm, 3 cm, 7 cm or 14 cm in the rotation plane. The experimental results 
were compared with that obtained via Monte Carlo (MC) simulations. We 
reproduced the experimental irradiation geometry with a MC code developed in 
house, based on Geant4 toolkit (version 10.00). A complete description of the MC is 
reported in Section 2.4. In De Lucia (2015), the author shows, by using a MC code 
68 
 
different from that used in this work, that the X-ray beam produced by the 
orthovoltage X-ray tube working at 300 kVp produces the same dose distribution in 
the PE phantom obtained with a monoenergetic X-ray beam of 175 keV. On this 
account, we simulated a rectangular X-ray source that generated a monoenergetic 
beam of 175 keV. The sizes of the X-ray source were varied according to the 
simulated case. The rotational irradiation was reproduced by rotating the source 
along a 360° circle, in step of 1°, around the phantom. Figure 2.2 shows the 
comparison between the radial dose profiles measured with the 100-mm pencil 
chamber (symbol) and those evaluated via MC simulation (line) for beam 
collimation of 1, 3, 7 and 14 cm. Different beam collimations produce different 
shapes of the radial profile. In particular, whilst a cup-shaped dose distribution 
results for irradiation with the 14-cm wide beam, a dose distribution peaked at the 
centre of rotation is obtained with a beam collimated at 1cm. The simulations agree 
with the measurements for beam collimation of 14 cm and 7 cm with maximal 
relative difference of 6%. However, significant discrepancies, up to 30%, were 
estimated for 1-cm collimated beam. De Lucia shows similar results in his study (De 
Lucia, 2015). Table 2.1 reports the mean percentage difference in the dose 
distribution between measurements and MC simulations estimated in this study and 
in (De Lucia,2015). These values are comparable for each beam collimation.  
 
 
Figure 2.1: Photo and scheme of the polyethylene cylindrical phantom with five cylindrical holes at 
various radial distances for hosting a 100-mm long ion chamber. (from Di Lillo et al. 2017b) 
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The discrepancy between measurements and simulations could be due to a 
misalignment of the cylindrical phantom with respect to the X-ray beam during the 
experiment. In this case, a different dose distribution is measured in the phantom. 
This effect is amplified in the case of the collimated beam in which the centre of 
rotation coincides with the position of the maximum doseIn addition, both MC codes 
were validated with additional tests (De Lucia, 2015, Section 2.4) confirming their 
good performance. Please note that the MC simulations have been carried out in 
parallel beam geometry. 
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Figure 2.2: Comparison between the measured (symbols) and simulated (lines) relative air kerma in 
a 14-cm diameter polyethylene cylindrical phantom for beam width of 1, 3, 7 and 14 cm. For the MC 
simulation, the dose distribution was evaluated by integrating the dose along 100 mm in the direction 
of the cylinder axis. 
Table 2.1: Mean percentage difference in the dose distribution between measurements and MC 
simulations evaluated in this work and in (De Lucia, 2015). 
Collimation of X-ray beam 
(cm) 
Mean Percentage Difference (%) 
This work  De Lucia, 2015 
15 2 ± 1 2 ± 1 
7 3 ± 2 3 ± 3 
3 6 ± 4 8 ± 6 
1 21 ± 7 18 ± 8 
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2.3 SR3T: Synchrotron Radiation Rotational Radiotherapy 
for breast cancer 
The orthovoltage X-ray tube used for kilovoltage external beam radiotherapy 
provides a polychromatic X-ray beam with moderately low flux (yet adequate for 
conventional dose fractionation strategies), e.g.  1 Gy/min at 50 cm from the source 
(Prionas et al, 2012). A polychromatic as well as monochromatic X-ray beam with 
higher flux (also suitable for hypofractionated dose delivery, a technique under 
extensive clinical investigation (De Rose et al, 2016)) can be obtained by using a 
synchrotron radiation source. Indeed, the SR may provide a monoenergetic (as well 
as a polyenergetic) X-ray beam with higher flux and lower energy (down to a few 
tens of keV) with respect to the orthovoltage X-ray tube. Experimental research on 
SR radiotherapy (SRT) is currently only possible at few facilities in the world, with 
the Australian Synchrotron (AS, Melbourne, Australia) and European Synchrotron 
Radiation Facility (ESRF, Grenoble, France) having active programs for developing 
clinical applications. Three methods are under investigations: the stereotactic 
radiotherapy (SSRT), the mini-beam (MBRT) and the micro-beam radiotherapy 
(MRT). SSRT (Bräuer-Krish et al, 2015, Renier et al, 2008, Edouard et al, 2010) 
employs a highly conformal irradiation geometry combined with a dose-
enhancement effect due to the injection of a high-Z element in the target. A clinical 
trial of this technique for brain cancer treatment is ongoing at ESRF by using a 
monochromatic X-ray beam at 80 keV with a dose rate of about 1 Gy/s. MBRT 
(Prezado et al, 2009a, Prezado et al, 2009b, Prezado et al, 2011, Prezado et al, 2012, 
Deman et al, 2012, Martinez-Rovira et al, 2014, Prezado et al, 2015) and MRT 
(Slatkin et al, 1992, Bravin et al, 2015, Grotzer et al, 2015, Crosbie et al, 2013, 
Martinez-Rovira et al, 2010, Martinez-Rovira et al, 2011, Martinez-Rovira et al, 
2012a, Martinez-Rovira et al, 2012b, Poole et al, 2017) use a geometric irradiation 
effect called spatial fractionation of the total dose delivery, whereas conventional 
radiotherapy adopts temporal fractionation (e.g. 50 Gy in 25 fractions for breast 
irradiation in the adjuvant radiotherapy of breast cancer). Temporal fractionation can 
be used in addition to spatial fractionation in MRT (Serduc et al, 2009). While MRT 
employs a polychromatic SR beam segmented into micro-beams of typical size in 
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the range 25-50 m, in MBRT a monochromatic X-ray beam divided into mini-
beams of size 500-600 m irradiates the target. At present, preclinical studies on 
MRT are ongoing at ESRF and AS, and preliminary experiments are underway at 
the Canadian Light Source (CLS). Although several small animal models have been 
used (mice, rats, rabbits, and piglets), nearly all preclinical SRT studies to date have 
focused on brain tissue. On the other hand, a pilot study on the monochromatic 
micro-beam therapy (m-MRT) technique applied to treat breast cancer tissue and cell 
samples was carried out at CLS recently (Wysokinski et al, 2016) showing a slowing 
down of the tumour growth implanted in mice and cancer cell apoptosis generated 
by m-MRT irradiation at 60 and 100 keV. The availability of world-class facilities 
and the associated expertise of the investigators enable studies that have the potential 
to substantially improve SRT for cancer and advance our understanding of 
fundamental tumour biology.  
In this work, we envisage the possibility of the use of the SR (De Lucia et al, 
2016, Di Lillo et al, 2016b, Di Lillo et al, 2017a,b) for breast cancer treatment with 
a rotational irradiation geometry similar to that of kilovoltage external beam 
rotational radiotherapy with an orthovoltage X-ray tube (Prionas et al, 2012). In SR 
rotational radiotherapy (SR3T), the patient is lying prone on a rotating/translating 
bed, with the breast hanging from a hole in the bed, while the SR beam (suitably 
collimated in the horizontal and vertical directions) irradiates the organ, incident 
from a plurality of azimuthal angles (Figure 2.3). A full rotation of the bed around a 
vertical axis centred at the tumour site permits to deliver the highest dose at isocentre 
and a reduced dose at the entrance and exit surfaces. A combination of successive 
horizontal and vertical translations of a robotized bed, interleaved by 360° rotations, 
permits to fully irradiate the tumour volume. Whole breast as well as partial breast 
irradiations can be performed with multiple rotation by tuning the beam collimation. 
Since dose rates largely exceeding 10 Gy/min (considered adequate for breast 
radiotherapy) can be obtained at SR sources, irradiation of the tumour (partial 
irradiation) or of the whole organ (total irradiation) of the female breast for total 
doses in the order of tens of grays can be performed in one or a few fractions. 
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Figure 2.3: Sketch of SR-EBRT. The patient is lying prone on a bed with her breast hanging from a 
hole. The bed is rotating around a vertical axis centered at the tumor site, while the collimated X-ray 
beam from a synchrotron radiation source irradiates the tumor. The bed is then translated vertically 
and horizontally and additional rotational scans are performed, in order to conform the treatment to 
the tumor volume. A dose enhancement can be obtained by using a radiosensitizer (e.g. gold 
nanoparticles or iodinated solutions). (by courtesy of P. Russo) 
SR3T will employ a monochromatic X-ray beam with energy in the range 60120 
keV. Rotational summation at the tumour (where the axis of rotation is positioned) 
will produce dose summation up to the prescribed level in the target tumour tissue, 
while the dose to the skin would be limited to levels in the order of 1/10 of the tumor 
dose. At the same time, low dose levels may be delivered to healthy internal organs 
and tissues (including lung, heart, carotid arteries) due to the limited photon scatter 
dose toward the chest wall (estimated at less than 5% of the tumour dose in Prionas 
et al, 2012 for a 320 kVp beam). The 3D localization of the tumour before as well as 
during the RT procedure with SR can be performed via parallel beam computed 
tomography (CT) imaging of the transmitted X-ray beam with the patient in prone 
position on the robotized support (Lindfors et al, 2008; O'Connell et al, 2010; Russo 
et al, 2010; Mettivier et al, 2011b; Sarno et al, 2015). This will implement SR breast 
CT (Longo et al, 2016; Mettivier et al, 2016, Sarno et al, 2016c) for the needs of 
image guided radiotherapy of breast cancer. The use of X-ray beam at energies lower 
than 120 keV, on the other hand, will permit to use an iodinated contrast medium 
(commonly adopted clinically for contrast enhanced digital mammography) or other 
radiosensitizers (e.g., gold nanoparticles, Lin et al, 2015) for realizing contrast-
enhanced breast CT as well as dose-enhanced radiotherapy. This technique exploits 
the increase of the absorbed energy in the tumour where the iodinated agent 
accumulates.  
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In the following sections, we illustrate the results of the feasibility study of SR3T 
performed at Australian Synchrotron, Melbourne, Australia and the European 
Synchrotron Radiation Facility, Grenoble, France. 
2.4  Monte Carlo simulations for SR3T 
We simulated the irradiation of a homogeneous phantom with SR3T technique. 
Simulation were performed with the GEANT4 toolkit (version 10.00).  The MC code 
used in this work is based on a previous version developed for breast dosimetry in 
mammography (Sarno et al, 2016a,b) and digital tomosynthesis (Sarno et al, 2017d) 
by Dr. A. Sarno during his PhD work (Sarno, 2017a). This code was modified by 
implementing the rotation of the X-ray source and the event position scoring. The 
parallel and monoenergetic X-ray beam was generated from a rectangular source of 
variable size tuned on the basis of the simulated cases. The source performed a 
rotation of 360°, in step of 1°, around a PE (density = 0.9325 g/cm3) or a PMMA 
(density = 1.19 g/cm3) cylindrical phantom (14-cm diameter, 15-cm height). We 
scored the energy deposited in the phantom produced by interactions of both primary 
and secondary photons (scattered photons, fluorescent and bremsstrahlung photons), 
as well as the energy deposited by the electrons produced at the photon interaction 
(multiple scattering included). The event position was also recorded. The scoring 
resolution was 1 × 1 × 1 mm3. The simulation output was a 3D matrix obtained by 
associating the energy absorbed by the phantom to the event position. Albeit the 
validation of the main part of the code is reported in (Sarno et al, 2016b), additional 
tests were performed to validate this last version. In particular, we performed a 
comparison with literature data reported by Prionas et al (2012) simulating the 
irradiation of a PE cylindrical phantom (diameter of 14 cm and height of 9 cm) with 
a monoenergetic laminar beam at 178 keV collimated at 14 cm × 0.1 cm (H × V). 
The cylinder axis was positioned along the vertical direction. The radial dose profile 
evaluated in the irradiated slice was taken into account for the comparison. Figure 
2.4 shows the comparison of the radial dose distribution in a 14-cm PE cylindrical 
phantom obtained for a beam width of 14 cm at 178 keV via our code and that 
reported by Prionas et al. (2012). A maximum deviation of 2% was observed. In the 
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following sections, we also report a comparison between the results from simulations 
and experimental data. Please note that the MC simulations of this work have been 
carried out in parallel beam geometry. 
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Figure 2.4:  Comparison between dose distributions (percentage dose versus radial distance) in a 14-
cm diameter PE cylinder obtained via MC simulation in this work (dashed red line)  and that reported 
by (Prionas et al., 2012) (continuous black line). (from Di Lillo et al. 2017a) 
2.4.1 Skin sparing effect 
The MC code was employed to investigate the feasibility of using a monoenergetic 
X-ray beam with energy down to 60 keV. In particular, the skin sparing effect was 
evaluated by using a monoenergetic beam at 60, 80, 100, 120, and 175 keV (this last 
being the depth-dose effective energy of the orthovoltage X-ray beam available at 
our Department's irradiation facility, close to the 178-keV effective energy simulated 
in the Davis' study (Prionas et al, 2012)). The simulations reproduced the irradiation 
of the PE cylindrical phantom (of 14 cm diameter and 15 cm height) - simulating the 
pendant breast with a diameter equal to the average diameter at chest wall of the 
uncompressed breast (Boone et al, 2005) - with the X-ray beam collimated at 150 
mm × 6 mm (H × V) and the centre of rotation along the phantom longitudinal axis. 
A possible skin sparing effect was evaluated in terms of periphery-to-centre dose 
ratio in the cylindrical phantom. Figure 2.5a and Figure 2.5b show the dose 
distribution obtained via MC simulation in a 14-cm diameter PE cylinder with X-ray 
beam of size 15 mm × 6 mm (H × V) at different energies in the range 60−175 keV 
and the periphery-to-centre dose ratio vs. the photon energy, respectively. The radial 
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dose distributions were normalized at their respective maximum, which occurs at the 
axis of rotation. At each energy the shape of the radial dose distribution for the 
collimated beam (peaked at the centre of rotation) changes (figure 2.5a). In 
particular, an exponential decrement of the periphery-to-centre dose ratio can be 
observed by increasing the photon energy (figure 2.5b), from a value of about 13.5 
% at 60 keV down to 10.5 % at 175 keV. From these data, we derived that for a 
tumour positioned at the phantom centre, the tumour-to-skin dose ratio would be 9.5 
at 175 keV and 7.4 at 60 keV photon energy.  
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Figure 2.5: Radial dose distribution in a 14-cm PE cylindrical phantom obtained with a collimated 
beam (15 mm × 6 mm) at 60, 80, 100, 120 and 175 keV (a) and corresponding periphery-to-centre 
dose ratio as a function of photon energy (b). (from Di Lillo et al. 2017a) 
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2.5  Measurements at Australian Synchrotron 
Australian Synchrotron (AS) is a third generation synchrotron facility with a 
circumference of 216 m operating in “top-up” mode at a nominal electron energy of 
3 GeV and a ring current of 200 mA. The rms electron beam size in the straight 
sections is 320 m horizontally and 16 m vertically, corresponding to a Gaussian 
FWHM of 754 m and 38 m, respectively (Stevenson et al, 2010, Stevenson et al, 
2017). The experiments were conducted at Imaging and Medical Beamline (IMBL) 
of AS. IMBL produces a fan beam of polychromatic radiation from a 
superconducting multi-pole wiggler (SCMPW) with 60 pole pairs (52 mm period) 
and a peak magnetic field of 4.0 T (Pelliccia et al, 2016). A double-crystal Laue 
monochromator (DCLM), with the centre at a distance of 16.2 m from the source, is 
used to select the single energy up to 120 keV (Stevenson et al, 2012). IMBL has six 
hutches: 1A, 2A, and 3A are the “optics” or beam-conditioning hutches, and 1B, 2B, 
and 3B are the experimental hutches. In each hutch, it is possible to work with 
monochromatic or pink photon beam.  
The measurements were performed in the hutch 3B, situated in a dedicated 
satellite building providing a source-to-sample distance of approximately 140 m. In 
this hutch the SR beam, which can reach the size of 500 mm × 40 mm (H × V), has 
a divergence of 3.8 mrad in the horizontal direction and 0.3 mrad in the vertical 
direction.  The magnetic field of SCMPW was 3.0 T. 
2.5.1 First feasibility study at 60 keV 
We carried out a first feasibility study of SR3T at a single photon energy of 60 keV. 
In particular, we performed Monte Carlo simulations and measurements on 
phantoms for evaluation of radial dose profiles, "skin-to-tumor" dose ratio, and non-
uniform dose distributions (dose painting applications). A variety of different 
dosimeters was used: ionization chamber (IC), radiochromic films and 
thermoluminescence dosimeters (TLDs). 
2.5.1.1 Dosimeters calibration and beam uniformity assessment 
As dosimeters for air kerma measurements performed free-in-air or in phantom, we 
used a 100-mm long pencil ionization chamber (mod. 20X6-3CT, Radcal Corp., 
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Monrovia, CA, USA, readout by a Radcal 2026C dosimeter), radiochromic films 
(GafChromic EBT3 and XR-QA2, Ashland, KY, USA) and TLD-100 LiF 
thermoluminescence dosimeters.  
The response of the pencil ionization chamber (IC) in the monoenergetic laminar 
beam at 60 keV  was calibrated in terms of air kerma in air with reference to a free-
in-air parallel-plate ionization chamber (model ADC IC-105) employed at the IMBL 
beamline (Crosbie et al, 2013, Stevenson et al, 2017). For calibration, the pencil 
chamber was scanned vertically through the SR beam at a constant speed (Prezado 
et al, 2011) and temperature as well as pressure correction was applied. The parallel 
chamber operated at 2 kV without any windows. In order to obtain different air kerma 
rate, layers of copper with different thicknesses attenuated the intensity of photon 
beam. We estimated that the contribution of the /3 (180 keV) for SCMPW (3.0 T) 
was in the order of 1%. 
 
 
Figure 2.6: a) Photo of the midplane face of the two halves cylindrical PMMA phantom containing a 
cavity for the ionization chamber and with the EBT3 film in place; b) Setup for TLD irradiation: four 
TLD chips inserted in the PMMA housing and 100-mm pencil ionization chamber (IC) placed along 
the vertical direction. The inset shows the four chips in place in the housing. (from Di Lillo et al. 
2017b) 
The response of the radiochromic films EBT3 (lot # 12011401) was calibrated in 
terms of air kerma evaluated in a polymethylmethacrylate (PMMA) phantom in the 
range 0.052 Gy, while the response of the XR-QA2 films (lot # 10261501) was 
calibrated in terms of air kerma free-in-air in the range 0.005-0.200 Gy. We used the 
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calibrated pencil ionization chamber to measure the air kerma. A PMMA cylindrical 
phantom (14-cm diameter, 25-cm height), composed of two semi-cylinders to permit 
the film placement and with a cylindrical hole (13-mm diameter) along the cylinder 
axis, was employed for the EBT3 calibration. During irradiation, the pencil chamber 
was allocated in the hollow cavity along the cylinder axis, while the film piece was 
at midplane of the cylinder, at 1 cm from the IC to avoid scatter radiation 
contamination (Figure 2.6a). The dosimeters placed in the PMMA phantom (for 
EBT3 calibration) or free-in-air (for XR-QA2 calibration) were translated along the 
beam height direction at a constant speed because of the laminar beam configuration 
(Prezado et al, 2011 Brown et al, 2012). The scanning method mimics an uniform 
irradiation of dosimeters. Different exposures were obtained by setting different scan 
speeds. Films were digitized in RGB scanning mode (72 dpi, 48-bit, TIFF image) 
with an Epson Perfection V750 Pro flat-bed scanner and their response in the red 
channel was evaluated. Following Devic et al, 2016 and Di Lillo et al, 2016a, the 
calibration curve was carried out for EBT3 and XR-QA2 films, respectively. We 
want to highlight that the same scanning protocol was used for all measurements 
with radiochromic film performed for the feasibility study at 60 keV (section 2.5.1). 
The irradiation protocol for TLD-100s calibration was similar to that used for the 
radiochromic films. The TLD chips placed in a PMMA housing (Figure 2.6b) (1 mm 
PMMA upstream and 1mm downstream) were exposed to the SR beam adopting the 
scanning method (Emiro et al, 2015). The dosimeter response was calibrated in terms 
of air kerma free-in-air measured with the pencil chamber in the range 0.5-1.7 Gy. 
For each calibration point, the average response of four different TLDs was 
evaluated. 
Figure 2.7 and Figure 2.8 show the calibration curves of the dosimeters response 
at 60 keV. A linear fit function was employed for the calibration of the pencil 
chamber response in terms of air kerma rate and for the calibration of the TLDs 
response in air kerma free-in-air. The film response evaluated in terms of net optical 
density (net OD) for EBT3 and net reflectance change (netR) for XR-QA2 was 
correlated by means of a power function with the air kerma measured in the PMMA 
phantom and air kerma free-in-air, respectively. 
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Figure 2.7: Calibration curve for the response of a) the pencil IC and b) TLD dosimeters at 60 keV. 
The continuous line is a linear fit to the data points. (from Di Lillo et al. 2017b) 
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Figure 2.8: Dose-response curves evaluated for a) EBT3 and b) XR-QA2 radiochromic films at 60 
keV. The power function indicated on the graphs was employed to fit the experimental data. (from Di 
Lillo et al. 2017b) 
A preliminary assessment of the beam uniformity was also performed by imaging 
the SR beam with a radiochromic film, Gafchromic XR-QA2. The SR beam size 
was 15 cm × 1.6 cm (H × V). Following Di Lillo et al (2015), the film response was 
converted to photon fluence per unit air kerma (mm-2 mGy-1) providing the 2D 
distribution of the beam intensity in a plane transverse to the beam axis. Figure 2.9 
shows the image of the SR beam acquired with radiochromic film XR-QA2 (Figure 
2.9a) and the corresponding horizontal line profile (Figure 2.9b). For comparison, 
the calculated “Roll-off” curve at 60 keV is showed together with the measured 
profile.  The measurement with radiochromic film yields a maximum variation of 
the beam flux along the horizontal direction of about 6%, in agreement with 
theoretical calculation. 
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Figure 2.9: a) Dose map of the SR beam at 60 keV acquired with radiochromic film XR-QA2, the 
film response was calibrated in terms of air kerma in air. b) Horizontal average profile in the ROI 
shown in a) at 60 keV evaluated in the radiochromic film dose map. The maximum horizontal 
variation is about 6%. (from Di Lillo et al. 2017b) 
2.5.1.2 Radial dose profile measurements 
The radial dose distribution was evaluated in the same polyethylene (PE) cylindrical 
phantom (14-cm diameter, 15-cm height) employed for measurement with the 
orthovoltage X-ray tube (section 2.2.1). We measured the air kerma in the phantom 
by irradiating the 100-mm pencil chamber at each position during a complete rotation 
of the phantom. The PE cylinder was placed on an assembly of PMMA slabs (20 × 
20 × 18 cm3) mimicking the chest wall (Figure 2.10). The axis of rotation coincided 
with the cylinder axis. The radial dose distribution was assessed with SR beam 
collimated to 0.8 cm vertically and to 1.5, 4, 7, or 15 cm horizontally. 
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z 
Figure 2.10:  Experimental setup for radial dose profile measurement at AS. In this image, the IC is 
positioned in the central hole of the phantom. (from Di Lillo et al. 2017b) 
The experimental setup was reproduced with MC code. In order to take into account 
the length of the pencil chamber, the dose along 100 mm in the direction of the 
cylinder axis was evaluated for the simulated data. Figure 2.11 shows the comparison 
between the dose profiles measured in the phantom (symbol) and profiles evaluated 
via MC simulation (line) at beam widths of 1.5, 4, 7, and 15 cm and a fixed beam 
height of 8 mm. The agreement in terms of mean percentage difference between 
simulations and measurements of dose profile at each collimation is within 5%. In 
particular, a mean percentage difference of 2.8% ± 0.7% and 4.7% ± 2.2% was 
evaluated for a collimated beam width of 15 and 1.5 cm, respectively. The data show 
that the shape of the radial dose profile depends on the SR beam width. In particular, 
for a 15-cm beam width the dose distribution is flat. When the beam width is 
progressively narrowed, the radial profile becomes peaked at the center of rotation. 
A periphery-to-center dose ratio of 103%, 48%, 33 %, 17% is estimated via MC 
simulation for beam width of 15, 7, 4 and 1.5 cm, respectively.  
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Figure 2.11: Comparison between the measured (symbols) and simulated (lines) relative air kerma in 
a 14-cm diameter polyethylene cylindrical phantom for beam width of 1.5, 4, 7 and 15 cm. For the 
MC simulation, the dose distribution was evaluated by integrating the dose along 100 mm in the 
direction of the cylinder axis.  (from Di Lillo et al. 2017b) 
The dose distributions shown in Figure 2.11 include two components: one due to the 
energy released in the volume directly irradiated with the 8-mm height beam and a 
second component due to the energy deposited by the scatter radiation in the phantom 
volume not directly exposed to the beam. It is of interest to evaluate the extent of the 
two separate terms in the total dose. Hence, we carried out MC simulations in which 
we derived the radial profile of the dose distribution in the 14-cm diameter PE 
phantom due to each separate contribution. Figure 2.12 shows the radial dose 
distribution obtained by scoring the energy only in the irradiated volume of the 
phantom (corresponding to ROI 1 in Figure 2.13), or in the zone outside the 
irradiated volume (reached by scattered photons) (corresponding to ROI 2 + ROI 3 
in Figure 2.13), or in the whole volume (where the total dose is the sum of the two 
components) (corresponding to ROI 1+ ROI 2 + ROI 3 in Figure 2.13). The dose 
distributions were evaluated in the case of a beam collimated to 1.5 cm in the 
horizontal direction (Figure 2.12a) or wide beam of 15-cm width (Figure 2.12b). For 
each profile, the dose was expressed in percent of the central value of the distribution.  
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Figure 2.12: Dose profile along a diameter, obtained via MC simulation in a 14-cm diameter 
polyethylene cylindrical phantom for beam width of a) 1.5 cm and b) 15 cm. For each beam 
collimation, the dose profile was evaluated scoring the energy in the irradiated volume (ROI 1 in 
Figure 2.13), in the not irradiated volume (ROI 2 + ROI 3 in Figure 2.13) and in whole volume used 
for the measurements (ROI 1+ ROI 2 + ROI 3 in Figure 2.13). Each profile was normalized to its 
central value (from Di Lillo et al. 2017b) 
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Figure 2.13: 2D map of the energy released in the 14-cm PE cylindrical phantom. The map was 
obtained via MC simulation. The ROIs used for evaluation of the dose distribution reported in figure 
2.12 are showed. 
For the collimated beam (Figure 2.12a), the dose profile in the irradiated 
volume is peaked at the center of rotation showing a dose distribution different from 
that evaluated in the whole volume. The dose profile in the not irradiated volume has 
a triangular shape with a maximum value at the rotation centre.  
The irradiation with the wide beam (Figure 2.12b) produces a cupped dose 
distribution in the irradiated volume because of the exponential attenuation of X-ray 
beam in the material, which provides a greater dose deposit at the periphery. A 
domed profile characterizes the dose distribution in the not irradiated volume and the 
combined effect of these two contributions results in a flat dose distribution in the 
total volume. For comparison, Figure 2.14  shows the radial distributions obtained 
scoring the energy only in the irradiated volume for different beam widths (from 1.5 
to 15 cm) at 60 keV. A periphery-to-centre dose ratio of about 171%, 62%, 35% and 
14% is estimated for beam width collimations of 15, 7, 4, and 1.5 cm, respectively. 
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Figure 2.14: Dose profile obtained via MC simulation in a 14-cm diameter polyethylene cylindrical 
phantom, for various widths of the horizontal collimation (from 1.5 cm to 15 cm). The dose profile 
was evaluated in the irradiated phantom slice. (from Di Lillo et al. 2017b) 
2.5.1.3 Assessment of the periphery-to-center dose ratio with radiochromic film 
and TLD 
We estimated the periphery-to-center dose ratio in a 14-cm diameter PMMA 
cylindrical phantom by measuring the air kerma at the phantom axis (centre) and at 
4 cm from the axis (periphery) during a complete rotation of the phantom. Air kerma 
measurements were made with both radiochromic film EBT3 and TLD-100. The 
cross-section of the SR beam was 15 mm (H) × 16 mm (V). A cylinder with two 13-
mm diameter cavities was used for measurements with TLD-100. Ten TLD chips 
filling the cavity were irradiated at each position and the average of their response 
was used to calculate the dose ratio. Radiochromic film were placed at midplane of 
the same phantom used for the calibration. The dose ratio was calculated by 
estimating the mean pixel value, calibrated in terms of air kerma, in two ROIs (centre 
and periphery) of area 3 mm × 3 mm. Table 2.2 reports the periphery-to-centre dose 
ratio at 4 cm from the cylinder axis measured with radiochromic film EBT3 and with 
TLDs. A dose ratio of 24% ± 3% was estimated with TLD chips, in agreement with 
simulation result within the experimental error. However, a dose ratio of 47% ± 3% 
was evaluated with radiochromic film. We investigated this discrepancy and 
attributed it, at least in part, to the process of film scanning. The films were scanned 
with the Scanner EPSON V750 PRO which has been in use in our laboratory for 
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many years. We noticed the onset of an artefact with excess pixel values on one side 
of the scanning field, which may produce alteration of the line profile measured with 
the film dosimeters. A new scanner EpsonV850 PRO was bought, but was available 
only in the last part of this thesis work. 
Table 2.2: Periphery-to-center dose ratio simulated with MC code and measured with TLD100, 
radiochromic film EBT for a SR beam collimated at 1.5 cm along the horizontal direction at 60 keV. 
(from Di Lillo et al. 2017b) 
 
Periphery-to-center dose ratio 
(%) 
Radiochromic film EBT3 47 ± 3 
TLD-100 24 ± 3 
MC Simulation 22.2 ± 0.3 
2.5.1.4 Dose painting application 
The feasibility of dose painting applications was studied by performing 
measurements with radiochromic film. Pieces of radiochromic film EBT3 of size 12 
cm × 5 cm (H × V) were positioned at mid-plane of a 14-cm diameter PMMA 
cylinder phantom placed at the isocenter. A collimated SR beam of size 1.5 cm × 1.6 
cm (H × V) irradiated the phantom at air kerma rate free-in-air of 2.22 Gy/min. Non-
uniform dose distributions – two-off center foci and a linear distribution of three hot 
spots – were obtained with multiple rotations of phantom shifting laterally the axis 
of rotation. The two off-center foci were irradiated by shifting the axis of rotation 
3.96 cm. The rotation speed was set at 10 °/s for the first turn (for delivering 0.6 Gy 
to the first focus) and at 5 °/s for the second turn (with 1.2 Gy delivered to the second 
focus). The three hot spots were obtained by rotating three times the phantom with a 
speed of 10°/s and shifting laterally the center of rotation by 0.75 cm at each rotation. 
Figure 2.15 and Figure 2.16 show the non-uniform dose distributions (two off-center 
foci and linear distribution of three hot spots) evaluated with both measurements 
(Figure 2.15) and MC simulations (Figure 2.16). The experimental dose distributions 
were evaluated averaging the dose profile in a ROI of size 11.5×1.2 cm on the 
radiochromic film images, as shown in Figure 2.15. The same approach was used to 
evaluate the dose distribution with MC simulation. The surface plots of the 
percentage of the maximum dose is also reported. The dose distribution is reported 
as percentage of the maximum dose. 
87 
 
 
  
Figure 2.15: a) 2D dose distributions evaluated with radiochromic film EBT3 in a 14-cm diameter 
PMMA phantom and b) corresponding surface plots of percentage of maximum dose: two off-center 
foci (left side) and line distribution (right side). ROIs where the average dose distributions were 
evaluated are showed. The intended dose distribution was obtained with multiple rotations. c) 
Showing, for ease of visualization of the sample geometry, a photo taken during the placement of one 
half of the cylindrical phantom on the rotation stage, where the piece of EBT3 film is visible at mid-
plane in the PMMA phantom. Above the film is visible the half cavity realized for hosting the ion 
chamber. (from Di Lillo et al. 2017b) 
 
Figure 2.16: Two off-center foci and line dose distributions in a 14-cm diameter PMMA phantom 
obtained via MC simulations and line dose profiles evaluated in terms of percentage of maximum 
dose. (from Di Lillo et al. 2017b) 
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The two off-centre foci irradiation resulted in two target doses of about 1.2 Gy and 
0.6 Gy with the low-dose focus near the centre of phantom. Both experimental and 
MC data show a flat dose distribution inside the low-dose focus, while the dose 
increases by increasing the distance from the phantom centre inside the other focus 
because of the X-ray attenuation in the phantom (Figure 2.17a). The overlap of the 
two dose distributions produces a dose deposition of about 30% of the maximal dose 
at the edge nearest the high-dose focus. At the opposite edge, measurements and MC 
simulation provide two different values of dose: 10% and 20% of the maximal dose, 
respectively.  
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Figure 2.17: Line dose profiles of the percentage of maximum dose for 60-keV irradiation of a) two 
off-center foci or b) for a linear distribution. For the two foci irradiation, the centre of the phantom 
was also indicated at position 55 mm. Dashed line: experimental; continuous line: simulated data. 
(from Di Lillo et al. 2017b) 
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The linear distribution of three hot spots resulted in a wide-peak profile with a non-
smooth shape due to the overlap of the hot spots. A dose deposition of 25% of the 
maximal dose is estimated at 3 cm from the peak of the dose distribution via 
measurements, while a dose value of 30% is calculated at the same distance with 
data from MC simulation (Figure 2.17b). Although the dose profiles obtained with 
the two different data sets (measurements and MC simulations) demonstrated similar 
shapes, we point out that a discrepancy exists between simulated and measured data, 
as it was shown in Figure 2.17. We have attributed this disagreement to the response 
of the radiochromic film to the rotational irradiation at low energy. In addition, we 
want to underline the choice of the normalization point could influence the behaviour 
of this discrepancy. In future works, a gamma test index (used in clinical routine for 
the evaluation of the treatment planning process) will be used to provide a better 
evaluation of the performance of the delivered dose strategy. 
2.5.2  Study of SR3T at high energy 
After the feasibility study at 60 keV, the investigation on SR3T was extended at 
higher energy with measurements of radial dose profile and dose distributions in 
phantom at 80 and 100 keV.  
2.5.2.1 Profile of X-ray beams 
An evaluation of the beam profiles at 80 and 100 keV was  performed with 
radiochromic film EBT3. A procedure similar to that reported in Di Lillo et al (2015) 
and used in section 2.5.1 was employed. The radiochromic film were scanned with 
EPSON V850 PRO in RGB mode (72 dpi, 48-bit, TIFF image). Their response in 
the red channel was calibrated in terms of photon fluence obtaining the 2D 
distribution of the beam intensity. The horizontal beam profiles evaluated in the 
centre of the beam height at 80 keV and 100 keV are reported in Figure 2.18.  
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Figure 2.18: Horizontal average profile in a ROI evaluated in the radiochromic film dose map at 80 
keV (a) and 100 keV (b). The position 0 corresponds to the center of the beam. 
The profiles were normalized at the maximum photon flux. A maximum variation 
of 6% along 16 cm was observed at 80 keV with a minimum in the centre of beam. 
The beam profile at 100 keV is asymmetric with minimum value on an edge of 80 
% of the maximum photon flux. This indicates that the beam collimation was likely 
not symmetric in respect to the beam centre. 
2.5.2.2 Radial Dose Profile 
Measurements of radial dose profile in a 14-cm diameter PE cylindrical phantom 
were performed at 60, 80 and 100 keV using a semiflex ionization chamber (PTW 
31010) with the dosimeter T10023 UNIDOS webline. The chamber was firstly 
calibrated in terms of air kerma free-in-air with reference to the ADC IC-105 
chamber of IMBL at each energy employing the calibration protocol already reported 
for the pencil chamber in the feasibility study at 60 keV (section 2.5.1.1). The use of 
this chamber permits to avoid trouble due to the partial irradiation of the dosimeter 
(section 2.5.1.2) because the X-ray beam height available at IMBL can be larger than 
the dosimeter size – sensitive volume 2.75 mm-radius, 6.5-mm-length 
(http://www.ptw.de/semiflex_chambers0.html). The radial dose profiles were 
evaluated with the same measurements protocol used for the feasibility study at 60 
keV(section 2.5.1.2). The beam height was fixed at 1.0 cm. The radial dose profile 
were acquired at beam width of 1.5, 4, 5.5, 7, or 16 cm. The air kerma rate at the 
centre of the phantom and the rotation speed were 152 mGy/s and 15 °/s at 60 keV, 
66.7 mGy/s and 10°/s at 80 keV, 28.7 mGy/s and 5°/s at 100 keV. The experiment 
was also simulated with the MC code (section 2.4).  
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Figure 2.19: Comparison between the measured (symbols) and simulated (lines) relative air kerma in 
a 14-cm diameter polyethylene cylindrical phantom for beam width of 1.5, 4, 5.5, 7 and 16 cm at 60 
keV (a), 80 keV (b), and 100 keV (c).  
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Table 2.3: Mean percentage difference in the dose distribution between measurements and MC 
simulations evaluated for beam collimations of 1.5, 4, 5.5, 7, and 16 cm at 60, 80, and 100 keV.  
Collimation of X-ray beam 
(cm) 
Mean Percentage Difference (%) 
60 keV  80 keV 100 keV 
16.0 1.5 ± 0.8 4± 3 2± 1 
7.0 1.4± 1.3 3± 2 1.7 ±1.3 
5.5 4± 5 3± 2 3 ±4 
4.0 5 ± 3 2.6± 0.9 5± 5 
1.5 4 ± 3 2.8±0.9 3± 3 
 
Figure 2.19 shows the radial dose distributions carried out from measurements as 
well as from simulations at 60 keV, 80 keV, 100 keV. As already shown in section 
2.5.1.2, the radial dose distribution depends on the beam collimation. A cupped 
profile with a minimum in the centre of the phantom was observed for beam width 
of 16 cm, while a dose distribution peaked in the centre of rotation results for 1-cm 
collimated beam. The comparison between measurements and simulations shows a 
good agreement. The analysis of data reveals mean percentage difference in the dose 
distribution between simulations and experimental data less than 5% (Table 2.3). The 
periphery-to-centre dose ratio was evaluated at 5.72 cm (1.5, 4, 5.5, 7, and 16 cm) at 
each energy (60, 80, and 100 keV) by using the results from measurements. The same 
evaluation was carried out at 6.5 cm via MC simulations.Table 2.4 and Table 2.5 
summarizes the estimated values. The dose ratio decreases with increasing the beam 
collimation in the horizontal direction at fixed energy. This behaviour is due the 
principle of rotational summation of dose. In particular, periphery-to-centre dose 
ratio ranges between 13.4% and 164 % at 60 keV, 12.5% and 160% at 80 keV, and 
11.9% and 156% at 100 keV at 6.5 cm. Moreover, a decrement of the dose ratio 
increasing the photon energy was observed at each beam collimation. A similar result 
was reported in section 2.4.1  for a beam of size 1.5 cm × 0.6 cm.  
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Table 2.4: Periphery-to-center dose ratio evaluated at 5.72 cm with measurements for beam 
collimations of 1.5, 4, 5.5, 7, and 16 cm at 60, 80, and 100 keV. 
Collimation of X-ray beam 
(cm) 
Periphery-to-centre dose ratio (%) 
60 keV  80 keV 100 keV 
16.0 147 ± 4 130 ± 4 138± 4 
7.0 61.9± 1.8 63.2± 1.8 57.3 ± 1.6 
5.5 48.2± 1.4 44.7± 1.3 44.3 ± 1.3 
4.0 35.3± 0.9 32.7± 0.9 32.2± 0.4 
1.5 14.5± 0.4 13.1±0.4 12.8± 0.4 
However, we note that the dose ratio evaluated at 5.72 cm via measurements for a 
16-cm width beam at 80 keV is lower than that obtained at 100 keV. This could be 
attributed to troubles during the measurement. Indeed, the experimental result at 80 
keV is also lower than the expected value as shown in the comparison between 
measurements and simulations at 80 keV (Figure 2.19): simulation provides a ratio 
of about 142% instead of 130% measured at the same distance. Figure 2.20 shows 
the periphery-to-centre dose ratio evaluated at 6.5 cm via MC simulation as a 
function of the photon energy. In spite of energy dependence, the values of dose 
ratios obtained at different energies are in the same magnitude order at fixed 
collimation, e.g. from 11.9% at 100 keV to 13.4% at 60 keV. This means that in 
terms of skin sparing there is not a large difference in using photons at 60 keV or 
100 keV (see also Figure 2.5)). Moreover, the photoelectric absorption at the tumour 
at energies lower than 100 keV is higher than that at 320 kV or 6 MV. These 
considerations encourage us to investigate the use of dose-enhancement agents at 
low energy (e.g. below 100 keV). A preliminary study on the use of these agents is 
reported in section 2.7. 
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Table 2.5: Periphery-to-center dose ratio evaluated at 6.5 cm via MC simulations for beam 
collimations of 1.5, 4, 5.5, 7, and 16 cm at 60, 80, and 100 keV. 
Collimation of X-ray beam 
(cm) 
Periphery-to-centre dose ratio (%) 
60 keV  80 keV 100 keV 
16.0 164 ± 3 160 ± 2 156 ± 2 
7.0 57.2 ± 0.9 54.3 ± 0.8 52.5 ± 0.8 
5.5 44.8 ± 0.7 42.4 ± 0.6 40.7 ± 0.6 
4.0 32.9 ± 0.5 31.1 ± 0.5 29.8 ± 0.4 
1.5 13.4 ± 0.2 12.5 ±0.2 11.9 ± 0.2 
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Figure 2.20: Percentage periphery-to-centre dose ratio obtained via MC simulations as a function of 
photon energy. The beam height was fixed at 1.5 cm, the beam width was set at 16, 7, 5.5, 4, or 1 cm. 
The periphery value was evaluated at 6.5 cm. 
2.5.2.3 Dose distribution in phantom 
The dose distribution in a 14-cm PMMA cylindrical phantom was evaluated 
with radiochromic film EBT3 at 100 keV. We used the same 14-cm diameter 
cylindrical phantom employed for the EBT3 calibration in the feasibility study at 60 
keV (section 2.5.1). Pieces of radiochromic film were placed at mid-plane in the 
phantom to image the 2D dose map produced by the irradiation of a target volume 
in the centre of phantom. A flat-bed scanner EPSON V850PRO digitized the films 
in RGB scanning mode (72 dpi, 48-bit, TIFF image). The radiochromic film were 
previously calibrated in terms of air kerma free-in-air (Figure 2.21) by using a power 
function.  
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Figure 2.21: Calibration curve for the response of radiochromic film EBT3 at 100 keV. The 
continuous line is a fit with a power function to the data points. 
 
We recorded the dose distribution obtained with a SR beam of size 1.5 cm × 
1.0 cm (H × V) at 100 keV with a piece of film of size (5 cm × 18 cm). The 14-cm 
diameter PMMA phantom rotated by 360° at a speed of 15°/s during the irradiation. 
We measured an air kerma rate in the phantom of 21 mGy/s at the central axis of the 
cylinder. The linear profile along the horizontal direction is reported in Figure 2.22. 
As expected because of the principle of dose summation and as already reported in 
the previous sections, the film recorded a dose distribution peaked in the centre of 
rotation for that narrow beam. The flat part of the profile has an extension of about 
1.5 cm, equal to the horizontal size of the irradiating beam, and indicates a target air 
kerma of about 0.6 Gy. The full width half maximum of the distribution is 2-cm 
wide. The air kerma profile outside the target decreases with the distance from the 
axis of rotation with an exponential behaviour, as shown in Figure 2.22. Please note 
that the line profile extended for a width of 18 cm, since the film pieces was larger 
than the diameter of the phantom (14 cm). 
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Figure 2.22: Line dose profile along the horizontal direction evaluated with radiochromic film for the 
irradiation of a single spot in the centre of the 14-cm diameter PMMA phantom. The beam size was 
1.5 cm × 1.0 cm (H×V). The inset shows the 2D air kerma map imaged by film. The cyan continuous 
lines are exponential fits to the left-hand and right-hand side tails of the distribution. 
 
 
Figure 2.23: Experimental setup for dose distribution measurement at AS. Three pieces of 
radiochromic film were placed at mid-plane of the 14-cm PMMA cylindrical phantom. The 
longitudinal section of the phantom was covered with film with the exception of a small rectangular 
area in the centre.  
 
The previous measurement provides the radial dose distribution at mid-plane only in 
the volume directly irradiated with SR beam. In order to evaluate the dose 
distribution in the whole phantom volume, three radiochromic pieces (8.5 cm × 20.3 
cm) were placed at mid-plane in the phantom (Figure 2.23). X-ray beam of size 1.5 
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cm × 2.0 cm (H×V) irradiated the phantom at air kerma rate in phantom of 23.1 
mGy/s. The rotation speed was set at 1°/s. The 2D dose map acquired with 
radiochromic film at mid-plane of the cylinder during a complete rotation of the 
phantom is shown in Figure 2.24. We assembled the images from each film taking 
into account their position during the irradiation. The dark area in the centre along 
the vertical direction corresponds to that non-covered by radiochromic film: pixel 
values in this region were set to 0. The collimated X-ray beam irradiated a volume 
resulting in a rectangular area along the diameter direction on the 2D map with a 
dose target of about 7 Gy in the centre of the phantom. The target is partially visible 
in the dose map. The isodose curves are showed in Figure 2.25. A dose from 2% and 
10% of the maximum value was measured in the phantom area which was not 
directly irradiated by the X-ray beam. This dose is due to the energy released by 
scatter radiation. Figure 2.26 shows the line profiles along the vertical direction 
evaluated at 1 cm (ROI 1 in Figure 2.24) and 5 cm from the cylinder axis (ROI 2 in 
Figure 2.24). Both of profiles were normalized to the maximum value of the 2D dose 
map. They show a peak corresponding to the positions where the ROIs used for the 
profile estimation cross the area directly irradiated by the primary beam. The peaks 
are asymmetric because of the vertical photon distribution of the SR beam. The 
profile at 1 cm from the cylinder axis has a peak value of 100% corresponding to the 
dose target, while a peak value of 23% was estimated from the vertical dose profile 
at 5 cm from the axis. The dose evaluated at 5 cm from the beam centre position in 
the vertical direction was about 5% of the maximum value in ROI 1 and 3% of the 
maximum value in ROI 2. Please note that the part of the radiochromic film was out 
of the phantom and that the phantom top surface was at about 8 cm from the beam 
centre along the vertical direction. 
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Figure 2.24: 2D dose map at mid-plane in a 14-cm PMMA cylindrical phantom. The pixel values 
are air kerma free-in-air in Gy. 
         
Figure 2.25: Isodose Curves obtained using a X-ray beam collimated at 1.5 cm in the horizontal 
direction. The dose distribution was evaluated in a 14-cm PMMA cylindrical phantom. The pixel 
value were normalized to the maximum. The isodose legends in percent of the maximum dose are 
indicated on the subpanel on the right side. 
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Figure 2.26: Vertical average profile evaluated in the radiochromic film dose map at 1 cm (a) and 5 
cm (b) from the cylinder axis at 100 keV. 
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Figure 2.27: 2D dose distributions and evaluated with radiochromic film EBT3 in a 14-cm diameter 
PMMA phantom at 100 keV and b) corresponding line dose profile. The intended dose distribution 
(two foci) was obtained with two rotations by shifting the center of rotation 2.5 cm. 
a) 
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We also investigated the dose distribution produced by two foci irradiation 
with a beam of size 1.5 cm × 1.0 cm (H × V) at 100 keV. Dose painting technique 
reported in section 2.5.1.4 was employed for the irradiation. In particular, two 
irradiations – one per each focus – were performed by shifting 2.5 cm the axis of 
rotation. The rotation speed was set at 15°/s for the first turn and 8 °/s for the second 
one. The air kerma rate in phantom was 21 mGy/s. The dose distribution was 
acquired with a piece of radiochromic film EBT3 (20 cm × 4 cm) at mid-plane in the 
14-cm PMMA phantom (Figure 2.27a). The line dose profile is shown in Figure 
2.27b. The irradiation resulted in a focus of higher dose of about 1.15 Gy and a 
second focus of about 0.8 Gy. The profile also reveals that in the low-dose focus the 
dose decrease with the increment of the distance from the other focus because of the 
overlap of the two dose distributions. 
Finally, an evaluation of the dose due to the scatter radiation in the 14-cm 
diameter PMMA cylinder along the phantom axis was performed with the semiflex 
ionization chamber at 100 keV. The dosimeter was placed in the phantom at 7 cm 
from the top surface. The phantom was translated along the vertical direction in step 
of 5 mm for a total path of 150 mm so that the X-ray beam of size 1.5 cm×2.0 cm 
(HxV) irradiated different sections of the object at each step. The air kerma rate was 
measured at each step. The acquired profile is shown in Figure 2.28. We observed a 
distribution peaked at the phantom position where the X-ray beam directly irradiated 
the ionization chamber. A dose rate 6.2% of the maximum value were evaluated for 
the X-ray beam irradiating the phantom at 5 cm from the ionization chamber. 
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Figure 2.28: Vertical air kerma rate profile evaluated in 14-cm diameter PMMA phantom along the 
cylinder axis with the semiflex ionization chamber at 100 keV. The dose rates were normalized to the 
maximum. 
2.6 Measurements at the European Synchrotron Radiation 
Facility 
The European Synchrotron Radiation Facility (ESRF) is one of the most brilliant 
third generation SR source in the world. It operated at a nominal electron energy of 
6 GeV and a ring current ranging from 40 mA to 200 mA depending on the filling 
mode (see http://www.esrf.eu/home/UsersAndScience/Accelerators.html). The 
ID17 is the beamline dedicated to the biomedical applications such as radiotherapy, 
radiobiology and biomedical imaging. The X-ray source is a multi-pole wiggler 
magnet (W150) with 21 poles (period of 15 cm) and a maximum magnetic field of 
1.6 T at the minimum allowed gap (24.8 mm) (Mittone, 2014b) corresponding to a 
maximal critical energy of 38.1 keV. If a higher photon flux is required, a second 
wiggler (W125) can be employed. W125 has 22 poles (12.5-cm period) and a 
maximum magnetic field of 1.8 T at a gap of 11 mm (Mittone, 2014b). ID17 includes 
two optical hutches corresponding to two experimental hutches. The first 
experimental hutch is at 40 m from the source and is dedicated to study for 
microbeam, mini beam and pencil beam radiotherapy as well as image-guided brain 
surgery by using a filtered white beam in the energy range 40 keV600 keV (see 
http://www.esrf.eu/UsersAndScience/Experiments/CBS/ID17). The experiments 
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with monoenergetic X-ray beam are conducted in the second hutch placed at 150 m 
from the source. The high distance from the source permits to obtain an high degree 
of spatial coherence and an X-ray beam of size up to 150×7mm2 (H×V) 
(http://www.esrf.eu/UsersAndScience/Experiments/CBS/ID17). Two different 
systems of monochromators are available to produce the monoenergetic X-ray beam. 
The first one is a Si-bent Laue crystal used for angiography, the second is a fixed-
exit monochromator composed of two water-cooled bent Si crystals in Laue 
geometry, which can nominally select energy up to 80 keV (Mittone, 2014b, 
http://www.esrf.eu/UsersAndScience/Experiments/CBS/ID17). However, X-ray 
beam with higher energy can be obtained with the monochromator working in 
particular conditions. The measurements performed at ESRF represent an extension 
of the first feasibility study at 60 keV conducted at AS and reported in section 2.5.1. 
The goal was to investigate the use of the SR3T at energy higher than 60 keV. For 
this purpose, the same measurements performed for the feasibility study were taken 
at energies in the range 80175 keV.  
2.6.1 Profile of the X-ray beams 
The X-ray beam was imaged with radiochromic film Gafchromic XR-QA2 at 80, 
100, 120, and 175 keV. The horizontal profiles are shown in Figure 2.29 reporting 
the photon flux normalized at the maximum as a function of the position along the 
horizontal direction.  We observe that the flux distribution turns more and more 
narrow with increasing the photon energy. In addition, beam profiles have a non-
symmetric structure at each energy. In particular, the variation of the beam intensity 
was estimated to be about 25% at 80 keV up to about 50% at 120 keV. The 
asymmetry might be due to the fact that the monochromator crystal was not in 
optimal Bragg position during the measurement. 
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Figure 2.29: Horizontal average profile in a ROI evaluated in the radiochromic film dose map at 80 
keV (a), 100 keV (b), 120 keV (c), and 175 keV (d). The position 0 corresponds to the center of the 
beam. 
 
 
Figure 2.30: Experimental setup for radial dose profile measurement at ESRF, in this image the IC is 
positioned in the central hole of the phantom. The PE phantom was placed on a single PMMA slice 
of thickness 1 cm. 
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2.6.2 Radial Profile in a cylindrical phantom 
The protocol employed for the measurements of the radial dose profile was the same 
used at AS (section 2.5.1.2). The experimental setup is shown in Figure 2.30. The air 
kerma was measured with the pencil ionization chamber (mod. 20x6-3CT, Radcal 
Corp., Monrovia, CA, USA). In contrast to experiment at AS, the PE phantom was 
placed on a single 1-cm thick slice of PMMA. Measurements were carried out at 
energy of 80 keV, 100 keV, 120 keV, and 175 keV. The X-ray beam was collimated 
to 6 mm vertically and to 1.5, 4, 7, or 15 cm horizontally. The same geometry of 
irradiation was reproduced with the MC code (section 2.4). Also in this case, the 
dose evaluation via MC simulation was obtained by scoring the deposited energy 
along 10 cm in the direction of the cylinder axes to reproduce the energy integration 
of the pencil chamber. The radial dose profiles are shown in Figure 2.31 and Figure 
2.32. The dose profile are reported as percentage of the central dose. A dose profile 
peaked at the center of rotation was observed for the collimated beam at each energy. 
In the case of the 15-cm beam width, MC simulations and mesurements show two 
different behaviors for the dose distribution: a cupped profile resulted from the 
simulations and a domed profile from the experimental data. Moreover, the mean 
percentage differences in the dose distribution between experimental values and 
simulations was estimated in the range 415% with a significant difference in the 
cases of 1.5-cm and 15-cm collimated beams (Table 2.6). This discrepancy between 
measurements and simulations is probably due to a misalignment of the PE phantom 
with respect to the X-ray beam. Indeed, a different normalization is obtained when 
the centre of rotation is not on the cylinder axes. In addition, for 15-cm collimated 
beam, since the beam is 1 cm wider than the phantom in the horizontal direction, the 
X-ray beam might not irradiate the entire phantom and therefore the ionization 
chamber might measure a lower dose when placed at the peripheral position. Finally, 
a last contribution to the discrepancy could be due to the beam profile which was 
supposed uniform in the simulation, whilst an asymmetric profile was observed in 
the real case. However, an asymmetric beam profile was also observed at 100 keV 
at AS without any strong influence on the experimental dose distribution which was 
comparable with that obtained via simulations.  
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Figure 2.31: Comparison between the measured (symbols) and simulated (lines) relative air kerma in 
a 14-cm diameter polyethylene cylindrical phantom for beam width of 1.5, 4, 7 and 14 cm at 80 keV 
(a) and 100 keV (b). For the MC simulation, the dose distribution was evaluated by integrating the 
dose along 100 mm in the direction of the cylinder axis. 
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Figure 2.32: Comparison between the measured (symbols) and simulated (lines) relative air kerma in 
a 14-cm diameter polyethylene cylindrical phantom for beam width of 1.5, 4, 7 and 14 cm at 120, and 
175 keV. For the MC simulation, the dose distribution was evaluated by integrating the dose along 
100 mm in the direction of the cylinder axis. 
Table 2.6: Mean percentage difference in the dose distribution between measurements and MC 
simulations evaluated for beam collimations of 1.5, 4, 7, and15 cm at 80, 100, 120, and 175 keV. 
Collimation of X-ray beam 
(cm) 
Mean Percentage Difference (%) 
80 keV  100 keV 120 keV 175 keV 
15 10 ± 9 12 ± 12 4 ± 2 15± 6 
7 5 ± 3 5 ± 3 5 ± 3 7 ± 3 
4 8 ± 7 7± 8 4± 3 4 ± 3 
1.5 13 ± 3 10± 2 9± 2 8 ± 5 
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2.6.3 Assessment of the periphery-to-centre dose ratio with TLD 
Measurements of the periphery-to-centre dose ratio in a PMMA phantom were 
carried out at 100 keV for beam collimation of 1.5 and 15 cm by using TLD-100. 
The TLD response was calibrated in terms of air kerma free-in-air in the range 
0.51.5 Gy at 100 keV following the irradiation protocol used at AS (section 2.5.1.3). 
Figure 2.33 shows the calibration curve, for which a linear fit was used. As for the 
measurements at AS, a 14-cm diameter PMMA phantom with two cavities for the 
dosimeters positioning was employed. The beam height was set at 5 mm. Five TLD 
chips were irradiated at each position and the average of their response was used to 
calculate the dose ratio. The irradiation was also simulated with MC code. The results 
obtained with measurements and MC simulations for beam collimations of 1.5 cm 
and 15 cm are reported in Table 2.7. We calculated a dose ratio of 122% ± 15% for 
a collimation of 15 cm by using the measurements from TLD chips, comparable with 
the ratio obtained from simulations within the experimental error. However, the dose 
ratio measured for a beam collimation of 1.5 cm was not comparable with that from 
simulations. It is quite likely that also in this case the phantom positioning was 
crucial. 
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Figure 2.33: Calibration curve for the response of TLD dosimeters at 100 keV. The continuous line 
is a linear fit to the data points. 
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Table 2.7: Periphery-to-centre dose ratio simulated with MC code and measured with TLD100 for a 
SR beam collimated at 1.5 cm and 15 cm along the horizontal direction at 100 keV. 
Collimation of X-ray beam 
(cm) 
Periphery-to-centre dose ratio 
(%) 
Measurement MC simulation 
15 122± 15 126±2 
1.5 35 ± 5 17±0.3 
 
2.6.4 Dose Painting  
Dose painting technique reported in section 2.5.1.4 was employed to obtain three 
irradiation spots (“tumour foci”) and a linear dose distribution at 100 keV. The dose 
distributions were imaged with radiochromic film EBT3 of size 12 cm × 5 cm (H × 
V) placed at mid-plane of a 14-cm diameter PMMA cylinder phantom. The 
radiochromic film were calibrated in terms of air kerma in PMMA following the 
calibration protocol reported in section 2.5.1. The scanner EPSON V750 PRO was 
used to scan the film in RGB mode (48 bit, TIFF image, 72 dpi). The cross-section 
of SR beam was 1.0 cm × 0.5 cm (H × V). Dose distributions were acquired with 
multiple rotations at a constant speed of 4°/s changing the position of the axis of 
rotation at each rotation. In particular, the axis was shifted by 1.5 cm at each rotation 
for the three foci irradiation, while the shift was 0.5 cm at each rotation in order to 
obtain a “line dose distribution”. Figure 2.34 and Figure 2.35 show the dose 
distribution measured with the radiochromic film. The three foci irradiation (Figure 
2.34a) obtained with three rotations – one rotation per focus – results in three target 
doses of about 400 mGy. In fact, the central focus produced during the first rotation 
shows a flat dose distribution of about 430 mGy, whilst the line profile (Figure 2.34b) 
reveals that in the two lateral foci the dose decreases increasing the distance from the 
central focus. This effect is a consequence of the overlap of the three dose 
distributions. In order to acquire a line dose distribution (Figure 2.35a), five dose 
target were irradiated by shifting the axis of rotation 0.5 cm at each rotation. The line 
profile resulted in a wide-peak distribution with a maximum of about 950 mGy and 
FWHM of 3 cm (Figure 2.35b).  
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Figure 2.34: 2D dose distributions evaluated with radiochromic film EBT3 in a 14-cm diameter 
PMMA phantom at 100 keV. and b) corresponding line dose profile. The intended dose distribution 
(three foci) was obtained with three rotations by shifting the centre of rotation 1.5 cm. 
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Figure 2.35: 2D dose distributions evaluated with radiochromic film EBT3 in a 14-cm diameter 
PMMA phantom at 100 keV. and b) corresponding line dose profile. The intended dose distribution 
(line distribution) was obtained with five rotations by shifting the centre of rotation 0.5 cm. 
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2.7 Ongoing work: Preliminary results of the use of dose-
enhancement agent 
The use of the contrast-enhancement agents for synchrotron radiation radiotherapy 
was studied with experiment in vitro (Estève et al, 2002, Corde et al., 2004, Bobyk 
et al, 2013) and in vivo (Adam et al, 2003, Adam et al, 2005, Adam et al, 2006, 
Obeid et al, 2014, Balosso et al, 2014, Bräuer-Krish et al, 2015). Measurements of 
dose enhancement factor with dosimeter are difficult because the dose-enhancement 
agent should be injected in the active volume of the dosimeter. However, techniques 
based on unlaminated radiochromic film (Morris et al, 2006, Rakowski et al, 2015) 
as well as 3D gel (Boudou et al, 2007, Rahman et al, 2012) were proposed in the 
literature. 
 We carried out a preliminary study on the use of iodinated solutions and gold 
nanoparticles for SR3T by measuring the air kerma in the solutions with 
radiochromic film EBT3 as well as the X-ray transmission from radiographic images 
at 60, 80, and 100 keV at IMBL of AS. The measurements with radiochromic film 
is based on the idea that the increased X-ray absorption in the solution in which the 
radiochromic films were immersed determines the decrease of the air kerma at the 
surface of the dosimeter. A 10-cm diameter PMMA phantom with a central cavity 
of diameter 2.5 cm was employed for measurements. The cavity was filled with 10 
ml of iodinated solutions containing different amount of contrast agent (320 mg I/ml, 
32 mg I/ml, 3.2 mg I/mg, 1 mg I/ml) or 10-ml stabilized suspensions in citrate buffer 
of gold nanoparticles with size 5, 20, or 100 nm (Sigma-Aldrich, Inv., Germany). 
The nanoparticles concentrations in the solutions were about 5.5×1013 particles/ml, 
6.5×1011 particles/ml, 3.9×109 particles/ml for 5-nm, 20-nm, 100-nm diameter 
nanoparticles, respectively (http://www.sigmaaldrich.com/technical-
documents/articles/materials-science/nanomaterials/gold-nanoparticles.html). The 
cross-section of SR beam was 16 cm × 2 cm (H × V). 
Measurements with radiochromic film 
In order to measure the air kerma in the solution, pieces of radiochromic film EBT3 
(2.5 cm × 4 cm) were immersed in the medium in the phantom cavity with the longer 
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side parallel to the cylinder axis and were irradiated by the SR beam from a single 
angle. The phantom was translated through the beam along the vertical position with 
a constant speed of 5 mm/s at 60 keV, 2.5 mm/s at 80 keV, and 1 mm/s at 100 keV. 
The air kerma rate was 450 mGy/s, 181 mGy/s, and 69 mGy/s at 60, 80, and 100 
keV, respectively. The radiochromic film were scanned in RGB scanning mode (72 
dpi, 48-bit, TIFF image) by using a flat-bed scanner EPSON V700 PHOTO available 
at IMBL and calibrated in terms of air kerma free-in-air. 
The comparison of the air kerma measured with the radiochromic film in air, water 
and in the solutions containing iodine or gold nanoparticles is shown in Figure 2.36. 
The figure shows average pixel value in the film image evaluated in a ROI of size 
0.3 cm × 1.0 cm (see Figure 2.37) and corresponding measurement uncertainty. The 
air kerma measured in water is indicated with a horizontal dash line on the graph. 
The lowest air kerma was measured in the iodinated solution with 320 mg I/ml at 
each energy: 13%, 38%, and 54% of the air kerma evaluated in water at 60, 80, and 
100 keV, respectively. The doses measured in solutions with gold nanoparticles were 
comparable to that estimated in water within the measurements uncertainty at 60 keV 
and 80 keV. This indicates that the concentration of gold nanoparticles in the solution 
is too low and that the solutions shows energy absorption similar to water. On the 
other hand, the air kerma in solutions of 20-nm diameter gold nanoparticle as well 
as 100-nm diameter gold nanoparticles is lower than air kerma evaluated in water at 
100 keV. We note that the absorption K-edge of gold is at 80.734 keV (Figure 2.38), 
so that the result at 100-keV photon energy may take into account the photoelectric 
interaction with K-shell electrons, in addition to L-shell electrons as may occur with 
60 keV and 80 keV photons.  
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Figure 2.36: Comparison of the dose measured with radiochromic film EBT3 in air, water, iodinated 
solutions with different concentration of iodine (320 mg I/ml, 32 mg I/ml) and solutions of gold 
nanoparticle of different size (5nm, 20 nm, 100 nm). The comparison is reported at 60 keV (a), 80 
keV (b) and 100 keV (c). The radiochromic film was calibrated in terms of air kerma free-in-air. The 
dose was estimated as the average pixel value in a ROI of size (0.3 cm × 1.0 cm) on the films. The 
horizontal dash line indicated the dose value measured when the film was immersed in water. 
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Figure 2.37: Dose map imaged with radiochromic film at 60 keV. The film was immersed in a 
iodinated solution with a concentration of 320 mg I/ ml. The ROI used for the dose evaluation is 
shown.  
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Figure 2.38: Absorption coefficient of air, water, iodine and gold as function of photon energy. The 
values were estimated with the XMuDat software (Nowotny, 1998). 
Measurements with radiographic image 
The measurements with radiographic image were based on estimation of X-
ray transmission defined by the Lambert-Beer Law: 
𝑰
𝑰𝒐
= 𝒆−𝝁𝒙     (2.1) 
where I is the transmitted beam intensity and I0 is the incident beam intensity.  
Radiographic images were acquired with a Hamamatsu C9252DK-14 flat panel 
detector featuring a 200 m pitch and a 1-mm thick CsI:Tl scintillator. The detector 
was at 6 m from the sample. The X-ray transmission image was obtained by dividing 
the images acquired with phantom on the beamline by a flat field image (obtained 
without phantom). We assumed the linear response of the detector after dark field 
correction. Figure 2.39 shows the comparison of the X-ray transmission evaluated 
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for each medium filling the phantom cavity. In particular, the average and standard 
deviation of the pixel values in a ROI of size (0.3 cm × 1.0 cm) (Figure 2.40) was 
estimated. The iodinated solutions with high concentration of iodine (320 mg I/ml 
and 32 mg I/ml) yield a transmission signal lower than that from water at each 
energy. This is due to the greater X-ray attenuation coefficient of iodine with respect 
to water (Figure 2.41). We also observe that the solution with a higher concentration 
of iodine caused a greater attenuation of the X-ray beam resulting in a lower X-ray 
transmission. The X-ray transmission produced by the solutions with gold 
nanoparticles as well as that from iodinated solutions with a low concentration (3.2 
mg I/ml and 1 mg I/ml) is comparable to that obtained for water at each energy 
indicating a too low concentration of dose-enhancement agents in the solutions. 
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Figure 2.39: Comparison of the X-ray transmission acquired with Hamamatsu C9252DK-14 flat panel 
detector. The phantom cavity was filled with air, water, iodinated solutions with different 
concentration of iodine (320 mg I/ml, 32 mg I/ml, 3.2 mg I/ml, 1 mg I/ml) and solutions of gold 
nanoparticle of different size (5nm, 20 nm, 100 nm). The comparison is reported at 60 keV (a), 80 
keV (b) and 100 keV (c). The X-ray transmission was estimated as the average of pixel values in a 
ROI of size (0.3 cm × 1.0 cm). The horizontal dash line indicates the transmission value measured 
when cavity was filled of water. 
 
Figure 2.40: Crop of the 2D map of X-ray transmission at 60 keV with the cavity filled of iodinated 
solution with a concentration of 32 mg I/ ml. The ROI used for the transmission evaluation is shown. 
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Figure 2.41: Attenuation coefficient of air, water, iodine and gold as function of photon energy. The 
values were estimated with the XMuDat software (Nowotny, 1998). 
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2.8 Discussion  
In this part of the thesis work, we provided a proof-of-principle showing the 
feasibility of the external beam radiotherapy for breast cancer treatment with SR at 
low energy (60 keV – 120 keV) with measurements performed at AS, ESRF and MC 
simulation. 
We showed that the shape of the dose distribution in a PE cylinder phantom 
depends on the SR beam collimation. The beam collimation in the direction 
perpendicular to the phantom axis produces a dose distribution peaked at the centre 
of rotation. In particular, we showed that it is possible to obtain a focus of dose in 
the centre of rotation with a dose to the skin of about 14% of the target dose at 60 
keV, for a beam collimation of 1.5 cm and the centre of rotation, corresponding to 
the tumour position, on the cylinder axis. The periphery-to-dose ratio was 12.5% at 
80 keV and 11 % and 100 keV. These values are comparable to that of 10 % obtained 
via MC simulation at 175 keV, in the same irradiation conditions. This last energy 
produces the same depth-dose distribution of an orthovoltage X-ray tube operating 
at 300 kVp (De Lucia, 2015). For comparison, Prionas et al, 2012 reported a dose 
to the skin <7% of the maximal dose for 320 kVp X-ray beam collimated at 1 cm, 
while Breitkreutx et al. (2017) in the feasibility study of KVAT at 200 kV reported 
lesion-to-skin ratio of 2.3 and 3.3 for lesion of 4 and 3 cm, respectively. In terms of 
tumour-to-skin dose ratio, for a target "tumour" in the centre of the phantom, the 
tumour-to-skin dose ratio was evaluated between 7.4 at 60 and 9.5 at 175 keV, 
respectively (this ratio is about 7 for 6-MV clinical beams, see Podgorsak, 2005).  
In the study performed at 60 keV at AS, periphery-to-centre dose ratio measured 
with TLDs at 4 cm from the cylinder axis [(24 ± 3)%] was comparable with that 
obtained via MC simulation. A similar agreement was observed for the same 
mesurements performed at ESRF at 100 keV for 15-cm collimated beam. On the 
other hand, a discrepancy of 50% between simulated and experimental data from 
ESRF was evaluated for a 1.5-cm width beam. 
The measurements performed with SR beam at ESRF and with the orthovoltage 
X-ray tube in the Dept. of Physics of Università di Napoli Federico II highlighted 
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that the accuracy of the beam collimation and the alignment of the sample with 
respect to X-ray beam are critical issue for SR3T. 
The dose painting feasibility was demonstrated with both MC simulations and 
measurements with radiochromic films in a 14-cm PMMA cylinder phantom. Non-
uniform dose distributions can be obtained by using multiple rotations, by shifting 
the centre of rotation and changing the rotation speed. In particular, we reproduced 
two off-centre foci and line dose distribution at 60 as well as 100 keV and a three 
off-centre foci at 100 keV. Different dose profiles were observed inside the foci 
depending on their position along the diameter and the overlap of the tails of dose 
distributions produced at each rotation. For dose painting, the comparison between 
simulated data and experimental data acquired with radiochromic film showed a 
systematic overestimation of simulated data with respect to the measurements at 60 
keV. This disagreement suggests the need to improve the study of EBT3 response to 
X-ray beam at low energy in the irradiation condition used for SR3T. Albeit we 
demonstrated the proof of principle of dose painting, the constraints stressed by 
Prionas et al (2012) – beam collimation accuracy, lesion proximity to the skin surface 
and chest wall, total treatment time – are still present.  
We also examined the use of low energy photon beams with a dose-enhancement 
agent. The availability of a monoenergetic X-ray beam with high dose rate combined 
with the use of possible dose-enhancement agents or contrast agents (e.g. iodinated 
solution or gold nanoparticles) would permit to optimize the breast irradiation by 
selecting the best SR beam energy. In particular, the use of low photon energy (e.g. 
120 keV or lower, with respect to MV photon energy of conventional radiotherapy) 
could increase the photoelectric absorption and hence increase the dose deposit in 
the region of accumulation of the radiosensitizer. In particular, the use of an iodinated 
medium (commonly adopted for contrast enhanced mammography) whose in vivo 
biochemical kinetics is well investigated, could be an advantageous addition to the 
technique, for dose enhanced SR3T (DE-SR3T technique). In order to investigate the 
use of the dose-enhancement agents (iodine and gold nanoparticles), we employed a 
technique based on the measurement of air kerma in the solution containing the 
radiosensitizer with radiochromic film EBT3 and another technique based on the 
evaluation of the X-ray transmission through the solution from radiographic images. 
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Both these technique do not permit to evaluate the dose-enhancement effect directly. 
However, effect of the use of different materials on the dose or on the X-ray 
transmission can be estimated.  
We note that the available air kerma rate free-in-air (e.g. 2.22 Gy/min at 60 keV 
at AS) can be comparable with the one adopted in conventional radiotherapy with 
MV X-ray beams (about 0.5 Gy/min) (Prionas et al, 2012) by using an appropriate 
beam filtration. As regards a future SR3T treatment session, taking as reference a 1-
min rotation time, the necessity of multiple rotations/translations of the patient bed 
for covering the tumor volume with the available beam size might require a scan 
time in the range of e.g. 10 min. This would be higher than the typical irradiation 
time for the single fraction of conventional breast radiotherapy. During the scan the 
breast should be immobilized in a suitable holder. With a dose rate of about 2 
Gy/min, a therapy session may deliver a tumor dose in the order of 2 Gy, as in a 
single fraction of fractionated conventional plan (25 fractions). However, we noted 
that a significantly higher dose rate is available for SR3T at SR sources, which would 
permit hypo-fractionated treatment plans with the same irradiation times.  
In addition, image guided SR3T (with or without contrast enhancement) can be 
performed, permitting real-time computed tomography imaging with additional 
delivery of glandular doses in the order of few mGy (Mettivier et al, 2016). 
Moreover, the use of a radio-sensitizer can also improve the performance of the 
imaging. Prionas et al (2010) reported the results of the first clinical trial of contrast-
enhanced BCT showing an improvement of the conspicuity of malignant breast 
lesion with respect unenhanced breast CT and a visibility of malignant calcification 
similar to mammography. They also calculated the lesion enhancement “as the 
difference between lesion intensity normalized to the adipose tissue intensity in pre-
contrast and post-contrast images” Prionas et al (2010) estimating an enhancement 
of 55.9 HU ± 4.0 and 59. HU ± 2.8 for malignant lesions and ductal carcinoma in 
situ, respectively. They also evaluated the benign lesions enhanced 17.6 HU ± 6.1 
Prionas et al (2010). 
Potential application of SR3T technique are limited fractions rotational 
radiotherapy, radiotherapy boost and small lesion irradiation. Sites potentially 
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suitable for SR3T are the AS in Melbourne, Australia, ESRF in Grenoble, France, 
and CLS in Saskatoon, Canada. 
The work reported in this thesis represents the starting point of the study on this 
new radiotherapy technique and shows its potential with dosimetric studies. In the 
next future, radiobiological studies will be performed in order to compare the 
radiobiological response of the breast cells to the SR3T irradiation to that obtained 
with a conventional radiotherapy irradiation.  
We foresee several possible implementations of the technique in order to resolve 
some critical issues showed in this work. A possible reduction of the number of 
rotations or translations for the treatment of large lesion could be obtained with spiral 
scan, or rotational scan over 180°, or a curved scan trajectory. We expected a spiral 
trajectory in a rotational scan around the tumour produces less dose to the skin than 
compared to circular orbit scan, as recently investigating by M. Donzelli at ESRF 
(Bräuer-Krisch, 2016). In addition, we have observed that in the case of multiple-
foci irradiations the use of a beam with a constant intensity during the rotational 
irradiation produces target doses with an uneven distribution. We suggest that an 
intensity modulation of the X-ray beam during the rotation could overcome this 
issue. The modulation could be obtained by using a combination of attenuators (e.g. 
PMMA attenuator) moving through the beam. The shape of attenuators can be 
studied in combination with its movement to obtain the desired intensity modulation 
during the treatment. The proposed technique is similar to that used in proton therapy 
for energy-modulation of the beam (Cirrone et al, 2004).  
Finally, we remind that the SR source also provides a polychromatic X-ray beam 
with high photon flux (pink or white beam), which is used for study of microbeam 
radiotherapy. These polyenergetic sources could be adopted for breast SR3T as well. 
We forsee an interesting application of the microbeam radiotherapy (MRT) to the 
breast in combination with the rotational or spiral irradiation of SR3T. A proposal 
together with scientist at CLS in Canada has been submitted recently by the medical 
physics group in Napoli to study this last application. 
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Conclusions 
 
Breast imaging techniques employing X-rays have undergone fundamental changes 
in the last two decades, with the introduction of 3D imaging techniques like DBT 
and cone-beam breast CT. SR research on breast imaging may play an important role 
in investigating the limits and potential of new dedicated techniques for 2D and 3D 
breast imaging, by exploiting the energy tunability and high spatial coherence of SR 
beam. In particular, phase-contrast breast mammography with SR and phase-contrast 
breast tomography with SR are under investigation. A leading international activity 
is carried out at the SYRMEP beamline of ELETTRA synchrotron radiation facility. 
I was involved since the beginning of the breast CT project at ELETTRA, as reported 
in the first part of this thesis. We showed the feasibility of the technique, under strict 
dosimetric limits which require a total glandular dose during the CT scan, not higher 
than the mean glandular dose of conventional two-view mammography. In order to 
prepare a future clinical protocol for breast CT with SR, both beam dosimetry and 
phantom dosimetry issues must be assessed, together with quality assurance 
procedures. As result of my work, an assessment has been provided of the energy 
dependent response of dosimeters adopted in the SYRMA-CT project.  
However, SR is an intense light source, whose dose rates are large enough to 
conceive its use for radiotherapy of breast cancer in addition to imaging of breast 
cancer. On the basis of the experience gained during my activity within SYRMA-CT 
project for breast CT, I performed a series of experiments at major SR centres (ESRF 
in Europe and AS in Australia) which represent the first experimental validation of 
the feasibility of a new radiotherapy technique for breast cancer. This technique is 
based on the rotation of the patient support table and a pendant breast, so that the 
fixed laminar SR beam irradiates the tumour in a circular orbit (or in a spiral orbit). 
The principle for this new SR3T technique relies on the spatial summation of the 
absorbed dose at kilovoltage energies along the axis of rotation passing through the 
tumour site. The very exciting possibility of introducing such a new experimental 
technique for breast cancer radiotherapy can now be founded on the very large 
dataset of measurements with breast phantoms reported in the second part of this 
thesis. In particular, the use of energy photons (in the range 60–120 keV) for breast 
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radiotherapy might open the way for higher photoelectric absorption and increased 
dose-enhancement factor when using radiosensitizing agents (e.g. gold 
nanoparticles) as under investigation for conventional radiotherapy. Moreover, due 
to the presence of an intense transmitted X-ray beam during a SR3T treatment, 
image-guided SR3T might be implemented, so as to localise during the treatment the 
irradiation target. Finally, the use an iodinated contrast agent can be envisaged as 
well for enhanced tumour contrast. 
 The research work exposed in this thesis is still ongoing, with new, exciting, 
scientifically stimulating observations to be expected in the next years. 
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Final remarks 
 
The work presented in this thesis demonstrated, for the first time, the 
possibility to employ the same setup based on SR to perform diagnostic breast 
computed tomography as well as image-guided breast rotational radiotherapy, by 
suitably tuning the energy, the shape and the intensity of the SR beam. In this setup, 
the patient lies prone on a translating/rotating bed with a hole for the pending 
uncompressed breast and the SR beam irradiates the organ during a complete or 
partial rotation of the bed. The use of the low energy beam (between 30 and 40 keV) 
with low dose rate (in the order of a few mGy/min) permits to perform diagnostic 
CT breast imaging, while radiotherapy applications can be investigated by using a 
high energy SR beam (60–120 keV) with high dose rate (several Gy/min). 
In the first part of this thesis, we have demonstrated how the high spatial 
coherence of the SR beam together with the use of a high-efficiency single-photon 
counting detector provided optimal conditions to perform phase-contrast breast CT. 
PhC-BCT imaging of a breast mastectomy specimen produced high-contrast and 
high-resolution maps of the tissue structures after retrieving the phase-map. We have 
also demonstrated that the use of the conventional clinical dose metric, MGD, can be 
not adeguate in the case of partial breast irradiation planned in the SYRMA-CT/3D 
project and can produce an underestimate of the risk from radiation. We introduced 
new dose metrics, MGDV and MGDT, which take into account the partial irradiation 
geometry. MGDV provides an estimate of the mean glandular dose in the irradiated 
tissue slice evaluated as the ratio of energy released in the irradiated slice by the 
glandular mass which was directely irradiated with X-ray beam, mg, , while MGDT  
is defined as the ratio of the energy released in the whole breast, and the masss mg. 
A complete characterization of TLD and radiochromic film dosimeters which will 
be used for phantom and beam dosimetry was also carried out in this thesis. Finally, 
we have assessed for the SYRMA-CT/3D setup a spatial resolution higher than that 
of cone-beam BCT systems present in the literature. 
In the second part of the thesis, we have demonstrated that the BCT setup can 
be used for radiotherapy application by changing the energy and the dose rate of the 
SR beam. We have showed the feasibility of the rotational breast radiotherapy with 
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SR at energies in the range 60–120 keV with MC simulations and experiments on 
phantoms. The use of low photon energy would provide a higher dose-enhancement 
when a radiosensitizing (e.g. gold nanoparticles) is used for breast radiotherapy. This 
new technique could be promising for the treatment of the small lesion and hypo-
fractionated radiotherapy, with a skin-to-lesion dose ratio comparable to that of 
conventional radiotherapy for lesion at the centre of the breast. The use of the same 
platform developed for BCT also permits to perform radiotherapy in the same 
geometry as for the diagnostic imaging. This could also reduce the issues due to the 
patient repositioning during fractionated radiotherapy. In addition, the use of an 
imaging detector during the treatment would permit to perform an image-guided 
radiotherapy.  
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